Cancer Guide Blog

Subscription Confirmation

2009-07-28T13:02:00.001-07:00

Dear Subscriber,

You are no longer subscribed to any newsletters from The HealthCentral Network.

If you are receiving this in error and wish to continue receiving newsletters, please click here to change your subscriptions now.

Sincerely,

The MyBreastCancerNetwork.com Team

If you have questions or comments about this newsletter or about our newsletter service in general, please contact us at comments@healthcentral.com.

Read our privacy policy

HealthCentral
2300 Wilson Blvd, #600
Arlington, VA 22201
(c) 2009 The HealthCentral Network, Inc. All rights reserved.

Subscription Confirmation

2009-07-21T11:32:00.001-07:00

Dear Subscriber,

You are no longer subscribed to any newsletters from The HealthCentral Network.

If you are receiving this in error and wish to continue receiving newsletters, please click here to change your subscriptions now.

Sincerely,

The MyBreastCancerNetwork.com Team

If you have questions or comments about this newsletter or about our newsletter service in general, please contact us at comments@healthcentral.com.

Read our privacy policy

HealthCentral
2300 Wilson Blvd, #600
Arlington, VA 22201
(c) 2009 The HealthCentral Network, Inc. All rights reserved.

Subscription Confirmation

2009-04-27T15:20:00.001-07:00

Dear Subscriber,

You are no longer subscribed to any newsletters from The HealthCentral Network.

If you are receiving this in error and wish to continue receiving newsletters, please click here to change your subscriptions now.

Sincerely,

The MyBreastCancerNetwork.com Team

If you have questions or comments about this newsletter or about our newsletter service in general, please contact us at comments@healthcentral.com.

Read our privacy policy

HealthCentral
2300 Wilson Blvd, #600
Arlington, VA 22201
(c) 2009 The HealthCentral Network, Inc. All rights reserved.

Medical News Today News Alert

2008-12-29T23:01:00.000-08:00

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

UM Nobel Laureate Researcher Discovers Antioxidant Activity Of Growth Hormone-Releasing Hormone Antagonists
http://www.medicalnewstoday.com/articles/134037.php
Researchers at the University of Miami Miller School of Medicine have discovered the antioxidant activity of growth hormone-releasing hormone (GHRH) antagonists in cancers. This discovery could lead to novel therapies against various cancers as well as neurodegenerative diseases, such as Alzheimer's.

PAION And ERGOMED Complete Enrolment Of Phase IIa Study With CNS 5161 In Opioid-Refractory Cancer Pain
http://www.medicalnewstoday.com/articles/134032.php
The biopharmaceutical company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8; London AIM: PAI) and ERGOMED Clinical Research Limited today announce the completion of an open-label, single-centre Phase IIa study with PAION's intravenous NMDA receptor antagonist CNS 5161.

Researchers Create Smaller, Brighter Probe Tailored For Molecular Imaging And Tumor Targeting
http://www.medicalnewstoday.com/articles/134013.php
Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic.

Mutations Common To Cancer And Developmental Disorder Examined In A Novel Disease Model
http://www.medicalnewstoday.com/articles/134003.php
New research sheds light on a common link between tumor formation and Costello Syndrome, an inherited developmental disorder in which patients have cardiac defects, mild mental retardation, and face-shape abnormalities.

E. coli Engineered To Produce Important Class Of Antibiotic, Anti-cancer Drugs
http://www.medicalnewstoday.com/articles/133993.php
Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have taken a major step forward in the field of metabolic engineering, successfully using the bacterium Escherichia coli to synthesize a class of natural products known bacterial aromatic polyketides, which include important antibiotic and anticancer drugs.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Drinkers With The Alcohol Dehydrogenase 1C*1 Gene Are At Greater Risk Of Colorectal Cancer
http://www.medicalnewstoday.com/articles/133901.php
Chronic drinking is a risk factor for colorectal cancer, possibly through the effects of acetaldehyde, which is created by the alcohol dehydrogenase (ADH) enzyme. This study investigated if a polymorphism of the ADH1C gene that is found in Caucasians may effect acetaldehyde concentrations.

----------------------------------------------
** LUNG CANCER News **

Common Food Additive Found To Increase Risk And Speed Spread Of Lung Cancer
http://www.medicalnewstoday.com/articles/134041.php
New research in an animal model suggests that a diet high in inorganic phosphates, which are found in a variety of processed foods including meats, cheeses, beverages, and bakery products, might speed growth of lung cancer tumors and may even contribute to the development of those tumors in individuals predisposed to the disease.

SNPs Of ABC Transporter Genes Linked To Lung Cancer Risk
http://www.medicalnewstoday.com/articles/134028.php
Individuals with particular variants of certain genes involved in metabolizing the most potent carcinogen found in cigarette smoke have an increased risk of developing lung cancer. That is the conclusion of a new study published in the February 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Medical News Today News Alert

2008-12-28T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

MRI Scans Funded For Younger Women At High Risk Of Breast Cancer, Australia
http://www.medicalnewstoday.com/articles/134002.php
National Breast and Ovarian Cancer Centre welcomes the addition of two new items to the Medicare Benefits Schedule (MBS) for the use of Magnetic Resonance Imaging (MRI) in the surveillance and diagnosis of women under 50 years of age at high risk of developing breast cancer.

----------------------------------------------
** CANCER / ONCOLOGY News **

Oncology Specialists Get More Connected With Patients - National Cancer Action Team Programme
http://www.medicalnewstoday.com/articles/134019.php
An innovative experiental programme to help cancer clinicians improve communication with patients and their families has just been launched by the National Cancer Action Team (NCAT). The NCAT communication skills programme, 'Connected', is designed to equip senior healthcare professionals in oncology with the communication skills necessary for the delivery of high-quality care.

Cancer Institute Of New Jersey Receives Nearly $768,000 To Investigate A New Therapeutic Path Against Melanoma
http://www.medicalnewstoday.com/articles/133917.php
With 2,300 New Jersey residents diagnosed with melanoma this year, the Garden State ranks sixth in the nation in new cases of the disease, according to the American Cancer Society. It is that statistic on which a scientist at The Cancer Institute of New Jersey (CINJ) hopes to have impact, thanks to a $768,000 grant awarded by the American Cancer Society to study melanoma development.

Newly Found Enzymes May Play Early Role In Cancer - Zebrafish Study Suggests New Targeted Treatment
http://www.medicalnewstoday.com/articles/133916.php
Researchers have discovered two enzymes that, whencombined, could be involved in the earliest stages of cancer. Manipulatingthese enzymes genetically might lead to targeted therapies aimed at slowingor preventing the onset of tumors.

Paediatric Patient Treated Using RapidArc™ Radiotherapy Technology In Switzerland
http://www.medicalnewstoday.com/articles/133914.php
A Swiss cancer clinic is among the first in the world to use a new, faster radiotherapy technology from Varian Medical Systems (NYSE: VAR) to treat a child patient. A 12-year-old girl with Hodgkin's lymphoma was treated using Varian's RapidArc™ technique at the Oncology Institute of Southern Switzerland (IOSI) in Bellinzona.

Study Of New Drug To Stimulate Immune System Of Cancer Victims: TGen, Scottsdale Healthcare, Mayo Clinic
http://www.medicalnewstoday.com/articles/133889.php
The Translational Genomics Research Institute (TGen), Scottsdale Healthcare and Mayo Clinic are testing a new drug that could help cancer patients by stimulating the immune system.Clinical trials of the drug VTX-2337 are being conducted at TGen Clinical Research Services at Scottsdale Healthcare, a partnership of Phoenix-based TGen and Scottsdale-based Scottsdale Healthcare Corp.

First Lung Lesion And First Lymph Node Metastasis Treated With AngioDynamics' IRE Technology At Australia's The Alfred Hospital
http://www.medicalnewstoday.com/articles/133852.php
AngioDynamics, Inc. (NASDAQ:ANGO) announced the use of its Irreversible Electroporation (IRE) technology on a lymph node metastasis and the first lung lesion case, at The Alfred in Melbourne, Australia.

Clinical Outcome Following Prostatic Capsule- And Seminal-Sparing Cystectomy For Bladder Cancer In 25 Men
http://www.medicalnewstoday.com/articles/133754.php
UroToday.com - In a recent article in the Scandinavian Journal of Urology and Nephrology, the authors evaluated the long-term outcomes of 25 men who underwent a prostate capsule- and seminal-sparing cystectomy.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Ingredient In Cough Medicine Could Effectively Treat Prostate Cancer
http://www.medicalnewstoday.com/articles/133891.php
A study published in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-27T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Researchers Stress Cancer Cells To Improve Treatment
http://www.medicalnewstoday.com/articles/134069.php
South Dakota State University scientists are investigating whether "stressing" cancer cells can make cancer radiation treatment and chemotherapy more effective.Professor Xiangming Guan of SDSU's Department of Pharmaceutical Sciences explained that when cancer cells are tired out, they are easier to kill using free radicals, the basic mechanism behind radiation and some chemotherapy drugs.

Northwest Biotherapeutics Reports Encouraging Data On First Patients Who Have Completed Its Phase I/II Clinical Trial Of DCVax(R)-L In Ovarian Cancer
http://www.medicalnewstoday.com/articles/134058.php
(OTC Bulletin Board: NWBO; AIM: NWBT and NWBS) Northwest Biotherapeutics, Inc. ("NWBT") announced encouraging data on clinical responses in the first two case reports of patients who have completed the Company's Phase I/II clinical trial with DCVax(R)-L personalized cancer vaccine for recurrent, metastatic ovarian cancer.

Sixth Annual Gastrointestinal Cancers Symposium Press Program Announced
http://www.medicalnewstoday.com/articles/133820.php
The sixth annual Gastrointestinal (GI) Cancers Symposium Press Program will highlight research on the prevention, screening and treatment of GI cancers. Study authors will discuss four notable studies in an embargoed presscast (press briefing via live webcast) on Tuesday, January 13 from 12:00-1:30 PM (EST).

Colonoscopy Significantly Reduces Death From Left-Sided Colon Cancer But Not From Right-Sided Colon Cancer
http://www.medicalnewstoday.com/articles/133811.php
Colorectal cancer is the second-leading cause of cancer death in North America. Colonoscopy is the "gold standard" for evaluation of the colon. Now, a new study published in Annals of Internal Medicine finds colonoscopy may not be as effective as previously believed.

FDA Clears Covidien's Evident™ Microwave Ablation System For Use In Nonresectable Liver Tumor Ablation
http://www.medicalnewstoday.com/articles/133800.php
Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products , today announced that the United States Food and Drug Administration (FDA) has issued a 510(k) marketing clearance for the Evident™ Microwave (MW) Ablation System, intended for use in the ablation of nonresectable liver tumors.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

FDA Approves Drug That Boosts Stem Cell Yield For Bone Marrow Transplants
http://www.medicalnewstoday.com/articles/133824.php
The U.S. Food and Drug Administration approved Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-26T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Glivec Receives US Approval As First Treatment To Reduce Risk Of Cancer Returning In Patients With Gastrointestinal Stromal Tumors
http://www.medicalnewstoday.com/articles/133953.php
Novartis announced that Glivec® (imatinib) has been approved by the US Food and Drug Administration (FDA) for the post-surgery treatment of adult patients following complete surgical removal of Kit (CD117)-positive gastrointestinal stromal tumors (GIST).

Newly Identified Gene Powerful Predictor Of Colon Cancer Metastasis - Low Gene Activity - Higher Survival Rate
http://www.medicalnewstoday.com/articles/133796.php
Cancer Researchers at the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch and the Charite - Universitats Medizin Berlin (Germany) have identified a gene which enables them to predict for the first time with high probability if colon cancer is going to metastasize.

Prophylactic Antibiotics, Air Quality Control And Barrier Isolation Combined Reduce Mortality In High-Risk Cancer Patients Receiving Chemotherapy
http://www.medicalnewstoday.com/articles/133794.php
A combination of prophylactic antibiotics, barrier isolation and air quality control measures substantially reduces the risk of death in high-risk cancer patients who are immunocompromised due to chemotherapy or stem cell transplantation.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

----------------------------------------------
** LUNG CANCER News **

PharmaMar Announces The Initiation Of Phase II Studies With Irvalec®
http://www.medicalnewstoday.com/articles/133805.php
PharmaMar, a biotechnology company from Zeltia Group, announces the initiation of a Phase II multicenter study of Irvalec® in patients with non- microcitic lung cancer. The study will test the therapy in patients who have undergone platinum based chemotherapy.

Merck Serono Acquires Manufacturing Rights And Facility For Stimuvax From Oncothyreon
http://www.medicalnewstoday.com/articles/133798.php
Merck Serono, a division of Merck KGaA, announced recently that it has modified the license from Oncothyreon to include the right to manufacture Stimuvax® (BLP25 liposome vaccine) and also has purchased current inventory and certain assets used for the manufacture of Stimuvax from Oncothyreon Inc.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Change Determinants In PSA Over Time - Its Association With Recurrence After External Beam Radiation Therapy For Prostate Cancer In 5 Large Cohorts
http://www.medicalnewstoday.com/articles/133737.php
UroToday.com - In the November 1, 2008 issue of International Journal of Radiation Oncology, Biology, Physics, Dr. CÃ©cile Proust-Lima and colleagues presented a linear mixed model to construct patient PSA profiles after radiotherapy (XRT) for prostate cancer (CaP).

Oncologic Outcome After Laparoscopic Radical Prostatectomy: 10 Years Of Experience
http://www.medicalnewstoday.com/articles/133734.php
UroToday.com - Long-term oncologic outcomes for laparoscopic radical prostatectomy (LRP) are lacking. In the online edition of European Urology, Dr. Karim Touijer and associates from Dr.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-25T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Groundbreaking, Inexpensive, Pocket-sized Ultrasound Device Can Help Treat Cancer, Relieve Arthritis
http://www.medicalnewstoday.com/articles/133840.php
A prototype of a therapeutic ultrasound device, developed by a Cornell graduate student, fits in the palm of a hand, is battery-powered and packs enough punch to stabilize a gunshot wound or deliver drugs to brain cancer patients.

Prozac: Not Just For Depression
http://www.medicalnewstoday.com/articles/133784.php
Prozac is regularly prescribed to ease the emotional pain of patients who are being treated for cancer. But can this common anti-depressant help to fight cancer itself?Dr. Dan Peer of the Department of Cell Research and Immunology at Tel Aviv University is proving that it can.

The Von Hippel-Lindau Gene: Turning Discovery Into Therapy
http://www.medicalnewstoday.com/articles/133732.php
UroToday.com - Cancer remains a leading cause of morbidity and mortality in the United States. Efforts to reduce the pain and suffering due to cancer have met with some successes over the last several decades.

The Use Of Urovysion™ Fluorescence In Situ Hybridization In The Diagnosis And Surveillance Of Non-Urothelial Carcinoma Of The Bladder
http://www.medicalnewstoday.com/articles/133730.php
UroToday.com - Urothelial carcinoma accounts for 90-95% of bladder cancers in the Western hemisphere. In the United States alone, 120,400 new cases were diagnosed in 2007 with 27,340 related deaths in the same year.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Gilda's Club Worldwide Spells 'HOPE' To Colon Cancer Patients And Survivors
http://www.medicalnewstoday.com/articles/133830.php
Cancer advocacy organization Gilda's Club Worldwide offers a message of hope this holiday season to the millions touched by colon cancer with a one-of-a-kind mosaic mural at its New York City headquarters.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-24T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

New York Times Examines Reconstructive Surgery Options For Women With Breast Cancer
http://www.medicalnewstoday.com/articles/134092.php
The <A href="http://www.nytimes.com/2008/12/23/health/23beauty.html?partner=rss&emc=rss" target=_new><CITE>New York Times</CITE></A><CITE> </CITE>on Tuesday examined reconstructive breast surgery options provided to cancer patients undergoing mastectomies.

----------------------------------------------
** CANCER / ONCOLOGY News **

Pre-clinical Research On EVATAKTM In Human Gastric (Stomach) Cancer Accepted For Publication
http://www.medicalnewstoday.com/articles/133749.php
Viralytics Limited (ASX: VLA) has received notice that publication of pre-clinical research data on the anti-cancer activity of its oncolytic virus candidate, EVATAK™ (Echovirus type 1), will occur shortly in the internationally acclaimed "Journal of Molecular Medicine".

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Denise Galloway And Gerald Smith Named AAAS Fellows
http://www.medicalnewstoday.com/articles/133756.php
Fred Hutchinson Cancer Research Center scientists Denise Galloway, Ph.D., a microbiologist, and Gerald Smith, Ph.D., a geneticist and microbiologist, have been awarded the distinction of AAAS Fellow.

----------------------------------------------
** COLORECTAL CANCER News **

Race And Insurance Status Impact Presentation And Treatment Of Diverticulitis
http://www.medicalnewstoday.com/articles/134075.php
While race may be associated with the level of presentation and mortality for diverticulitis, but insurance status is associated with other aspects of treatment, according to an article released on December 15, 2008 in Archives of Surgery, one of the JAMA/Archives journals.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Seed Displacements After Permanent Brachytherapy For Prostate Cancer In Dependence On The Prostate Level
http://www.medicalnewstoday.com/articles/133720.php
UroToday.com - Interstitial brachytherapy became an established treatment for localized prostate cancer in the last decade with excellent long-term results. CT-based dosimetry is currently recommended as the standard for postimplant dosimetry, with a suggested interval of four weeks after I-125 brachytherapy.

Relief By Botulinum Toxin Of Lower Urinary Tract Symptoms Owing To Benign Prostatic Hyperplasia: Early And Long-Term Results
http://www.medicalnewstoday.com/articles/133717.php
UroToday.com - Botulinum toxin (BTX) is used therapeutically for several disorders associated with excessive muscular contractions including focal dystonias. Recently BTX has been successfully used for the treatment of disorders of the gastrointestinal and urinary tracts.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-23T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Lymphedema Risk For Breast Cancer Survivors Increased By Obesity
http://www.medicalnewstoday.com/articles/133691.php
Throughout the world, 10 million breast cancer survivors have a lifetime risk for developing lymphedema, a chronic condition that involves swelling of the limbs and impacts physical and psychosocial health.

----------------------------------------------
** CANCER / ONCOLOGY News **

Removal Of Pelvic Lymph Nodes Or Radiotherapy Cannot Be Recommended As Routine Treatments In Women With Early Endometrial Cancer (ASTEC Study)
http://www.medicalnewstoday.com/articles/134035.php
Two Articles published Online first and in an upcoming edition of The Lancet show that two common adjuvant treatments for women with early endometrial cancer - removing the pelvic lymph nodes or external beam radiotherapy - should not be part of routine care.

NCCN Provides Oncology Training For Nearly 200 Medical Professionals In Philadelphia
http://www.medicalnewstoday.com/articles/133700.php
With the recent news that cancer is expected to be the world's new leading cause of death by 2010, it is crucial that individuals who help manage patients with cancer are educated on the latest advances in oncology care.

CHMP Recommends Granting Marketing Authorisation For FIRMAGON(R) (degarelix) For Treatment Of Prostate Cancer
http://www.medicalnewstoday.com/articles/133655.php
Ferring Pharmaceuticals received notification that the Committee for Medicinal Products for Human Use (CHMP), part of the European Medicines Agency (EMEA), has adopted a positive opinion and is recommending to grant a marketing authorization for FIRMAGON(R) (degarelix), a new GnRH receptor antagonist indicated for patients with advanced, hormone-dependent prostate cancer.

Breakthrough In Cancer Therapy Using Radiation - Linac-MR System Operational With MR Imaging During 6 MV Irradiation
http://www.medicalnewstoday.com/articles/133652.php
Fallone from the Cross Cancer Institute (CCI) , Alberta Cancer Board of the Alberta Health Services (Edmonton, AB) reports that CCI medical physicists have produced the first image from a linac-MR hybrid system on December 10, 2008.

Hotel, Restaurant And Carpentry Trades Are Among Professions Posing Highest Risks For Cancer Of The Oesophagus
http://www.medicalnewstoday.com/articles/133644.php
A new study led by Spanish researchers has revealed that exposure to certain substances may increase the risk of cancer of the oesophagus. The hotel and restaurant trades, animal handling, mining and carpentry are some of the professions posing the highest risk.

Dangerous Skin Cancer
http://www.medicalnewstoday.com/articles/133640.php
The German Cancer Society has worked out new guidelines for the diagnosis and treatment of malignant melanoma a disease with unfavorable prognosis. Malignant melanoma is responsible for 90% of deaths from skin cancer.

A Cellular Task Force To Safeguard Genome Stability
http://www.medicalnewstoday.com/articles/133639.php
The maintenance of genome stability is crucial for protecting an organism against the onset of cancer and the study of the mechanisms controlling genome stability represents one of the most promising frontiers in cancer research.

Scientists Study How Asbestos Fibers Trigger Cancer In Human Cells
http://www.medicalnewstoday.com/articles/133636.php
Ohio State University scientists believe they are the first in the world to study the molecular underpinnings of cancer by probing individual bonds between an asbestos fiber and human cells. Though any clinical application is years away, the researchers hope their findings could aid in drug development efforts targeting illnesses caused by excessive exposure to asbestos, including the deadly cancer called mesothelioma.

PTC Therapeutics Initiates Two Clinical Trials Of PTC299 In Cancer Patients
http://www.medicalnewstoday.com/articles/133628.php
PTC Therapeutics, Inc. (PTC) announced the initiation of two clinical trials of the company's product candidate PTC299 in adult patients with solid tumor cancers and Kaposi Sarcoma, a HIV-related cancer.

Lance Armstrong Foundation Awards Nearly $2 Million With 11 Grants To Leading Research Institutions In The U.S. And Australia
http://www.medicalnewstoday.com/articles/133617.php
Recently the Lance ArmstrongFoundation (LAF) awarded nearly $2 million with 11 grants to leadingresearch institutions in the U.S. and Australia. The 2008 researchgrantees represent City of Hope (Duarte, CA); University ofCalifornia at Los Angeles (Los Angeles, CA); University ofConnecticut (Storrs, CT); Georgetown University (Washington, DC);Veterans Affairs Medical Center (VAMC) and Indiana University(Indianapolis, IN); Montana State University (Bozeman, MT);Massachusetts General Hospital (Boston, MA); Columbia University (NewYork, NY); Ohio State University (Columbus, OH); and the University ofSydney (Sydney, Australia).

Institute Of Cancer Research Named UK's Top Research Centre
http://www.medicalnewstoday.com/articles/133615.php
The Institute of Cancer Research has been ranked as the UK's leading academic research centre by the Times Higher Education, today. The coveted independent ranking of the UK's 132 educational research centres was based on the Higher Education Funding Council's Research Assessment Exercise.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

High HPV Vaccination Coverage Already Achieved In England
http://www.medicalnewstoday.com/articles/133998.php
More than 70 per cent of 12-13 year old girls have already had their first HPV (human papillomavirus) jab since the vaccination campaign started in September, Public Health Minister Dawn Primarolo announced today.

Swedish Officials Investigate Ties Between AstraZeneca, Nobel Foundation Over Award For Discovery Of HPV
http://www.medicalnewstoday.com/articles/133985.php
Swedish officials are investigating whether the pharmaceutical company <A href="http://www.astrazeneca.com/" target=_new>AstraZeneca</A> could have improperly influenced this year's Nobel Prize for medicine, which was <A href="News2?news_iv_ctrl=-1&abbr=daily2_&page=NewsArticle&id=13724" target=_new>awarded</A> to the researcher who discovered the human papillomavirus, London's <A href="http://www.

----------------------------------------------
** COLORECTAL CANCER News **

Maslinic Acid, Isolated From Olive Pomace, Provides A Natural Defence Against Colon Cancer
http://www.medicalnewstoday.com/articles/133641.php
Researchers from the University of Granada and the University of Barcelona have shown that treatment with maslinic acid, a triterpenoid compound isolated from olive-skin pomace, results in a significant inhibition of cell proliferation and causes apoptotic death in colon-cancer cells.

----------------------------------------------
** LUNG CANCER News **

American Lung Association Offers Seven Tips To Quit Smoking This New Year
http://www.medicalnewstoday.com/articles/133630.php
Many people will make New Year's resolutions to quit smoking this year. With the economy in turmoil, quitting smoking is not only good for your health, but also your wallet. Having a solid smoking cessation plan can greatly improve one's chance for success.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

-------------------------------------------------------------

Medical News Today News Alert

2008-12-22T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

IU Simon Cancer Center's Tissue Bank Collecting Samples Jan. 10
http://www.medicalnewstoday.com/articles/133594.php
Would you like to contribute to breast cancer research? You can help by donating a tissue sample to the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center from 8:30 a.m. to 2:30 p.

----------------------------------------------
** CANCER / ONCOLOGY News **

Dendrimer Reduces Toxicity Of Cancer Drug
http://www.medicalnewstoday.com/articles/133612.php
Starpharma Holdings Ltd (ASX:SPL)(PINK:SPHRY) reported an important advance in its dendrimer-based drug-delivery program. A Starpharma dendrimer combined with a widely-used cancer drug (doxorubicin) has achieved a significant extension of the drug's plasma half-life and a marked reduction in drug toxicity compared to administration of the drug alone.

New Study Finds Endonasal Surgery Offers Hormonal Benefits For Pituitary Gland Tumor Patients
http://www.medicalnewstoday.com/articles/133606.php
Patients diagnosed with a brain tumor affecting the body's "master gland" have encouraging news: When the tumor is removed using minimally invasive surgery, patients can enjoy a good chance of restoring normal hormonal function and recovering their health.

Cornerstone Pharmaceuticals Announces $6 Million Financing To Further Advance Clinical Trials In Cancer Patients
http://www.medicalnewstoday.com/articles/133597.php
Cornerstone Pharmaceuticals, Inc., a privately-held pharmaceutical company focused on developing drugs in the emerging field of cancer bioenergetics, announced recently that it has raised a minimum of $6 million from a private investor group.

Modified Gene Targets Cancer Cells A Thousand Times More Often Than Healthy Cells
http://www.medicalnewstoday.com/articles/133573.php
Researchers at the University of Rochester have designed a gene that produces a thousand times more protein in cancer cells than in healthy cells.The findings may help address the prime challenge in anti-cancer therapy: improving treatments' ability to specifically and effectively target cancer cells.

6th ESOU Meeting: Updates In Onco-Urology
http://www.medicalnewstoday.com/articles/133553.php
The 6th Meeting of the European Society of Oncological Urology (ESOU) will be held in the Ceylan InterContinentall in Istanbul (TR), from 16 to 18 January 2009, with organisers presenting the latest updates on treatment strategies to onco-urology specialists.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

EpiCept Announces Health Canada's Approval For Ceplene Filing For The Treatment Of Acute Myeloid Leukemia
http://www.medicalnewstoday.com/articles/133547.php
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) has announced that, at a recent pre-New Drug Submission (pre-NDS) meeting with representatives of Health Canada, it received permission to proceed with a New Drug Submission (NDS) filing for Ceplene® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) in Canada.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Evaluation Of Treatments For Benign Prostatic Enlargement
http://www.medicalnewstoday.com/articles/133549.php
Research published by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme has found that transurethral resection, the most common operation for benign prostatic enlargement (BPE), remains a clinically and cost-effective treatment.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-21T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Baby Girl Free Of Breast Cancer Gene Due To Be Born Soon
http://www.medicalnewstoday.com/articles/133904.php
The first British baby girl free of the faulty BRCA 1 gene, which significantly raises a woman's chances of developing breast cancer, is due to be born soon. The girl has been genetically selected to be free of the faulty gene.

----------------------------------------------
** CANCER / ONCOLOGY News **

Phase 1 Clinical Trial Of FG-3019, Anti-Connective Tissue Growth Factor (CTGF) Investigational Therapy, In Patients With Pancreatic Cancer Launched
http://www.medicalnewstoday.com/articles/133581.php
FibroGen, Inc. has announced that an open-label, phase 1 clinical trial designed to evaluate the safety and tolerability of FG-3019, a fully human monoclonal antibody against connective tissue growth factor (CTGF), in combination with gemcitabine and erlotinib in patients with locally advanced or metastatic pancreatic cancer has commenced.

SRA Supports Groundbreaking Cancer Research
http://www.medicalnewstoday.com/articles/133432.php
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, has announced that it collected and managed all of the research data associated with a groundbreaking brain tumor study recently released by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI).

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

INVIRION Diagnostics Launches Successful Hybrid Instrument At EUROGIN 2008
http://www.medicalnewstoday.com/articles/133551.php
INVIRION Diagnostics, LLC, successfully launched their new Molecular Hybrid Platform (MoHP) at EUROGIN 2008 (European Research Organization on Genital Infection and Neoplasia). EUROGIN is the leading international multidisciplinary organization involved in research, training, screening, prevention and information concerning genital infections, pre-cancers and cancers in women.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

FDA Approves Genzyme's Mozobil - Provides Stem Cell Mobilization For Autologous Transplantation In NHL And Multiple Myeloma Patients
http://www.medicalnewstoday.com/articles/133562.php
Genzyme Corporation (Nasdaq: GENZ) has announced that the U.S. Food and Drug Administration has granted marketing approval for Mozobil™ (plerixafor injection), a drug intended to be used in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM).

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-20T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

'Molecular Manual' For 100s Of Inherited Diseases Compiled By Researchers
http://www.medicalnewstoday.com/articles/133548.php
An international research team has compiled the first catalogue of tissue-specific pathologies underlying hundreds of inherited diseases. These results provide information that may help treat conditions such as breast cancer, Parkinson's disease, heart disease and autism.

Extra-Virgin Olive Oil Has Anti-Cancer Components
http://www.medicalnewstoday.com/articles/133535.php
Good quality extra-virgin olive oil contains health-relevant chemicals, 'phytochemicals', that can trigger cancer cell death. New research published in the open access journal BMC Cancer sheds more light on the suspected association between olive oil-rich Mediterranean diets and reductions in breast cancer risk.

----------------------------------------------
** CANCER / ONCOLOGY News **

Medical Alliance Pays Off-Collaboration Leads To Expanded Research Opportunities
http://www.medicalnewstoday.com/articles/133430.php
A vast resource of information critical to cancer research is now leading to new opportunities for scientists - information that could lead to improved cancer treatments.The collaboration known as the Huntsman-Intermountain Cancer Care Program is now yielding data that can be used for studies relating to genetics, health services and public health.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Colonoscopy Study Underscores Importance Of Quality Standards
http://www.medicalnewstoday.com/articles/133546.php
A study by Baxter, et al. scheduled to be published in the Jan. 6, 2009, edition of Annals of Internal Medicine, concluded that while screening colonoscopy is associated with fewer deaths from colorectal cancer, the association is primarily limited to deaths from cancer developing in the left side of the colon.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Stem Cells And Leukemia Battle For Marrow Microenvironment
http://www.medicalnewstoday.com/articles/133633.php
Learning how leukemia takes over privileged "niches" within the bone marrow is helping researchers develop treatment strategies that could protect healthy blood-forming stem cells and improve the outcomes of bone marrow transplantation for leukemia and other types of cancer.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Prostate Cancer Patient From Warrington Becomes First In UK To Be Treated Using RapidArc™ Radiotherapy From Varian Medical Systems
http://www.medicalnewstoday.com/articles/133413.php
65-year-old grandfather of six, Graham McCormack has become the first cancer patient in the UK to be treated using RapidArc radiotherapy technology from Varian Medical Systems . Mr McCormack, from Warrington in Cheshire, received the fast and efficient treatment at Clatterbridge centre for Oncology in the Wirral, the first UK cancer centre to introduce the revolutionary new treatment technique.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-19T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Breast Cancer Recovery Hampered By Poor Marriage
http://www.medicalnewstoday.com/articles/133645.php
Researchers in the US found that breast cancer patients who had a poor relationship with their spouse or partner were likely to recover more slowly and experience worse physiological as well as psychological outcomes.

----------------------------------------------
** CANCER / ONCOLOGY News **

Annual Congress European Association Of Urology: Highlights In Stockholm
http://www.medicalnewstoday.com/articles/133555.php
The 24th Annual Congress of the European Association of Urology (EAU) will be held from 17 to 21 March 2009 in the Stockholm International Fairs (SE). The scientific programme covers the whole range of the urological field.

New Partnership Between The Journal Of Pain And Symptom Management And The AAHPM
http://www.medicalnewstoday.com/articles/133517.php
Elsevier, world-leading publisher of scientific, technical, and medical information products and services, is pleased to announce that, beginning in January 2009, the internationally respected Journal of Pain and Symptom Management (JPSM) (<a href="http://www.

Sorafenib Is Effective In Asian-Pacific Patients With Advanced Liver Cancer
http://www.medicalnewstoday.com/articles/133433.php
Sorafenib significantly increases overall survival in Asian-Pacific patients with advanced hepatocellular carcinoma - a group where surgical treatments can be limited - according to findings of a phase III trial reported in an Article published early Online and in the January edition of The Lancet Oncology.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Male Circumcision Can Help Protect Against HPV And HIV, Studies Show
http://www.medicalnewstoday.com/articles/133667.php
Circumcision can protect men and their female sex partners from contracting human papillomavirus, as well as help to protect men from contracting HIV, according to three studies published in the <CITE>Journal of Infectious Diseases</CITE>, <A href="http://africa.

Fears Of Promiscuity Pose Barrier To Cervical Cancer Vaccinations
http://www.medicalnewstoday.com/articles/133521.php
The public's concerns about costs and increased promiscuity among teenagers appear to be hindering use of a vaccine against the human papilloma virus (HPV) to prevent life-threatening diseases, according to a study by researchers at Yale School of Public Health.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-18T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Daily Women's Health Policy Report Examines Latest Research On Breast Cancer
http://www.medicalnewstoday.com/articles/133474.php
The following summarizes news coverage of recently reported studies on breast cancer. ~ Tumor removal: An experimental device developed by a team at <A href="http://medschool.duke.

Ovarian, Breast And Lung Cancer Survival Linked To Two Proteins
http://www.medicalnewstoday.com/articles/133454.php
US scientists found that levels of two proteins called Dicer and Drosher that are involved in shutting down genes were linked to a woman's chances of surviving ovarian cancer and similar effects were also found in lung and breast cancer patients.

Cabinet Secretary For Health & Wellbeing Hears Breast Cancer Patient Experiences At Breakthrough Breast Cancer's Scottish Launch Event
http://www.medicalnewstoday.com/articles/133389.php
Nicola Sturgeon, MSP and Deputy First Minister & Cabinet Secretary for Health & Wellbeing heard breast cancer patients talk about their experiences of breast cancer services in Scotland at Breakthrough Breast Cancer's Scottish Conversation event on Wednesday 10th December.

ERMA's Ban On The Use Of Endosulfan A Significant Step Forward For New Zealand Women
http://www.medicalnewstoday.com/articles/133312.php
Breast Cancer Network NZ is delighted that ERMA has decided to ban the pesticide endosulfan in New Zealand. This chemical is acutely toxic and has hormone-mimicking qualities that are of great concern to Breast Cancer Network.

Gene Subnetworks Predict Cancer Spread
http://www.medicalnewstoday.com/articles/133270.php
The metastasis or spread of breast cancer to other tissues in the body can be predicted more accurately by examining subnetworks of gene expression patterns in a patient's tumor, than by conventional gene expression microarrays, according to a presentation at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec.

----------------------------------------------
** CANCER / ONCOLOGY News **

American Indian Health Expert Discusses Findings Of Recent Cancer Study
http://www.medicalnewstoday.com/articles/133498.php
<cite> </cite><a href="http://www.indiancountrytoday.com/living/36061614.html" target="_new"><cite>Indian Country Today</cite></a> on Tuesday published an interview with Judith Kaur, a member of the Choctaw Nation, who discussed a recent <a href="http://www.

Weakened RNA Interference Reduces Survival In Ovarian Cancer
http://www.medicalnewstoday.com/articles/133449.php
Levels of two proteins in a woman's ovarian cancer are strongly associated with her likelihood of survival, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the Dec.

Molecular Marker Identifies Normal Stem Cells As Intestinal Tumor Source
http://www.medicalnewstoday.com/articles/133437.php
Scientists at St. Jude Children's Research Hospital have answered a central question in cancer biology: whether normal stem cells can give rise to tumors. Stem cells are immature cells that can renew themselves and give rise to mature differentiated cells that compose the range of body tissues.

Pre-Existing Diabetes For Persons Diagnosed With Cancer Linked With Higher Risk Of Death
http://www.medicalnewstoday.com/articles/133375.php
Patients with diabetes at the time of a cancer diagnosis have an increased risk of death compared to patients without diabetes, according to a meta-analysis of studies reported in the December 17 issue of JAMA.

Researcher Refining Synthetic Molecules To Prevent HIV Resistance
http://www.medicalnewstoday.com/articles/133361.php
Evolving HIV viral strains and the adverse side effects associated with long-term exposure to current treatments propel scientists to continue exploring alternative HIV treatments. In a new study, a University of Missouri researcher has identified broad-spectrum aptamers.

Study Of Placenta Unexpectedly Leads To Cancer Gene
http://www.medicalnewstoday.com/articles/133357.php
University of Rochester Medical Center scientists discovered a gene mutation that impairs the placenta and also is influential in cancer development, according to a study published online December 16, 2008, in the journal PLoS (Public Library of Science) Biology.

M. D. Anderson's Cohen Honored For Contributions To Traditional Chinese Medicine
http://www.medicalnewstoday.com/articles/133354.php
Lorenzo Cohen, Ph.D., Director of the Integrative Medicine Program at The University of Texas M. D. Anderson Cancer Center is the recipient of the 2007 International Scientific and Technological Cooperation Award of Shanghai Municipality (ISTCASM) and the 2008 Magnolia Memorial Award for his contributions in furthering research into the use of traditional Chinese medicine in cancer therapies.

First Patients In International Study To Confirm That Cellvizio(R) Improves Cancer Detection Rates In Barrett's Esophagus Patients
http://www.medicalnewstoday.com/articles/133343.php
Doctors in the U.S. and Germany have enrolled the first patients in an international, multi-center study designed to add to the growing body of clinical evidence that shows that Cellvizio®, the world's smallest microscope, helps physicians confirm if Barrett's Esophagus has progressed so they can treat the dysplastic or cancerous condition immediately with fewer biopsies.

Moffitt Cancer Center Receives Award For Lung Cancer Research
http://www.medicalnewstoday.com/articles/133336.php
<a href="http://www.moffitt.org/Site.aspx?spid=1868A49EC35848BCAADC81CB6CAB7EC6&SearchType=Researcher" target="_blank" rel="nofollow">Dr. Eric Haura</a>, newly appointed program leader of <a href="http://www.

Cancer Cells Viewed In 'Real' Time In Living Mouse
http://www.medicalnewstoday.com/articles/133271.php
A breakthrough technique that allows scientists to view individually-labeled tumor cells as they move about in real time in a live mouse may enable scientists to develop microenvironment-specific drugs against cancer, researchers reported at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec.

Gene Function 'Lost' In Melanoma And Glioblastoma
http://www.medicalnewstoday.com/articles/133253.php
Researchers at Georgetown University Medical Center have found a gene they say is inactivated in two aggressive cancers - malignant melanoma, a form of skin cancer, and glioblastoma multiforme, a lethal brain tumor.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Death From Left-Sided Colon Cancer Significantly Reduced By Colonoscopy
http://www.medicalnewstoday.com/articles/133250.php
A new study finds that colonoscopy is strongly associated with fewer deaths from colorectal cancer. However, the risk reduction appears to be entirely due to a reduction in deaths from left-sided cancers.

----------------------------------------------
** LUNG CANCER News **

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Medivation Completes Enrollment Of Phase 1-2 Trial Of MDV3100 In Castration-Resistant Prostate Cancer Patients
http://www.medicalnewstoday.com/articles/133443.php
Medivation, Inc. (Nasdaq: MDVN) announced that it has completed patient enrollment in a Phase 1-2 dose-escalation clinical trial of MDV3100, its novel androgen receptor antagonist, in castration-resistant prostate cancer patients, and that it will seek approval from the U.

Review Of Prostate Cancer Prevention Study Shows No Benefit For Use Of Selenium And Vitamin E Supplements
http://www.medicalnewstoday.com/articles/133383.php
Initial, independent review of study data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), funded by the National Cancer Institute (NCI) and other institutes that comprise the National Institutes of Health shows that selenium and vitamin E supplements, taken either alone or together, did not prevent prostate cancer.

Combining Radiotherapy With Hormone Treatment Halves Mortality In Men With Locally Advanced Prostate Cancer, UK
http://www.medicalnewstoday.com/articles/133351.php
The Prostate Cancer Charity comments on an article to be published in The Lancet which claims that combining radiotherapy with hormone therapy treatment halves mortality in men with locally advance prostate cancer.

First Patient Treated With New Tissue-Specific UroCool(TM) System In Robotic-Assisted Prostate Surgery Study
http://www.medicalnewstoday.com/articles/133306.php
Cardium Therapeutics (NYSE Alternext US: CXM) and its operating unit InnerCool Therapies, Inc., announced enrollment of the first patient in a study of Hypothermic Radical Prostatectomy being conducted by researchers at the University of California, Irvine.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-17T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Women With HER2-Positive Breast Cancer Should Be Treated Aggressively, Researchers Report
http://www.medicalnewstoday.com/articles/133345.php
Women with breast cancer who test positive for the HER2 gene -- one of the most aggressive forms of the disease -- should be treated aggressively after surgery, even in cases where present tumors are very small, researchers said Friday at the <A href="http://www.

Aromasin (exemestane) Shows Some Advantages Over Tamoxifen As Adjuvant Therapy In Early Breast Cancer; First Results Of The TEAM Trial
http://www.medicalnewstoday.com/articles/133281.php
Interim findings of the TEAM (Tamoxifen Exemestane Adjuvant Multicenter) trial reported on 11th December at the 2008 San Antonio Breast Cancer Symposium (SABCS) suggest women with early invasive breast cancer can expect fewer breast cancer recurrences and a longer time to the occurrence of distant metastases if they are treated with the aromatase inhibitor Aromasin (exemestane) rather than the standard adjuvant therapy tamoxifen after initial therapy (surgery plus chemotherapy and/or radiotherapy).

How Tamoxifen Prevents Breast Cancer In Some Women But Not Others
http://www.medicalnewstoday.com/articles/133260.php
The power of the drug tamoxifen to reduce breast density is key in preventing breast cancer - according to a presentation in America by Cancer Research UK scientists. Researchers monitored the extent to which tamoxifen could reduce breast density in 7000 healthy post menopausal women who are at high risk of breast cancer in a trial called IBIS 1.

New Research Moves Us One Step Closer To Personalised Breast Cancer Treatment
http://www.medicalnewstoday.com/articles/133259.php
CANCER RESEARCH UK scientists have found that a test, already used in breast cancer diagnosis, can also predict who will and who won't benefit from commonly used chemotherapy drugs. The research shows that women who have a duplication of chromosome 17 in their tumour will benefit from anthracycline drugs, while others can be spared the side-effects of the treatment.

Breast Cancer Recurrence In Women Without Hot Flashes May Be Reduced By Diet
http://www.medicalnewstoday.com/articles/133215.php
A secondary analysis of a large, multicenter clinical trial has shown that a diet loaded with fruits, vegetables and fiber and somewhat lower in fat compared to standard federal dietary recommendations cuts the risk of recurrence in a subgroup of early-stage breast cancer survivors - women who didn't have hot flashes - by approximately 31 percent.

Abraxis BioScience Launches Abraxane(R) In European Union
http://www.medicalnewstoday.com/articles/133195.php
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, announced the launch in the European Union of Abraxane® Paclitaxel 5 mg/ml powder for suspension for infusion.

Study Throws Light On How Pregnancy And Lactation Affects Cancer Outcomes
http://www.medicalnewstoday.com/articles/133183.php
Being diagnosed with cancer during pregnancy or while breastfeeding is not associated with increased risk of cancer-related death - with the exception of breast and ovarian cancer diagnosed during lactation, according to a study of women in Norway.

Computer-Aided Mammography Finds More Cancer, More False Positives
http://www.medicalnewstoday.com/articles/133168.php
Computer programs designed to help radiologists could identify more cases of breast cancer, but they might also increase the number of false-positive results, which can lead to biopsies in healthy women, according to a recent systematic review.

----------------------------------------------
** CANCER / ONCOLOGY News **

New Tool Could Unpick Complex Cancer Causes & Help Sociologists Mine Facebook
http://www.medicalnewstoday.com/articles/133298.php
Researchers at the University of Warwick's Department of Statistics and Centre for Complexity Science have devised a new research tool that could help unpick the complex cell interactions that lead to cancer and also allow social scientists to mine social networking sites such as Facebook for useful insights.

Researchers Identify New Anti Tumor Gene
http://www.medicalnewstoday.com/articles/133288.php
Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with and suppress a key protein that is overexpressed in 90 percent of human cancers.

Colonoscopy Significantly Reduces Death From Left-Sided Colon Cancer But Not From Right-Sided Colon Cancer
http://www.medicalnewstoday.com/articles/133265.php
A new study finds that colonoscopy is strongly associated with fewer deaths from colorectal cancer. However, the risk reduction appears to be entirely due to a reduction in deaths from left-sided cancers.

The American Brain Tumor Association (ABTA) Offers Tips For Coping With Holiday Stress, Emotions
http://www.medicalnewstoday.com/articles/133198.php
If you are living with a brain tumor, caring for someone with a brain tumor or other serious illness, or have recently lost a family member or close friend, the holidays can be stressful, overwhelming, and difficult.

Lung Cancer Screening Feasibility Study Funded
http://www.medicalnewstoday.com/articles/133182.php
A study to assess the feasibility of undertaking a UK-based screening trial for lung cancer has been commissioned by the National institute for Health Research Health Technology Assessment (NIHR HTA) programme.

Pre-Existing Diabetes For Persons Diagnosed With Cancer Associated With Increased Risk Of Death
http://www.medicalnewstoday.com/articles/133092.php
Patients with diabetes at the time of a cancer diagnosis have an increased risk of death compared to patients without diabetes, according to a meta-analysis of studies reported in the December 17 issue of JAMA.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Quality Colonoscopy Exam Remains Best Strategy For Detection Of Polyps And Cancers
http://www.medicalnewstoday.com/articles/133284.php
Publication of a Canadian study on colonoscopy's impact on reducing colon cancer deaths suggests a lower impact on mortality than previously reported. Physician experts from the American College of Gastroenterology urge patients and the public to recognize that even if the assumptions and design of this case-control study have produced accurate data, colonoscopy remains the best available option for detection of precancerous colon polyps and the only test with the potential to prevent colorectal cancer by removing these growths.

ASGE Urges Patients To Seek A Qualified Endoscopist Before Undergoing A Colonoscopy For Colorectal Cancer
http://www.medicalnewstoday.com/articles/133282.php
A study released in the Annals of Internal Medicine found that colonoscopy is associated with lower death rates from colorectal cancer, however, the procedure missed lesions more often on the right side of the colon versus the left side.

Racial Gap Growing In Colorectal Cancer According To New Report
http://www.medicalnewstoday.com/articles/133237.php
A new report from the American Cancer Society says despite unprecedented progress in reducing incidence and death rates from colorectal cancer, the gap between blacks and whites continues to grow.

Mapping New Path To Colon Cancer Therapy
http://www.medicalnewstoday.com/articles/133217.php
University of Texas Medical Branch at Galveston researchers have identified a promising new target in the battle against colorectal cancer - a biochemical pathway critical to the spread of tumors to new locations in the body.

Smoking Associated With Increased Risk For Colorectal Cancer And Death
http://www.medicalnewstoday.com/articles/133093.php
An analysis of previous studies indicates that smoking is significantly associated with an increased risk for colorectal cancer and death, according to an article in the December 17 issue of JAMA.

----------------------------------------------
** LUNG CANCER News **

Largest Ever Prostate Cancer Screening Program In USA Shows High Compliance And Consistent Results
http://www.medicalnewstoday.com/articles/133213.php
Just under five per cent of the men who took part in the prostate cancer element of the USA's largest ever cancer screening trial were diagnosed with the disease and the majority of those were picked up by screening programmes, according to research published in the December issue of the urology journal BJU International.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Preventing A Recurrence Of The Northwick Park Trial
http://www.medicalnewstoday.com/articles/133211.php
Scientists investigating the 2006 Northwick Park drug-trial disaster that left six healthy volunteers hospitalised say they have developed new pre-clinical tests that could have stopped the trial from ever going ahead.

One Step Closer To A Treatment For Mixed-Lineage Leukemia
http://www.medicalnewstoday.com/articles/133188.php
Infants and adults with the blood cancer mixed-lineage leukemia (MLL) typically have a poor prognosis, and most infants die before their first birthdays. Although there are varying causes of MLL, most cases are caused by a fusion of two genes, the MLL and the AF4 genes.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System In Robotic Assisted Prostate Surgery Study
http://www.medicalnewstoday.com/articles/133286.php
.Cardium Therapeutics (NYSE Alternext US: CXM) and its operating unit InnerCool Therapies, Inc., announced enrollment of the first patient in a study of Hypothermic Radical Prostatectomybeing conducted by researchers at the University of California, Irvine.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-16T23:02:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Studies Presented At Symposium Examine Efficacy Of Breast Cancer Treatments
http://www.medicalnewstoday.com/articles/133155.php
The following summarizes news coverage of two studies presented last week at the <A href="http://www.sabcs.org/" target=_new>San Antonio Breast Cancer Symposium</A> in Texas. ~ Zometa: Women with breast cancer who take <A href="http://www.

Evolution, Instability Of Cancer Shown By Breast Cancer Genome
http://www.medicalnewstoday.com/articles/133119.php
A newly published genome sequence of a breast cancer cell line reveals a heavily rearranged genetic blueprint involving breaks and fusions of genes and a broken DNA repair machinery, said researchers at Baylor College of Medicine in a report that appears online in the journal Genome Research.

Preventing Metastasis To 'Stop Cancer From Killing People'
http://www.medicalnewstoday.com/articles/133110.php
Metastasis is the ability of cancer cells to spread from a primary site, to form tumours at distant sites. It is a complex process in which cell motility and invasion play a fundamental role.

Using Light To Detect Cancer Withing Second - Breast Surgeon Wins Prestigious Healthcare Innovation Award, England
http://www.medicalnewstoday.com/articles/133100.php
A Royal Free breast surgeon has won a prestigious healthcare innovation award with a state-of-the-art technique that uses light to detect cancer within seconds. Mr Mohammed Keshtgar, consultant surgical oncologist, has won a 2008 Medical Futures Cancer Innovation Award and been shortlisted in the category of overall winner of the award with his pioneering work in optical biopsy.

ABRAXANE In Combination With Gemcitabine And Epirubicin Evaluated As Neoadjuvant Treatment For Patients With Locally Advanced Breast Cancer
http://www.medicalnewstoday.com/articles/133065.php
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced the presentation of preliminary results from a single-arm, open-label, Phase II clinical trial evaluating ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin- bound) in combination with gemcitabine and epirubicin for the treatment of patients with locally advanced breast cancer (neoadjuvant treatment).

Cancer Prevention Study Reveals Encouraging News For Exemestane
http://www.medicalnewstoday.com/articles/133060.php
An interim analysis of a breast cancer prevention study using exemestane (Aromasin®) finds an "acceptable" level of bone loss.The ongoing phase II study details reported by Jennifer Eng-Wong, MD, a breast cancer specialist at Georgetown's Lombardi Comprehensive Cancer Center at the San Antonio Breast Cancer Symposium, examines the use of exemestane in postmenopausal women who are at an increased risk of developing breast cancer based on commonly used risk assessment measures.

Potential Links Discovered Between Breast Density And Breast Cancer Risk
http://www.medicalnewstoday.com/articles/133058.php
Having dense breasts - areas that show up light on a mammogram - is strongly associated with increased breast cancer risk, but "why" remains to be answered. Now, by examining dense and non-dense tissue taken from the breasts of healthy volunteers, researchers from Mayo Clinic have found several potential links.

In Young Women With Benign Breast Disease, Breast Cancer Risk Varies According To Mayo Clinic Researchers
http://www.medicalnewstoday.com/articles/133057.php
A type of benign breast disease (BBD) known as atypical hyperplasia substantially increases a young woman's risk of developing breast cancer, even if there is no history of breast cancer in her family, say researchers at Mayo Clinic.

Tau Protein Expression Predicts Breast Cancer Survival -- Though Not As Expected
http://www.medicalnewstoday.com/articles/133056.php
Expression of the microtubule-binding protein Tau is not a reliable means of selecting breast cancer patients for adjuvant paclitaxel chemotherapy, according to research led by The University of Texas M.

----------------------------------------------
** CANCER / ONCOLOGY News **

Unique U-M Surgery Creates Fully Usable Tongue Following Tongue Cancer
http://www.medicalnewstoday.com/articles/133139.php
The night before her surgery for tongue cancer, 30-year-old Lisa Bourdon-Krause realized she might never be able to speak to her toddler son again. So she sat up half the night recording messages to him: "Hi, how was your day?," "You're so handsome," "You have a stinky butt.

American Academy Of Dermatology Issues Statement On FDA Report To Congress About Labeling Information On Indoor Tanning Devices
http://www.medicalnewstoday.com/articles/133138.php
The American Academy of Dermatology (Academy) issued a statement in response to the Food and Drug Administration's Report to Congress about labeling information on the relationship between the use of indoor tanning devices and development of skin cancer or other skin damage.

Cylene Pharmaceuticals Initiates Phase II Clinical Trial Of Quarfloxin (CX-3543) In Patients With Carcinoid/Neuroendocrine Tumors
http://www.medicalnewstoday.com/articles/133135.php
Cylene Pharmaceuticals announced the initiation of a Phase II clinical trial of quarfloxin (CX-3543) in patients with carcinoid/neuroendocrine tumors (C/NET), which are malignant cancers arising from neural crest cells.

Shared Survival Mechanism Explains Why 'Good' Nerve Cells Last And 'Bad' Cancer Cells Flourish
http://www.medicalnewstoday.com/articles/133120.php
Cancer cells and nervous system neurons may not look or act alike, but both use strikingly similar ways to survive, according to new research from the University of North Carolina at Chapel Hill School of Medicine.

Possible Therapeutic Target For Pancreatic Cancer
http://www.medicalnewstoday.com/articles/133108.php
A possible new therapeutic target for pancreatic cancer, the most lethal form of human cancer, has been identified in the proteins whose DNA recipe comes from gene, "Seven-In-Absentia," according to researchers at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec.

Clatterbridge Centre For Oncology Ranked As One Of The Best Healthcare Organisations To Work For In The UK
http://www.medicalnewstoday.com/articles/132953.php
Clatterbridge Centre for Oncology is one of the Top 100 healthcare organisations to work for in the UK according to a survey by the Health Service Journal. The survey asked employees at the Centre a range of questions and the Centre has been included in the Top 100 list! The final results will be announced in March 2009, when the Centre will find out where they came in the top 100.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Colon Cancer Mortality Gap Between Blacks, Whites Widening, Report Finds
http://www.medicalnewstoday.com/articles/133179.php
The gap in colon cancer mortality between blacks and whites has been widening over the last two decades, in part because of blacks' lower screening rates and poorer access to care, according to an <a href="http://www.

Aspirin Not Effective In Preventing Lynch Syndrome
http://www.medicalnewstoday.com/articles/133144.php
Aspirin, recommended as a preventive approach for patients at risk of hereditary colorectal cancer, does not provide protection against Lynch syndrome, the most common form of hereditary colorectal cancer, according a study published in the Dec.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

USA's Largest Ever Prostate Cancer Screening Programme Shows High Compliance And Consistent Results
http://www.medicalnewstoday.com/articles/133095.php
Just under five per cent of the men who took part in the prostate cancer element of the USA's largest ever cancer screening trial were diagnosed with the disease and the majority of those were picked up by screening programmes, according to research published in the December issue of the UK-based urology journal BJU International.

Low Income Men Diagnosed More Often With Advanced Prostate Cancer, The Journal Of Urology
http://www.medicalnewstoday.com/articles/133068.php
Coincident with the widespread adoption of PSA screening, the proportion of American men diagnosed with organ-confined, low risk prostate cancer has increased significantly during the last two decades.

Combining Radiotherapy With Hormone Treatment Halves Prostate Cancer Mortality
http://www.medicalnewstoday.com/articles/133067.php
In patients with locally advanced or high-risk prostate cancer, combining prostate radiotherapy with the conventional endocrine (hormone) treatment halves mortality. Thus endocrine treatment plus radiotherapy should be the new standard.

Centers Nationwide Participating In Clinical Trial To Determine Effectiveness Of High-Intensity Focused Ultrasound Procedure For Prostate Cancer
http://www.medicalnewstoday.com/articles/133050.php
EDAP Technomed, Inc. announces the launch of a phase II/III clinical trial evaluating the effectiveness of a non-invasive medical device designed to target and treat prostate cancer with high-intensity focused ultrasound (HIFU).

Study Finds That Low-Income Men Are More Likely To Be Diagnosed With Advanced Prostate Cancers
http://www.medicalnewstoday.com/articles/133048.php
Low-income men are more likely to present with advanced prostate cancers, most likely because they don't receive screening services shown to reduce the diagnosis of later-stage cancers, a UCLA study found.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-15T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Nab-Paclitaxel Added To Gemcitabine And Epirubicin Shows Potential As Neoadjuvant Treatment For Early Breast Cancer
http://www.medicalnewstoday.com/articles/133085.php
SAN ANTONIO - NabTM-paclitaxel (<a href="http://www.abraxane.com" target="_blank" rel="nofollow">Abraxane</a>), used in tandem with gemcitabine and epirubicin, is showing good anti-tumor activity and tolerability as neoadjuvant treatment for women with locally advanced breast cancer, according to phase II results released at the 2008 San Antonio Breast Cancer Symposium (SABCS).

Fall In Breast Cancer Rates Tied To Less Use Of Hormone Therapy
http://www.medicalnewstoday.com/articles/133064.php
A new study showed that taking menopausal hormone therapy comprising estrogen plus progestin for five years doubled a woman's risk of breast cancer, and suggested that the recent fall in breast cancer rates is predominantly due to a decrease in women having combined menopausal hormone therapy.

Novelos Therapeutics Announces Presentation Of Positive Results In Ongoing Phase 2 Neoadjuvant Breast Cancer Trial
http://www.medicalnewstoday.com/articles/133043.php
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, announced that today the Braman Family Breast Cancer Institute at the Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine, in collaboration with Medical University of South Carolina Hollings Cancer Center, is presenting a poster highlighting further positive results from an ongoing Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer at the AACR Breast Cancer Symposium in San Antonio, TX.

Monogram Announces Presentation Of Clinical Data For The HERmark™ Breast Cancer Assay At The CTRC-AACR San Antonio Breast Cancer Symposium
http://www.medicalnewstoday.com/articles/133042.php
Monogram Biosciences, Inc. (Nasdaq:MGRM) announced that new results from a study of the predictive power of its HERmark™ Breast Cancer Assay were presented at the CTRC-AACR San Antonio Breast Cancer Symposium in San Antonio, Texas.

Significant Improvement In Progression-Free Survival For Triple Negative Metastatic Breast Cancer Patients Treated With IXEMPRA™ Plus Capecitabi
http://www.medicalnewstoday.com/articles/133039.php
<a href="http://www.bms.com" target="_blank" rel="nofollow">Bristol-Myers Squibb</a> Company (NYSE:BMY) today announced new data from studies of IXEMPRA™ (ixabepilone) plus capecitabine compared to capectabine alone, including a pre-specified sub set analysis demonstrating a significant increase in progression free survival (PFS) in patients with triple negative breast cancer.

Women At High Risk Of Breast Cancer May Benefit From Alternating Mammography And MRI
http://www.medicalnewstoday.com/articles/133038.php
Magnetic resonance imaging (MRI) alternated with mammography at six-month intervals can detect breast cancers not identified by mammography alone, a research team from The University of Texas M.

Research On Tamoxifen Leads To Recommendation For CYP2D6 Gene Test
http://www.medicalnewstoday.com/articles/133035.php
Findings from a new study have prompted Mayo Clinic researchers to recommend CYP2D6 gene testing for postmenopausal women about to begin tamoxifen therapy. This data confirms that women with an inherited deficiency in the CYP2D6 gene, which is important for the metabolism of tamoxifen, have a nearly fourfold higher risk of early breast cancer recurrence compared to women who have not inherited the deficiency.

Early Stage, HER2-Positive Breast Cancer Patients At Increased Risk Of Recurrence
http://www.medicalnewstoday.com/articles/133023.php
Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M.

Pfizer Announces Results From Trial Of AROMASIN In Postmenopausal Women With Hormone Sensitive Early Breast Cancer
http://www.medicalnewstoday.com/articles/133018.php
Pfizer today announced results from a first planned analysis of the TEAM (Tamoxifen, Exemestane, Adjuvant, Multicenter) trial. TEAM was originally designed in 2001 as a comparison of 5 years of upfront AROMASIN® (exemestane tablets) vs.

What Biomarkers Can Reveal About Breast Cancer
http://www.medicalnewstoday.com/articles/133009.php
As cancer researchers move away from the general use of chemotherapy and into more targeted approaches, scientists are working to discover effective ways to measure response and risk. Data presented at the CTRC-AACR San Antonio Breast Cancer Symposium illustrate the cutting edge of biomarker discovery and development.

Agendia's Breast Cancer Test MammaPrint(R) Identifies New Subset Of Low Risk HER2+ Patients
http://www.medicalnewstoday.com/articles/133008.php
Dr. Michael Knauer from the Netherlands Cancer Institute today announced data uncovering a substantial group of traditionally miscategorized low risk HER2+ patients. Agendia's highly accurate breast cancer tumor recurrence test, MammaPrint(R), was used to differentiate between patients at high and low risk for recurrence.

Breast Cancer: Patient Management, Quality Of Life And Beyond
http://www.medicalnewstoday.com/articles/133007.php
Breast cancer is a multifaceted disease requiring creative solutions for diagnosis, quality of life management and adjuvant therapies. Data presented at the CTRC-AACR San Antonio Breast Cancer Symposium explored these areas.

Tykerb™ Plus Letrozole Delays Disease Progression In Post-menopausal Women With ErbB2 Positive Metastatic Breast Cancer
http://www.medicalnewstoday.com/articles/133006.php
New results from a study in metastatic breast cancer presented today at the 31st Annual CTRC-AACR San Antonio Breast Cancer Symposium showed that the combination of Tykerb™ (lapatinib ditosylate) plus letrozole, as a first line treatment regimen, provided a significant improvement in delaying disease progression when compared to treatment with Femara® (letrozole) alone.

Breakthrough Breast Cancer's Scottish Conversation Event
http://www.medicalnewstoday.com/articles/132972.php
Nicola Sturgeon, MSP and Deputy First Minister & Cabinet Secretary for Health & Wellbeing heard breast cancer patients talk about their experiences of breast cancer services in Scotland at Breakthrough Breast Cancer's Scottish Conversation event on Wednesday 10th December.

Most Triple-Negative Breast Cancers Express Muc-1 Target, Ireland Cancer Center Researcher Discovers
http://www.medicalnewstoday.com/articles/132965.php
Research out of the Ireland Cancer Center of University Hospitals Case Medical Center has found that the vast majority of triple negative breast cancers express the MUC-1 target. This first-of-its-kind finding, presented at the San Antonio Breast Cancer Symposium, has paved the way for an upcoming vaccine trial for patients with early stage triple negative breast cancer that could potentially prevent recurrence of this aggressive type of breast cancer.

DNA Repair Company Announces New Clinical Findings Which May Help To Guide Breast Cancer Treatment
http://www.medicalnewstoday.com/articles/132911.php
The DNA Repair Company (DNAR), an early-stage company focused on personalized approaches to cancer treatment, announced today that it has identified a promising set of protein biomarkers that may aid in the treatment of a particularly aggressive form of breast cancer.

----------------------------------------------
** CANCER / ONCOLOGY News **

Guy's And St Thomas' First Trust In UK To Use Pathwork(R) Tissue Of Origin Test For Tumours Of Unkown Origin
http://www.medicalnewstoday.com/articles/132988.php
Guy's and St Thomas' NHS Foundation Trust has announced a collaboration with Pathwork Diagnostics, a molecular diagnostics company which focuses on cancer diagnosis and treatment. Clinical and research staff at the Trust will be the first in the UK to conduct a research study which aims to establish whether the company's Pathwork® Tissue of Origin Test, a unique microarray test, will increase their ability to diagnose tumours of 'unknown origin'.

Nanotubes Sniff Out Cancer Agents In Living Cells - Carbon Nanotubes Used To Monitor Chemotherapy, Detect Toxins At The Single-Molecule Level
http://www.medicalnewstoday.com/articles/132806.php
MIT engineers have developed carbon nanotubes into sensors for cancer drugs and other DNA-damaging agents inside living cells. The sensors, made of carbon nanotubes wrapped in DNA, can detect chemotherapy drugs such as cisplatin as well as environmental toxins and free radicals that damage DNA.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Irish Advocates Call For Government To Reinstate HPV Vaccination Plan
http://www.medicalnewstoday.com/articles/132977.php
Some women's health advocates in Ireland are protesting a decision last month by Minister for Health Mary Harney to cancel the government's plan to vaccinate all 12-year-old girls against human papillomavirus, the <A href="http://www.

----------------------------------------------
** COLORECTAL CANCER News **

Colorectal Cancer: Race Gap Still Growing Among Americans
http://www.medicalnewstoday.com/articles/133104.php
A new report by a leading US cancer organization said that although progress in reducing the rate of new colorectal cancer cases and deaths is better than ever, the gap between blacks and whites is still growing, with the latest figures showing that among African Americans the death rates are about 45 per cent higher than among white Americans.

----------------------------------------------
** LUNG CANCER News **

International Tobacco Control Leaders Recognized By American Cancer Society
http://www.medicalnewstoday.com/articles/133030.php
The American Cancer Society has announced the winners of the 2009 Luther L. Terry Awards for Exemplary Leadership in Tobacco Control. The awards are named for the late United States Surgeon General Luther L.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Genta To Appeal FDA Decision On New Drug Application For Genasense(R) In Patients With Chronic Lymphocytic Leukemia
http://www.medicalnewstoday.com/articles/133015.php
Genta Incorporated (OTCBB: GNTA.OB) announced that the Company has filed an appeal of the recent negative decision by the Food and Drug Administration's (FDA) Office of Oncology Drug Products (OODP) regarding the Company's New Drug Application (NDA) for Genta's lead oncology product, Genasense® (oblimersen sodium) Injection.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Why Do Men Refuse Prostate Cancer Screening? Demographic Analysis In Turkey
http://www.medicalnewstoday.com/articles/132936.php
UroToday.com - Prostate cancer is one of the most common cancers in men, with a high incidence rate in Turkey. However, the early detection and diagnosis rates are considerably lower among Turkish men as compared with their counterparts in Western countries.

The Evolving Role Of Oestrogens And Their Receptors In The Development And Progression Of Prostate Cancer
http://www.medicalnewstoday.com/articles/132935.php
UroToday.com - The androgen receptor (AR) is currently the major target for prostate cancer (PCa) prevention and treatment. Nevertheless, there are multiple lines of evidence to suggest that oestrogens and their receptors are also involved in PCa development and tumor progression.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-14T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Cytokinetics Announces Clinical And Preclinical Data Regarding Ispinesib For Breast Cancer Treatment
http://www.medicalnewstoday.com/articles/132906.php
Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that two posters, one summarizing interim Phase I clinical trial data evaluating ispinesib in the treatment of breast cancer and another containing preclinical data for ispinesib, were presented at the 31st Annual San Antonio Breast Cancer Symposium (SABCS) held on December 10-14, 2008.

Agendia's MammaPrint(R) Predicts Response To Neoadjuvant Chemotherapy In Breast Cancer
http://www.medicalnewstoday.com/articles/132903.php
Agendia, a world leader in molecular cancer diagnostics, today announced MammaPrint(R)'s ability to predict response to neoadjuvant chemotherapy in breast cancer. Â Â Â Dr. Laura van 't Veer, from the Netherlands Cancer Institute, presented the data at the 2008 San Antonio Breast Cancer Symposium (SABCS) during the session Molecular profiling for guiding therapeutic decisions.

----------------------------------------------
** CANCER / ONCOLOGY News **

World's First Low Radiocarbon Food May Reduce Risks Of Cancer And Birth Defects
http://www.medicalnewstoday.com/articles/132904.php
An Ohio-based company has successfully grown the first Low Radiocarb(TM) food, in this case soybeans, with significantly lower levels of harmful radioactive carbon-14 than normally found in food.

Removal Of Pelvic Lymph Nodes Or Radiotherapy Cannot Be Recommended As Routine Treatments In Women With Early Endometrial Cancer (Astec Study)
http://www.medicalnewstoday.com/articles/132802.php
Two Articles published Online first and in an upcoming edition of The Lancet show that two common adjuvant treatments for women with early endometrial cancer - removing the pelvic lymph nodes or external beam radiotherapy - should not be part of routine care.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Recent London Improvements In Curative Radiation Therapy For Relevant Early Prostate Cancer
http://www.medicalnewstoday.com/articles/132934.php
UroToday.com - The most effective form of treatment for localized prostate cancer remains a matter of great debate. There are no randomized controlled trials comparing radiotherapy with prostatectomy.

Evaluation Of T2-Weighted And Dynamic Contrast-Enhanced MRI In Localizing Prostate Cancer Before Repeat Biopsy Radiology
http://www.medicalnewstoday.com/articles/132919.php
UroToday.com - Even with extended biopsy protocols, a negative set of biopsies does not rule out the presence of cancer. Among the patients with negative 10- to 12-core biopsy schemes, 17-21.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-13T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Herceptin Given Prior To Surgery Improves The Chance Of Survival Without Relapse For Women With HER2-positive Breast Cancer
http://www.medicalnewstoday.com/articles/132933.php
Standard one year Herceptin treatment provides long-term benefit to patients with high risk of recurrenceAbout 70% of women with locally advanced HER2-positive breast cancer were free of their disease three years after initiation of therapy when treated with Herceptin plus chemotherapy before surgery, compared to only around 50% of patients receiving pre-operative chemotherapy alone.

Wyeth Announces Positive Data From Phase 2 Study Of Neratinib In Advanced HER-2-Positive Breast Cancer
http://www.medicalnewstoday.com/articles/132916.php
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced data from an open-label phase 2 clinical trial of neratinib (HKI-272) in women with advanced HER-2-positive breast cancer. These data suggest that neratinib has antitumor activity in patients with advanced breast cancer positive for the ErbB-2 receptor (also known as HER-2 or Neu).

RAD001 Shows Potential To Reverse Resistance To Herceptin(R) In Metastatic Breast Cancer Patients, Leading To Phase III Trial
http://www.medicalnewstoday.com/articles/132915.php
New data from two early clinical studies show that RAD001(R) (everolimus) may overcome resistance to Herceptin(R) (trastuzumab) in women with HER2-positive metastatic breast cancer. These results support the initiation of a Phase III clinical trial program to fully explore the potential of RAD001 (proposed brand name Afinitor(R)) in breast cancer.

RAD001 Shows Promise In Tough-to-Treat Breast Cancer Patients
http://www.medicalnewstoday.com/articles/132914.php
SAN ANTONIO - Investigators are reporting favorable early results using RAD001 (Afinitor) combined with weekly paclitaxel and trastuzumab to treat patients with HER-2 overexpressing metastatic breast cancer who have demonstrated prior resistance to trastuzumab.

Scholarships For San Antonio Breast Cancer Symposium Awarded To Influential Breast Cancer Advocates
http://www.medicalnewstoday.com/articles/132708.php
The HER2 Support Group, an organization dedicated solely to supporting women with HER2 breast cancer, has announced the recipients of a prestigious scholarship. Along with the Alamo Breast Cancer Foundation (ABCF), the HER2 Support Group selected Heather Gilbert of Lakeforest, California, and Gayla Little of Fair Oaks, Indiana, to attend the ABCF Advocate Program.

----------------------------------------------
** CANCER / ONCOLOGY News **

Good News For Young Male Cancer Patients
http://www.medicalnewstoday.com/articles/132928.php
"Young men undergoing treatment for cancer often want to know how the disease and its treatment affect their chances of fathering healthy children. Our large-scale study shows that there is a slightly higher risk of deformities, but the actual risk of having a child with deformities is nevertheless extremely low.

Potential For Early Cancer Diagnosis Technique
http://www.medicalnewstoday.com/articles/132875.php
A team led by a Northwestern University biomedical engineer has developed a new optical technique that holds promise for minimally invasive screening methods for the early diagnosis of cancer.

Comment By American Heart Association On The International Agency For Research On Cancer, World Cancer Report
http://www.medicalnewstoday.com/articles/132809.php
The International Agency for Research on Cancer (IARC), a division of the World Health Organization (WHO), has released updated cancer death projections in a call to action, asking the government to help fund cancer prevention and research initiatives and international tobacco control policies.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-12T23:02:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Tyverb(R)/Tykerb(R) Plus Letrozole Significantly Delayed Disease Progression In Post-menopausal Women With ErbB2 Positive Metastatic Breast Cancer
http://www.medicalnewstoday.com/articles/132882.php
New results from a study in metastatic breast cancer showed that the combination of Tyverb®/Tykerb® (lapatinib) plus letrozole as a first line treatment regimen provided a significant improvement in delaying disease progression when compared to treatment with Femara® (letrozole) alone.

Breast Cancer Drugs In The Pipeline
http://www.medicalnewstoday.com/articles/132869.php
Scientists in the clinic and the laboratory continue to work to drive breast cancer mortality rates down with breakthrough drugs. With tamoxifen's discovery 30 years behind us, and the impact of Herceptin still being felt, researchers are studying zoledronic acid, aromatase inhibitors and monoclonal antibodies, among others, with encouraging results.

New Data Shows Zometa(R) Enhances Impact Of Chemotherapy On Reducing Breast Tumour Size
http://www.medicalnewstoday.com/articles/132855.php
New data released today demonstrates that the addition of Zometa(R) (zoledronic acid) infusion to standard chemotherapy before breast cancer surgery reduces the size of breast tumours more effectively than chemotherapy alone in women with early-stage disease.

Women With Metastatic Breast Cancer Can Benefit From Estrogen Pills
http://www.medicalnewstoday.com/articles/132854.php
For breast cancer survivors, the idea of taking estrogen pills is almost a taboo. In fact, their doctors give them drugs to get rid of the hormone because it can fuel the growth of breast cancer.

Tamoxifen's Power Comes From Endoxifen, Mayo Clinic Researchers Find
http://www.medicalnewstoday.com/articles/132836.php
Mayo Clinic researchers have discovered that a chemical known as endoxifen appears to be the primary metabolite responsible for the effectiveness of tamoxifen in treating breast cancer, and that it works against cancer in an entirely unexpected way.

Age-Related Breast Cancer Rates Differ Among Black, White Women, Study Finds
http://www.medicalnewstoday.com/articles/132803.php
Black women have higher rates of early-onset breast cancer and lower rates of late-onset breast cancer than their white counterparts, according to a study published in the December <cite>Journal of the National Cancer Institute</cite>, <a href="http://www.

Study Adds To Evidence That Age-Related Breast Cancer Rates Differ Among Racial Groups
http://www.medicalnewstoday.com/articles/132781.php
White women have lower rates of early-onset breast cancer and higher rates of late-onset breast cancer compared with black women, according to a <A href="http://jnci.oxfordjournals.org/cgi/content/full/djn411" target=_new>study</A> published in the <CITE>Journal of the National Cancer Institute</CITE>, <A href="http://www.

Femara 1st Aromatase Inhibitor To Indicate Overall Survival Benefit Versus Tamoxifen When Taken For Five Years After Breast Cancer Surgery
http://www.medicalnewstoday.com/articles/132767.php
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding - In a separate censored analysis excluding patients after they crossed over to Femara, reduction in risk of death was 19% (HR= 0.

Zoledronic Acid With Neoadjuvant Chemotherapy May Boost Pathological Response In Breast Cancer Patients
http://www.medicalnewstoday.com/articles/132761.php
SAN ANTONIO - New data suggest that adjuvant treatment with the bisphosphonate zoledronic acid (<a href="http://www.zometa.com" target="_blank" rel="nofollow">Zometa</a>) plus chemotherapy may have a direct anti-tumor effect in women with breast cancer who are at high risk of a relapse.

Tamoxifen's Power Comes From Endoxifen, Which They Say Could Potentially Be Turned Into A Breast Cancer Drug
http://www.medicalnewstoday.com/articles/132753.php
Mayo Clinic researchers have discovered that a chemical known as endoxifen appears to be the primary metabolite responsible for the effectiveness of tamoxifen in treating breast cancer, and that it works against cancer in an entirely unexpected way.

Meta Analyses Of Global Trials Finds In Favor Of Aromatase Inhibitors
http://www.medicalnewstoday.com/articles/132746.php
Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back.

New Data Show Zometa(R) Enhances Impact Of Chemotherapy On Reducing Breast Tumor Size
http://www.medicalnewstoday.com/articles/132734.php
New data released demonstrate that the addition of Zometa(R) (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than chemotherapy alone in women with early-stage disease.

Easton Honored With Inaugural AACR Outstanding Investigator Award In Breast Cancer Research
http://www.medicalnewstoday.com/articles/132730.php
Douglas Easton, Ph.D., whose international studies in breast cancer explained the genetic patterns and causes of the BRCA1 and BRCA2 gene mutations which indicate a person's risk for breast cancer, has been selected to receive the inaugural American Association for Cancer Research (AACR) Outstanding Investigator Award in Breast Cancer Research.

Breast Cancer - AstraZeneca's Response To Letrozole Datapresented At San Antonio Breast Cancer Symposium (SABCS), 11 -14 December 2008
http://www.medicalnewstoday.com/articles/132727.php
AstraZeneca is pleased to see additional data presented at SABCS reinforce that there is no evidence that a sequencing strategy is superior to a 5 year aromatase inhibitor (AIs) strategy. AstraZeneca believes that AIs should be used upfront in all newly diagnosed breast cancer postmenopausal women as it is critical to keep patients cancer free for as long as possible.

----------------------------------------------
** CANCER / ONCOLOGY News **

GTCbio Announces Its 2nd Annual Oncology Biomarkers Conference
http://www.medicalnewstoday.com/articles/132868.php
GTCbio just announced its 2nd Annual Oncology Biomarkers Conference taking place on January 19-20, 2009 in Miami, Florida.The conference will take attendees through "The Life Cycle of a Cancer Biomarker"; examining the path from the identification of a candidate biomarker, development through validation, onto the clinic to be able to identify unmet needs and spark new discoveries back in the laboratory.

Samir Hanash To Give Keynote Speech At GTCbio's 2nd Oncology Biomarkers Conference On January 19-20, 2009 In Miami, Florida
http://www.medicalnewstoday.com/articles/132867.php
Dr. Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center in Seattle, WA will give the keynote address on the discovery and development of biomarkers at the 2nd annual Oncology Biomarkers Conference on January 19-20, 2009 in Miami, Florida.

Viralytics Positive Pre-clinical Research Results On CAVATAKTM In Human Brain Cancer
http://www.medicalnewstoday.com/articles/132849.php
Viralytics Limited (ASX:VLA) Researchers from the University of Newcastle and Viralytics Limited have demonstrated the first step to "proof of concept" with the destruction of human brain tumours by CAVATAKTM , Viralytics' lead product.

Researcher Invents Lethal 'Lint Brush' To Capture And Kill Cancer Cells In The Bloodstream
http://www.medicalnewstoday.com/articles/132747.php
In a new tactic in the fight against cancer, Cornell University researcher Michael King has developed what he calls a lethal "lint brush" for the blood -- a tiny, implantable device that captures and kills cancer cells in the bloodstream before they spread through the body.

Enrollment In Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point
http://www.medicalnewstoday.com/articles/132738.php
Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company testing its proprietary Percutaneous Hepatic Perfusion ("PHP") System for the treatment of cancers of the liver, announced today that the first fifty percent (46 of 92) of patients have been enrolled in the Phase III clinical trial treating metastatic cutaneous and ocular melanoma to the liver.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

January Is Cervical Health Awareness Month
http://www.medicalnewstoday.com/articles/132751.php
According to the American Cancer Society, 3,870 mothers, daughters, and wives will die from cervical cancer in 2008. Over 11,000 new cases of cervical cancer will be diagnosed by year's end. The Cancer Institute of New Jersey (CINJ) is making experts available to discuss risk factors, treatment and prevention options surrounding cervical cancer.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

NM Tech, Biomoda Win Legislative Support For Lung Cancer Screening
http://www.medicalnewstoday.com/articles/132759.php
The New Mexico State Legislature's Interim Tobacco Settlement Committee has recommended $730,000 in funding to continue a pilot program to screen veterans for early-stage lung cancer. The request in favor of the clinical study administered by the New Mexico Department of Veterans Services (NMDVS) came from the New Mexico Institute of Mining and Technology (NM Tech) and Biomoda, Inc.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Promising Results From Two Trials Highlighting Developmental Oral IMiDS(R) Compound Pomalidomide Presented At The ASH
http://www.medicalnewstoday.com/articles/132881.php
Celgene International Sarl (Nasdaq: CELG) today announced that its next IMiDs compound, pomalidomide, has shown promising activity with manageable safety and tolerability for the treatment of relapsed/refractory multiple myeloma (MM) and myelofibrosis.

Clinical Trial Focuses On New Drug For Solid Cancer Tumors And NHL
http://www.medicalnewstoday.com/articles/132752.php
Researchers at The Cancer Institute of New Jersey (CINJ) have opened a clinical trial, which aims to evaluate a new treatment for solid cancer tumors and non-Hodgkin's lymphoma (NHL) in combination with a chemotherapy agent called cyclophosphamide.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-11T23:02:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

New Data Evaluating ABRAXANE In Early-Stage Breast Cancer And In Combination With Novel Investigational Agents To Be Presented At SABCS
http://www.medicalnewstoday.com/articles/132696.php
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced that multiple studies of ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin bound) will be presented at the 31st Annual San Antonio Breast Cancer Symposium on December 10-14, 2008.

Roswell Park Receives Grant To Study Link Between Breast Cancer And Low Vitamin D Levels
http://www.medicalnewstoday.com/articles/132552.php
Roswell Park Cancer Institute is the recipient of a $199,998 award from The Breast Cancer Research Foundation to study the link between vitamin D and the occurrence of breast cancer in white and African-American women.

----------------------------------------------
** CANCER / ONCOLOGY News **

Guided Therapeutics, Inc. Submits First Module Of Premarket Approval Application For Painless Cervical Cancer Detection To FDA
http://www.medicalnewstoday.com/articles/132713.php
<a href="http://www.guidedinc.com/" target="_blank" rel="nofollow">Guided Therapeutics, Inc.</a> (GT) (Pink Sheets: GTHP) today announced it submitted the first of three modules of its Premarket Approval (PMA) application to the U.

New Way Of Viewing Cells Could Lead To Easier Routes For Drug Manufacture
http://www.medicalnewstoday.com/articles/132701.php
Research by a Michigan State University chemist could eventually lead to a quicker and easier way of developing protein-based drugs that are key to treating a number of diseases, including cancer, diabetes and hepatitis.

Alnylam Forms Collaboration With University Of California, San Francisco To Investigate Therapeutic Silencing Of Key Gene Implicated In Uveal Melanoma
http://www.medicalnewstoday.com/articles/132697.php
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has formed an exclusive collaboration with the University of California, San Francisco (UCSF) to evaluate the potential of an RNAi therapeutic targeting a heterotrimeric G protein alpha-subunit, known as G-alpha q or GNAQ, for the treatment of metastatic uveal melanoma.

Data From Eight Clinical Trials Facilitated By The Multiple Myeloma Research Consortium (MMRC) Presented At The ASH Annual Meeting
http://www.medicalnewstoday.com/articles/132694.php
The Multiple Myeloma Research Consortium (MMRC) today announced that data from eight clinical trials in its portfolio as well as findings from the MMRC Multiple Myeloma Genomics Initiative were presented at the American Society of Hematology's (ASH) 50th Annual Meeting and Exposition held Dec.

Cancer pain - Orexo: Abstral Receives Marketing Approval In Germany
http://www.medicalnewstoday.com/articles/132688.php
Orexo (STO:ORX) confirms the announcement made by ProStrakan Group plc (LSE:PSK), Orexo's partner for Abstral® in Europe and North America, that it has received a Marketing Authorisation from the German regulatory authority, BfArM for Abstral (for breakthrough cancer pain).

Oncology Drug Iressa Better Than Chemotherapy In Some Patients, According To New Report From Cutting Edge Information
http://www.medicalnewstoday.com/articles/132678.php
Iressa's sales are poised to increase on positive clinical results suggesting that AstraZeneca's targeted lung cancer therapy performs better than standard chemotherapy in many patients, according to a new report, <a href="http://www.

Gene Mutation That Causes Eye Cancer Discovered By UBC Researchers
http://www.medicalnewstoday.com/articles/132664.php
A University of British Columbia geneticist has discovered a gene mutation that can cause the most common eye cancer - uveal melanoma.Catherine Van Raamsdonk, an assistant professor of medical genetics in the UBC Faculty of Medicine and a team of researchers, have discovered a genetic mutation in a gene called GNAQ that could be responsible for 45 per cent of the cases of uveal melanoma.

Expected Surge In Older Cancer Survivors As Baby Boomers Age
http://www.medicalnewstoday.com/articles/132654.php
The United States could be faced with a national health care crisis in the coming decades as the country's baby boomer population ages and a growing number of older adults find themselves diagnosed with and living longer with cancer.

Earlier Diagnosis Of Oral Cancers
http://www.medicalnewstoday.com/articles/132642.php
Worldwide, more than 500,000 new cases of cancer of the mouth are diagnosed each year. The majority of these cancers are found too late, causing many people to die within five years of finding out they have cancer.

Survival Stable For Common Cancers In England
http://www.medicalnewstoday.com/articles/132607.php
Figures released by the Office for National Statistics today show that survival continues to vary widely between different types of cancer. Over 96 per cent of men diagnosed in England in 2000-2004 with cancer of the testis survived five years, as did 81 per cent of women diagnosed with breast cancer.

Tiny Delivery System With A Big Impact On Cancer Cells - Nano Letters
http://www.medicalnewstoday.com/articles/132592.php
Researchers at Penn State University are reporting for the first time that nanoparticles 1/5,000 the diameter of a human hair encapsulating an experimental anticancer agent, kill human melanoma and drug-resistant breast cancer cells growing in laboratory cultures.

Neogenix Oncology To Begin First Clinical Trial For A New Generation Of Diagnostic Products
http://www.medicalnewstoday.com/articles/132559.php
Neogenix Oncology, Inc. (Neogenix) announced today that the Institutional Review Board (IRB) at Conemaugh Valley Memorial Hospital (Memorial Medical Center) in Johnstown, Pennsylvania, has approved the company's protocol for its first Diagnostic Clinical Trial.

American Cancer Society Launches Quitline Program In India
http://www.medicalnewstoday.com/articles/132557.php
The American Cancer Society today announced that it is launching its Quitline® service in India. The program will be provided through multi-national employers with operations in India. The Society's Quitline program is a clinically proven, free telephone-based counseling service that provides counseling and pharmacological service to more than 100 employers and health plans and 13 states in the U.

Parents' Reactions To Child Cancer Determined By Type
http://www.medicalnewstoday.com/articles/132555.php
The type of cancer a child has goes a long way towards determining how his or her parents cope with the situation, according to a study from Karolinska Institutet. Parents of children treated for skeletal and brain tumours run a relatively much higher risk of becoming distressed and depressed than parents of children with other common types of cancer.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Seattle Genetics Announces Interim Safety Analysis Supports Continuation Of Lintuzumab Phase IIb Clinical Trial
http://www.medicalnewstoday.com/articles/132714.php
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that an Independent Data Monitoring Committee (IDMC) has completed a pre-specified safety review of data from the ongoing phase IIb trial of lintuzumab (SGN-33) in combination with low-dose cytarabine chemotherapy for older patients with acute myeloid leukemia (AML).

ERYtech Pharma Announces The Results Of Its Phase II Clinical Trial
http://www.medicalnewstoday.com/articles/132700.php
ERYtech Pharma, the specialty pharmaceuticals company developing red cell-based medicinal products, announces the results of its phase II clinical trial. GRASPALL 2005-1 was presented orally on the 8th December 2008 at the 50th Annual Meeting of the American Society of Hematology in San Francisco (USA).

Group In Lymphoma Research Chooses Revlimid For Study In Disease's Largest Patient Population
http://www.medicalnewstoday.com/articles/132674.php
Celgene International Sarl (Nasdaq: CELG) and the Groupe d'Etude des Lymphomes de l'Adulte (GELA) today announced the initiation of an international randomized, double-blind, controlled Phase III study to evaluate the therapeutic potential of REVLIMID (lenalidomide) as a maintenance therapy for elderly, high-risk patients with diffuse large B-cell lymphoma (DLBCL) who have responded to standard first line Rituximab, Cyclophosphamide, Doxorubicin, Oncovin and Prednisolone (R-CHOP).

Prolonged Overall Survival For Patients With Acute Myeloid Leukemia Demonstrated By Data
http://www.medicalnewstoday.com/articles/132593.php
The Myelodysplastic Syndromes (MDS) Foundation have announced that data presented at this year's American Society of Hematology (ASH) Meeting in San Francisco demonstrate that patients with acute myeloid leukemia (AML) who were treated with VIDAZA (azacitidine) had significantly increased overall survival compared to those treated with conventional care regimens (CCR).

Promising Results From 2 Trials Highlighting Pomalidomide Presented At ASH
http://www.medicalnewstoday.com/articles/132590.php
Celgene International Sarl (Nasdaq: CELG) has announced that its next IMiDs compound, pomalidomide, has shown promising activity with manageable safety and tolerability for the treatment of relapsed/refractory multiple myeloma (MM) and myelofibrosis.

Data Presented At This Year's ASH Meeting Demonstrate Prolonged Overall Survival For Patients With Acute Myeloid Leukemia
http://www.medicalnewstoday.com/articles/132560.php
The Myelodysplastic Syndromes (MDS) Foundation announced today that data presented at this year's American Society of Hematology (ASH) Meeting in San Francisco demonstrate that patients with acute myeloid leukemia (AML) who were treated with VIDAZA (azacitidine) had significantly increased overall survival compared to those treated with conventional care regimens (CCR).

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Cardiac Deaths Do Not Appear To Be Increased By Hormone Therapy For Prostate Cancer
http://www.medicalnewstoday.com/articles/132704.php
Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers.

Vitamin E Or Selenium Supplementation Not Associated With Reduced Risk Of Prostate Or Other Cancers
http://www.medicalnewstoday.com/articles/132532.php
Supplementation with either selenium or vitamin E does notappear to reduce the risk of prostate cancer or other cancers,according to a study released on early December 9, 2008 Online in JAMA.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-10T23:02:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Survival In Patients With Metastatic Breast Cancer Improved By Nonhormonal Treatment Regimens
http://www.medicalnewstoday.com/articles/132467.php
Nonhormonal treatment regimens, including anthracycline-based regimens and taxanes, have improved overall survival in women with advanced (metastatic or recurrent inoperable) breast cancer over the last 35 years, according to a systematic review published December 9 in the Journal of the National Cancer Institute.

----------------------------------------------
** CANCER / ONCOLOGY News **

Curis Announces Genentech's Initiation Of Phase II Clinical Trial In Advanced Ovarian Cancer With Hedgehog Pathway Inhibitor
http://www.medicalnewstoday.com/articles/132526.php
Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation proprietary targeted medicines for cancer treatment, today announced that its collaborator Genentech has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog pathway inhibitor, as a maintenance therapy for ovarian cancer patients in second or third complete remission.

CyDex Pharmaceuticals Receives Orphan-Drug Designation For Melphalan
http://www.medicalnewstoday.com/articles/132524.php
CyDex Pharmaceuticals, Inc. today announced that it has received orphan-drug designation from the U.S. Food and Drug Administration (FDA) for melphalan "as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation.

Geron Presents Interim Clinical Data On Its Telomerase Inhibitor Drug Trial In Patients With Multiple Myeloma
http://www.medicalnewstoday.com/articles/132506.php
Geron Corporation (Nasdaq:GERN) today announced the presentation of interim data at the 2008 meeting of the American Society of Hematology in San Francisco, CA, for its ongoing clinical trial of GRN163L, a telomerase inhibitor drug, in patients with relapsed and refractory multiple myeloma.

Cancer Deaths To Double Over Next Two Decades
http://www.medicalnewstoday.com/articles/132500.php
Tobacco use and the spread of Westernized lifestyles are the two main factors pushing up cancer death figures in developing countries globally, according to a new report issued by <a href="http://www.

CAL-101, An Oral P110Î´ Isoform-Selective PI3 Kinase Inhibitor, Demonstrates Preclinical Activity In Hematologic Cancer Cells
http://www.medicalnewstoday.com/articles/132494.php
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective PI3 kinase inhibitors for the treatment of cancer and inflammatory diseases, today announced the presentation of data demonstrating that the Company's oral, p110Î´(delta) selective PI3 kinase inhibitor CAL-101 has broad preclinical anti-tumor activity against a range of hematologic malignancies.

Landmark Analysis Shows Continuous Treatment With REVLIMID(R) Plus Dexamethasone Significantly Increases Overall Survival In Multiple Myeloma Patients
http://www.medicalnewstoday.com/articles/132493.php
Celgene International SÃ rl (NASDAQ: CELG) announced that data from a landmark analysis of patients with relapsed/refractory multiple myeloma found that continuous treatment with REVLIMID (lenalidomide) in combination with dexamethasone after achieving best response resulted in significantly longer overall survival and increased time to disease progression compared to those who discontinued treatment after ten months or less.

GPC Biotech Opens Enrollment In Phase 1 Trial Evaluating RGB-286638 Multi-Targeted Protein Kinase Inhibitor In Patients With Advanced Solid Tumors
http://www.medicalnewstoday.com/articles/132486.php
GPC Biotech AG (Frankfurt Stock Exchange: GPC; NASDAQ: GPCB) today announced that enrollment has opened in a Phase 1 study evaluating RGB-286638 in patients with advanced solid tumors. This is the first time that this novel drug candidate is being studied in human clinical trials.

Radon Causes 100 Times More Deaths Than Carbon Monoxide Poisoning - EPA Launches National Radon Action Month
http://www.medicalnewstoday.com/articles/132483.php
Jamey J. Gelina, President of Air Quality Control, the Nation's largest radon gas mitigation and engineering agency is reminding the media that National Radon Action Monthis quickly approaching.

Mutation In Bone Marrow Cancers Blocked By Promising New Drug , May Also Help Patients With Rheumatoid Arthritis
http://www.medicalnewstoday.com/articles/132473.php
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.The oral drug, called CYT387, was tested in mice as well as in human cells.

News From The Journal Of The National Cancer Institute, Dec. 9
http://www.medicalnewstoday.com/articles/132470.php
Age-Related Crossover in Breast Cancer Incidence Between Black and White Ethnic Groups Appears RobustAmong women younger than 40 years, black women have a higher incidence of breast cancer than white women.

The Economic Cost Of Cancer Mortality Is High In The US, Regardless Of How Cost Is Measured
http://www.medicalnewstoday.com/articles/132468.php
The economic cost of death due to cancer is high in the United States, regardless of whether researchers estimate the economic impact in lost work productivity or in a more global measure using the value of one year of life, according to two studies published online December 9 in the Journal of the National Cancer Institute.

Vitamin C Or E Supplementation Not Associated With Reduced Risk Of Prostate Or Other Cancers
http://www.medicalnewstoday.com/articles/132410.php
Long-term supplementation with either vitamin E or vitamin C does not appear to reduce the risk of prostate cancer or other cancers, according to a study released on early December 9, 2008 Online in JAMA.

Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials Of Carfilzomib In Multiple Myeloma At The 50th Annual Meeting
http://www.medicalnewstoday.com/articles/132389.php
Proteolix, Inc. announced positive clinical data demonstrating that the company's lead product, carfilzomib, has single-agent activity and promotes durable responses in patients with relapsed and refractory multiple myeloma.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Clinical Studies Identify Oral Drug As Promising Future Treatment For Patients With Rare Subtype Of Non-Hodgkin Lymphoma
http://www.medicalnewstoday.com/articles/132539.php
Lenalidomide, an oral drug targeting the immune system, appears to have promise as a novel future treatment for patients with relapsed or refractory mantle-cell lymphoma, according to a study led by <a href="http://www.

ZIOPHARM Presents Positive Darinaparsin Phase II Data At ASH Meeting
http://www.medicalnewstoday.com/articles/132527.php
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that on December 6th it presented positive data from a Phase II study of darinaparsin (ZinaparTM) for the treatment of advanced lymphomas at the 50th American Society of Hematology (ASH) Annual Meeting held in San Francisco, CA.

Intense Chemotherapy Wards Off Recurrence In Half Of Mantle Cell Lymphoma Patients After Seven Years
http://www.medicalnewstoday.com/articles/132511.php
More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as frontline treatment remain in remission seven years later, researchers at The University of Texas M.

Dangerous Side Effect For Lymphoma Patients Prevented By New Therapy
http://www.medicalnewstoday.com/articles/132509.php
Patients respond well to a new three-drug combination for indolent B cell lymphoma that also spares them prolonged, potentially lethal, suppression of blood production in the bone marrow, researchers at The University of Texas M.

ChemGenex's Omacetaxine Demonstrates 80% Complete Hematological Response Rate In Drug-Resistant CML Patients With The T315I Mutation
http://www.medicalnewstoday.com/articles/132501.php
ChemGenex Pharmaceuticals (ASX: CXS) (NASDAQ: CXSP) announced today positive interim clinical data from 44 patients enrolled in its ongoing phase 2/3 trial of omacetaxine mepesuccinate in chronic myeloid leukemia (CML) patients with the T315I mutation.

VIDAZA(R) AZA-001 Study Reports Unprecedented Survival Benefit In Higher-Risk MDS Extends To AML Patients
http://www.medicalnewstoday.com/articles/132490.php
Celgene International SÃ rl (NASDAQ: CELG) today announced results from a subset analysis of the international phase III trial (AZA-001) demonstrating that the overall survival benefit observed in higher-risk MDS patients extends to patients with acute myeloid leukemia (AML).

Dacogen(R) (decitabine For Injection) Data On Phase II Clinical Trial In Elderly Patients With Acute Myeloid Leukemia (AML)
http://www.medicalnewstoday.com/articles/132469.php
Eisai Corporation of North America today announced data from a Phase II trial evaluating a five-day dosing regimen of Dacogen® (decitabine for injection) in acute myeloid leukemia (AML), the most common form of leukemia.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-09T23:02:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Discovery Of Protein That Contributes To Cancer Spread
http://www.medicalnewstoday.com/articles/132370.php
In an important finding published online in Developmental Cell, researchers at Albert Einstein College of Medicine of Yeshiva University, along with collaborators at Massachusetts Institute of Technology, have identified a protein likely responsible for causing breast cancer to spread.

Controversy Over Breast Cancer Screening: Oldest Old 'Hanging In The Balance?'
http://www.medicalnewstoday.com/articles/132348.php
A lack of clear-cut, scientific evidence illustrating the benefits of mammography screening in women over 80 has created a trail of controversy leading to a disturbing conclusion about cancer care in America.

Poorer Outcomes For Breast Cancer Patients With Marital Problems
http://www.medicalnewstoday.com/articles/132334.php
Breast cancer patients who have a poor relationship with their spouse may face a more difficult road to recovery than would other women, according to a new study.Researchers found that, over five years, patients in distressed marriages had higher levels of stress, less physical activity, slower recovery and more symptoms and signs of illness than did similar patients who reported good marriages.

Tools Designed To Help Guide Treatment Decisions In Breast Cancer Are Too Complex For Most Patients To Understand, UM Study Finds
http://www.medicalnewstoday.com/articles/132302.php
A new study from researchers at the University of Michigan Comprehensive Cancer Center found that a tool commonly used by doctors to estimate the risk of a woman's breast cancer returning after surgery is not very effective at explaining risk to patients.

----------------------------------------------
** CANCER / ONCOLOGY News **

New Medicine Recommendation By SMC Means Better Quality Of Life For Palliative Care Patients In Scotland
http://www.medicalnewstoday.com/articles/132376.php
The Scottish Medicines Consortium (SMC) has today recommended Relistor (methylnaltrexone bromide) for use by the NHS in Scotland. Relistor is a new treatment developed to help overcome opioid-induced constipation, a common problem for many end-of-life patients receiving palliative care.

State Policies Have Little Effect On Reducing Minors' Indoor Tanning Use
http://www.medicalnewstoday.com/articles/132363.php
A new analysis finds that state policies meant to limit minors' indoor tanning use have had little effect. Published in the January 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that additional efforts are needed to reduce indoor tanning use in youth.

Genetic Signature Predicts Outcome Of Pediatric Liver Cancer
http://www.medicalnewstoday.com/articles/132356.php
Scientists have identified a genetic signature that is remarkably effective at predicting the prognosis of an aggressive liver cancer in children. The research, published by Cell Press in the December issue of the journal Cancer Cell, may lead to better treatments for pediatric liver cancers.

Brief Inhibition Of Cancer Target Is Effective And Less Toxic
http://www.medicalnewstoday.com/articles/132355.php
New research shows that the delicate balance between maximum clinical impact and toxicity may not be quite as fragile as scientists had previously believed. The study, published by Cell Press in the December issue of the journal Cancer Cell, is likely to have a major impact on the future design and implementation of targeted cancer therapies.

UK Kidney Cancer Patients Face Toxic, Out-dated Treatments With Little Hope Of Change If NICE Has Its Way
http://www.medicalnewstoday.com/articles/132343.php
Leading oncologist Professor Tim Eisen has expressed concerns that patients with advanced kidney cancer could be condemned to toxic, barely effective, 20 year-old treatments because the National Institute for Health and Clinical Excellence (NICE) is likely to rule out using all four of the new treatments it has assessed.

Race A Factor In Receiving Transplant Treatment For Bone Marrow Cancer But Does Not Affect Outcomes
http://www.medicalnewstoday.com/articles/132338.php
A new study by researchers at The Medical College of Wisconsin Cancer Center Milwaukee, has found that African Americans and whites have identical survival rates after undergoing autologous (self donor) bone marrow transplant treatment for a common cancer of the bone marrow (multiple myeloma).

Blocking Tumor Signals May Improve Anti-Tumor Response
http://www.medicalnewstoday.com/articles/132324.php
Blocking tumor driven signaling immune cells may improve a patient's immune response to cancer, according to a study conducted by Matthew Farren, in the laboratory of <a href="http://www.roswellpark.

Discovery Of An Achilles Heel In Cancer Cells
http://www.medicalnewstoday.com/articles/132312.php
A protein that shields tumor cells from cell death and exerts resistance to chemotherapy has an Achilles heel, a vulnerability that can be exploited to target and kill the very tumor cells it usually protects, researchers from the University of Illinois at Chicago show in a new study published in the Dec.

New Medicine Recommendation By Scottish Medicines Consortium Means Better Quality Of Life For Palliative Care Patients In Scotland
http://www.medicalnewstoday.com/articles/132311.php
The Scottish Medicines Consortium (SMC) has today recommended Relistor (methylnaltrexone bromide) for use by the NHS in Scotland. Relistor is a new treatment developed to help overcome opioid-induced constipation, a common problem for many end-of-life patients receiving palliative care.

Colorado State Study Looks At Cancer And Poverty
http://www.medicalnewstoday.com/articles/132287.php
A report released today by the Colorado Cancer Coalition and the Colorado Comprehensive Cancer Program of the Colorado Department of Public Health and Environment recommends that efforts should be made to reduce health disparities in disadvantaged populations by ensuring that Colorado residents, regardless of income, have access to quality health education, cancer screening and cancer treatment.

Prostate Cancer Drug Reduces Testosterone Levels In As Little As Three Days Without Initial Hormone Surge
http://www.medicalnewstoday.com/articles/132282.php
More than 95 % of men who took degarelix for prostate cancer saw their testosterone levels fall dramatically as early as three days after they started treatment, according to a paper in the December issue of BJU International.

OncoGenex Announces Significant Survival Advantage In Phase II Metastatic Prostate Cancer Trial
http://www.medicalnewstoday.com/articles/132217.php
On December 3, 2008, OncoGenex Pharmaceuticals (NASDAQ:OGXI) announced the results of its Phase 2 clinical trial comparing treatment of metastatic prostate cancer patients with its OGX-011 in combination with docetaxel and prednisone (the "OGX-011 arm") versus patients that received docetaxel and prednisone alone (the "control arm").

CHMP Recommends Approval In The European Union (EU) For New Options For Patients With Certain Primary Brain Tumors
http://www.medicalnewstoday.com/articles/132195.php
Schering-Plough Corporation (NYSE: SGP) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of the intravenous (IV) formulation of TEMODAL(R) (temozolomide) as an alternative to the already approved oral form of temozolomide in the EU.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Protein Levels Indicate Risk Of Death In Some Colorectal Cancer Patients
http://www.medicalnewstoday.com/articles/132350.php
A pair of proteins may help explain why people with surgically removed colorectal cancer and who are overweight, physically inactive, and follow a Western-pattern diet may have an increased risk of dying of the disease or other causes, Dana-Farber Cancer Institute scientists report in a new study.

Pilot Program Providing Colonoscopies To The Underserved - Connecticut
http://www.medicalnewstoday.com/articles/132293.php
An estimated 600 uninsured or underinsured Connecticut residents will be screened for colorectal cancer over the next year as part of a pilot program in which the University of Connecticut Health Center is a primary partner.

----------------------------------------------
** LUNG CANCER News **

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Preclinical Data On Kinase Inhibitor, AP24534, Demonstrating Inhibition Of All Known Variants Of The CML Target Protein BCR-ABL
http://www.medicalnewstoday.com/articles/132375.php
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced results of studies on its investigational, multi-targeted kinase inhibitor - AP24534 - showing complete inhibition of all known mutant variants of the target protein, Bcr-Abl, including the T315I mutant that is resistant to currently marketed therapies for chronic myeloid leukemia (CML).

Study Finds Statins Do Not Interfere With Rituximab Treatment For Lymphomas
http://www.medicalnewstoday.com/articles/132339.php
Statins, drugs widely prescribed to lower cholesterol, do not interfere with a commonly used medication to treat lymphomas, according to a Mayo Clinic study presented at the 50th Annual Meeting of the American Society of Hematology (<a href="http://www.

Data Shows Longest Ever Survival For Patients With Life-Threatening Leukaemia Treated With Breakthrough Treatment
http://www.medicalnewstoday.com/articles/132337.php
Nearly nine out of ten patients (86 percent) with a life-threatening leukaemia are still alive seven years after diagnosis when treated with Glivec (imatinib). Data from the largest clinical trial in newly diagnosed patients with Philadelphia chromosome positive (Ph+) chronic myeloid leukaemia (CML) demonstrate the longest overall survival observed to date in this disease area.

Why Gleevec-Type Drugs Control, But Do Not Eradicate Leukemia
http://www.medicalnewstoday.com/articles/132335.php
Oregon Health & Science University Knight Cancer Institute researchers are closer to understanding why certain chronic myeloid leukemia mutations are not stopped by the revolutionary targeted cancer pill, Gleevec, or similar therapies in that drug family.

'Networks' Of Interactive Genes May Predict If Leukemia Is Aggressive Or Slow-Growing
http://www.medicalnewstoday.com/articles/132323.php
Rather than testing for individual marker genes or proteins, researchers at the University of California, San Diego (UC San Diego) and the Moores UCSD Cancer Center have evidence that groups, or networks, of interactive genes may be more reliable in determining the likelihood that a form of leukemia is fast-moving or slow-growing.

Roswell Park Researchers Clarify Mechanisms Of Novel Therapy In Non-Hodgkin's Lymphoma Cells
http://www.medicalnewstoday.com/articles/132318.php
A significant number of patients with <a href="http://www.roswellpark.org/Site/Patient_Care/Types_of_Cancer/Hematology_Center/Lymphoma/Non_Hodgkin_Lymphoma_NHL" target="_blank" rel="nofollow">non-Hodgkin's lymphoma </a> have poor clinical outcomes because their cancer cells have become resistant to immunochemotherapy.

Second-Generation CML Drugs Show Promise As Frontline Therapy
http://www.medicalnewstoday.com/articles/132288.php
Two drugs approved as fallback therapy for chronic myelogenous leukemia (CML) appear to outperform historical benchmarks of the frontline medication when used as a first treatment in separate clinical trials, researchers at The University of Texas M.

Potential Breakthrough For T-Cell Lymphoma Patients With Drug That Mimics Folic Acid
http://www.medicalnewstoday.com/articles/132216.php
Preliminary results of a pivotal Phase 2 clinical trial of pralatrexate (PDX), a drug that partially works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma (PTCL).

Clinical Trial Finds Lenalidomide Safe As Single Therapy For Elderly CLL Patients
http://www.medicalnewstoday.com/articles/132214.php
The oral medication lenalidomide is safe and well-tolerated for elderly patients with chronic lymphocytic leukemia, a group without a well-defined frontline therapy for their disease, researchers from The University of Texas M.

Older Age Doesn't Affect Survival After Bone Marrow Transplant
http://www.medicalnewstoday.com/articles/132213.php
Age alone should not determine whether an older patient with acute myeloid leukemia or myelodysplastic syndrome receives a blood stem cell transplant from a matched donor, researchers of the Center for International Blood and Marrow Transplant Research reported at the 50th annual meeting of the American Society of Hematology.

International Clinical Study Confirms Effectiveness Of Lenalidomide For Patients With Relapsed, Aggressive Lymphoma
http://www.medicalnewstoday.com/articles/132212.php
Results of an international clinical study confirm the efficacy and safety of lenalidomide, an oral treatment, for patients with relapsed, refractory diffuse large B cell lymphoma (DLBCL). The research, led by Myron Czuczman, MD, Department of Medicine, Roswell Park Cancer Institute (RPCI), will be presented at the 2008 annual meeting of the American Society of Hematology, December 6-9, San Francisco, CA.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

-------------------------------------------------------------

Medical News Today News Alert

2008-12-08T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Professor Jan Vermorken Is The New Editor-in-chief Of Annals Of Oncology
http://www.medicalnewstoday.com/articles/132162.php
Professor Jan B. Vermorken, an internationally respected medical oncologist based at Antwerp University Hospital (Edegem, Belgium), has been appointed to be the next editor-in-chief of the cancer journal, Annals of Oncology.

First International Conference On Inflammatory Breast Cancer
http://www.medicalnewstoday.com/articles/132115.php
The University of Texas M. D. Anderson Cancer Center held the first international inflammatory breast cancer (IBC) conference on December 6-7, to bring together internationally recognized breast cancer clinicians and scientists.

U.K. Geneticists Concerned Patent Ruling On Breast Cancer Gene Test Could Stifle Innovation
http://www.medicalnewstoday.com/articles/132069.php
A recent ruling by the <A href="http://www.epo.org/" target=_new>European Patent Office</A> could make it more difficult and costly for health care providers in the United Kingdom to test for the BRCA1 genetic mutation, which can increase a woman's risk for breast cancer, London's <A href="http://www.

----------------------------------------------
** CANCER / ONCOLOGY News **

Precious Metal, Osmium, Could Lead To Next Generation Of Cancer Treatments
http://www.medicalnewstoday.com/articles/132175.php
A precious metal which has never before been used in a clinical setting is being developed as an anti-cancer agent by Warwick researchers. The metal, osmium, is closely related to platinum, which is widely used to treat cancers in the form of the drug cisplatin.

Supposed Help Against Tumors - How Glioblastoma Tumor Cells Use The Body's Protection
http://www.medicalnewstoday.com/articles/132136.php
Glioblastoma is one of the most common but also most aggressive brain tumors, almost invariably leading to death in a short time. It consists of different cell types and their precursors, complicating successful treatment.

Cancer Specialists Struggle With Giving Patients Bad News And Discussing High Cost Drugs
http://www.medicalnewstoday.com/articles/132131.php
Oncologists need more guidance to help them talk to their patients about difficult topics such as the cost of medication and treatment failure, according to a study published the latest issue of the <a href="http://www.

American Society Of Hematology Annual Meeting Late-Breaking Data
http://www.medicalnewstoday.com/articles/132121.php
Four studies highlighting late-breaking research advances in the treatment of cancer and sickle cell disease were presented at the 50th Annual Meeting of the American Society of Hematology in San Francisco, CA.

Study Shows Racial, Economic Disparities In Head, Neck Cancer Survival Rates
http://www.medicalnewstoday.com/articles/132100.php
Blacks and people living in poverty have lower survival rates for head and neck cancers than other groups, according to a report published recently in the journal <cite>Cancer</cite>, <a href="http://www.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Adding Rituximab (MabThera) To Chemotherapy Almost Doubles Complete Remission For People With Chronic Lymphocytic Leukaemia (CLL)
http://www.medicalnewstoday.com/articles/132177.php
Impressive new data presented today from two landmark studies show that a new 'immunochemotherapy' treatment combination allows people with the most common form of leukaemia(1,2,3) to almost double their chance of achieving a complete remission*, compared to those treated with chemotherapy alone(4,5).

Seattle Genetics Reports Durable Objective Responses With SGN-35 In Lymphoma - American Society Of Hematology 50th Annual Meeting
http://www.medicalnewstoday.com/articles/132159.php
Seattle Genetics, Inc. (Nasdaq: SGEN) today reported data from a phase I clinical trial of SGN-35, an antibody-drug conjugate (ADC), demonstrating multiple complete and partial responses at well-tolerated doses in patients with relapsed or refractory Hodgkin lymphoma and other CD30-positive hematologic malignancies.

Rituxan In Combination With Chemotherapy Improves Progression-Free Survival In Difficult-to-Treat Form Of Blood Cancer
http://www.medicalnewstoday.com/articles/132157.php
Genentech, Inc. (NYSE:DNA) and Biogen Idec (Nasdaq:BIIB) today announced that two global Phase III studies in chronic lymphocytic leukemia (CLL), CLL8 and REACH, showed Rituxan® (rituximab) plus chemotherapy significantly increased the time patients lived without their disease advancing, as defined by the primary endpoint of progression-free survival (PFS), when compared to chemotherapy alone.

Hairy-Cell Leukemia: 50 Years Of Research
http://www.medicalnewstoday.com/articles/132109.php
In 1958, Ohio State University cancer researcher Dr. Bertha Bouroncle first identified a deadly disease now known as hairy-cell leukemia, a once fatal disease that can now be effectively treated.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

European Prostate Cancer Device Market Will Be Driven By Earlier Detection Of Prostate Cancer, According To Millennium Research Group
http://www.medicalnewstoday.com/articles/132148.php
According to Millennium Research Group's (MRG's) European Markets forUrological Devices 2009 report, the prostate cancer device market-comprisingbrachytherapy seeds, cryotherapy, and high-intensity focused ultrasound(HIFU) devices-will be driven by earlier detection of prostate cancer due toan increase in screening over the next five years.

Reduced Muscle Strength And Functional Performance In Men With Prostate Cancer Undergoing Androgen Suppression: Cross-Sectional Investigation
http://www.medicalnewstoday.com/articles/132142.php
UroToday.com - It is becoming clearer that androgen suppression therapy (AST) is associated with undesirable side effects.1 While the decline in bone and lean mass following AST has been consistently documented, 2, 3 only scant information exists regarding the impact of testosterone suppression on muscle strength and physical performance.

Association Study Of Prostate Cancer Susceptibility Variants With Risks Of Invasive Ovarian, Breast, And Colorectal Cancer
http://www.medicalnewstoday.com/articles/132140.php
UroToday.com - A large genome-wide association study only identifies a modest association between prostate cancer (CaP) susceptibility loci and risk of ovarian and breast cancer susceptibility.

Targeted Delivery Of Cisplatin To Prostate Cancer Cells By Aptamer Functionalized Pt(IV) Prodrug-PLGA-PEG Nanoparticles
http://www.medicalnewstoday.com/articles/132139.php
UroToday.com - In the November 11, 2008 issue of the Proceedings of the National Academy of Sciences, USA, Dr. Shanta Dhar and researchers from MIT and Harvard presented in vitro and in vivo data on delivery of cisplatin to prostate cancer (CaP) cells by nanoparticles (NPs).

Men With Wives, Significant Others More Likely To Be Screened For Prostate Cancer
http://www.medicalnewstoday.com/articles/132134.php
Although the link between early screening and prostate cancer survival is well established, men are less likely to go for early screening unless they have a wife or significant other living with them, according to a study published in <a href="http://cebp.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-07T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Growing Focus On PI3-Kinase Pathway In Cancer Research Reported In GEN
http://www.medicalnewstoday.com/articles/131965.php
Researchers are taking a closer look at the phosphoinositide 3-kinase (PI3-kinase) pathway as studies continue to demonstrate that inhibiting this biological route suppresses tumor growth, reports Genetic Engineering & Biotechnology News (GEN).

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Doctor Assisted Suicides Ruled As Legal By Montana Judge
http://www.medicalnewstoday.com/articles/132104.php
Judge Dorothy McCarter ruled that a Billings, Montana, man who has terminal cancer may legally undergo doctor-assisted suicide. The ruling may well be appealed as Montana state says the State, rather than the court, should decide on such issues - whether a terminally ill patient has the right to take his/her own life.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Management Of The Side Effects Of Androgen Deprivation Therapy In Men With Prostate Cancer
http://www.medicalnewstoday.com/articles/132055.php
UroToday.com - This featured abstract and related review article describe the current management and prevention of the sequela of androgen deprivation therapy (ADT). While some side effects of ADT such as hot flashes have been appreciated for many years, other consequences such as the metabolic changes associated with ADT have only recently been highlighted in the medical literature.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-06T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Cryoablation Of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According To Study Presented At RSNA
http://www.medicalnewstoday.com/articles/132036.php
Early clinical experience with the FDA cleared Visica 2(TM) Treatment System from Sanarus Medical confirms the effectiveness of ultrasound guided cryoablation to completely eradicate small, unifocal Invasive Ductal Breast Cancer (IDC).

Mammograms Might Detect Cancers That Would Regress
http://www.medicalnewstoday.com/articles/132033.php
When women in four Norwegian countries began regular mammography every two years, breast cancer rates increased significantly, and this suggests that the mammography may have be detecting cancers that might have spontaneously regressed, according to an article released on November 24, 2008 in the Archives of Internal Medicine, one of the JAMA/Archives journals.

Few Ontario Women With Invasive Ovarian Cancer Referred For Genetic Testing Of Breast Cancer Genes
http://www.medicalnewstoday.com/articles/131962.php
An Ontario study of 491 women with invasive ovarian cancer found only a small proportion, 19%, were referred for genetic testing of BRCA1 and BRCA2, the breast cancer genes, which means family members are not informed of their cancer risk.

----------------------------------------------
** CANCER / ONCOLOGY News **

No news for this category today.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

The Power Of Ideas: A Proposal To Ignore "pussycat" Prostate Cancer
http://www.medicalnewstoday.com/articles/132048.php
Leading cancer scientists win innovation award for patient careScientists from The Institute of Cancer Research and The Royal Marsden Hospital have been named as the 2008 winners at the Medical Futures Innovation Awards ceremony celebrating clinical and commercial excellence this week.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-05T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Cancer Research Giants Collaborate To Present The CTRC-AACR San Antonio Breast Cancer Symposium
http://www.medicalnewstoday.com/articles/131977.php
This year marks the first <a href="http://www.aacr.org/home/scientists/meetings--workshops/ctrc-aacr-san-antonio-breast-cancer-symposium.aspx" target="_blank" rel="nofollow">San Antonio Breast Cancer Symposium</a> to include the collaborative efforts of the American Association for Cancer Research, the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio and the Baylor College of Medicine.

----------------------------------------------
** CANCER / ONCOLOGY News **

Geron Announces Initiation Of Phase I Clinical Trial Of Vaccine Candidate Targeting Telomerase By Merck & Co., Inc.
http://www.medicalnewstoday.com/articles/131888.php
Geron Corporation (Nasdaq:GERN) announced today that its collaborator, Merck & Co., Inc., has initiated a Phase I clinical trial of V934/V935, a non-dendritic cell based cancer vaccine candidate targeting telomerase.

Gene Packaging Tells Story Of Cancer Development
http://www.medicalnewstoday.com/articles/131876.php
To decipher how cancer develops, Johns Hopkins Kimmel Cancer Center investigators say researchers must take a closer look at the packaging.Specifically, their findings in the December 2, 2008, issue of PLoS Biology point to the three dimensional chromatin packaging around genes formed by tight, rosette-like loops of Polycomb group proteins (PcG).

More Than 200 Abstracts At ASH And SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current And Pipeline Therapies
http://www.medicalnewstoday.com/articles/131869.php
More than 200 abstracts from therapies across the Novartis Oncology portfolio will be presented at two December medical congresses, providing new data and profiling potential patient benefits from ongoing collaboration with the oncology community.

VentiRx Pharmaceuticals Commences Phase I Clinical Trial Of VTX-2337, A Novel TLR8 Agonist For The Treatment Of Oncology
http://www.medicalnewstoday.com/articles/131866.php
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer, respiratory and autoimmune diseases, announced today that it has initiated a Phase I clinical trial of VTX-2337, a selective TLR8 agonist for the treatment of cancer.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Black Women With Cervical Cancer Appear To Have Fewer Chemotherapy-Related Side Effects Than White Women, Study Finds
http://www.medicalnewstoday.com/articles/131946.php
Black women who have advanced and recurrent cervical cancer seem to have fewer side effects from a commonly used form of chemotherapy than white women, according to a study published in the November issue of the <cite>American Journal of Obstetrics and Gynecology</cite>, <a href="http://www.

GlaxoSmithKline To Reduce Price Of HPV Vaccine Cervarix In South Africa
http://www.medicalnewstoday.com/articles/131918.php
<A href="http://www.gsk.com/" target=_new>GlaxoSmithKline</A> on Wednesday announced it will reduce the cost of its human papillomavirus vaccine Cervarix in South Africa, <A href="http://www.

BD Receives FDA Approval For The BD FocalPoint(TM) GS Imaging System To Enhance The Detection Of Cervical Cancer
http://www.medicalnewstoday.com/articles/131870.php
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for the BD FocalPoint(TM) GS Imaging System.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Feline Leukemia May Provide Pathway For Curing Human Diseases
http://www.medicalnewstoday.com/articles/131953.php
Researchers at The Hospital for Sick Children (SickKids) are studying how feline leukemia viruses (FeLVs) - one of the leading causes of death in young cats - can be used to treat human diseases.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Cell Genesys And Takeda Announce Termination Of Collaboration Agreement For GVAX Immunotherapy For Prostate Cancer
http://www.medicalnewstoday.com/articles/131856.php
Cell Genesys, Inc. (Nasdaq:CEGE) and Takeda Pharmaceutical Company Limited (TSE:4502), together with its wholly owned subsidiary Millennium: The Takeda Oncology Company, today announced that they have mutually agreed to suspend the further development of GVAX immunotherapy for prostate cancer and that Takeda has ended the collaboration agreement with Cell Genesys for the development and commercialization of the product.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-04T23:02:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Novel Basis Identified For Tamoxifen Failure
http://www.medicalnewstoday.com/articles/131800.php
Tamoxifen may worsen breast cancer in a small subset of patients. Research published in BioMed Central's open access journal Breast Cancer Research suggests that in patients who show reduced or absent expression of the protein E-cadherin, commonly used anti-oestrogen drugs such as tamoxifen may promote more harmful cancer cell behaviour.

Breast Radiation Exposure Reduced By 50 Percent Using Angled Gantry Technique
http://www.medicalnewstoday.com/articles/131789.php
A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers.Ethan Halpern, M.D., associate professor of Radiology at Jefferson Medical College of Thomas Jefferson University in Philadelphia, presented the research at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America.

Molecular Breast Imaging Identifies Occult Cancer
http://www.medicalnewstoday.com/articles/131708.php
Breast-Specific Gamma Imaging (BSGI) is shown to be an effective method of identifying mammographically and clinically occult (hidden) breast cancer. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers.

New Breast Imaging Technology Targets Hard To Detect Cancers
http://www.medicalnewstoday.com/articles/131705.php
Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA).

----------------------------------------------
** CANCER / ONCOLOGY News **

Discovery Of New Enzyme In Cancer Growth May Explain Why Cancer Grows; Spreads
http://www.medicalnewstoday.com/articles/131821.php
While studying the mechanics of blood clots, researchers at the University of Oklahoma Health Sciences Center discovered a new enzyme that not only affects the blood, but seems to play a primary role in how cancer tumors expand and spread throughout the body.

Best Treatments For Long-Term Survival In Brain Tumor Patients Identified By Mayo Clinic
http://www.medicalnewstoday.com/articles/131819.php
A new Mayo Clinic study found that patients with low-grade gliomas survived longest when they underwent aggressive surgeries to successfully remove the entire tumor. If safely removing the entire tumor was not possible, patients survived significantly longer when surgery was followed by radiation therapy.

New Criteria Identify Additional Patients With Cancer Who Benefit From Liver Transplantation
http://www.medicalnewstoday.com/articles/131811.php
A substantial number of patients with hepatocellular carcinoma (HCC) who exceed the Milan criteria (which are currently used to select transplant candidates) could also be good candidates for successful transplantation, according to findings of a web-based survey of 1112 patients, which is published in an Article early Online and in the January edition of The Lancet Oncology.

Plasmid IL-12 And Electroporation Combination Against Metastatic Melanoma Achieves Systemic Response
http://www.medicalnewstoday.com/articles/131808.php
Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today the final results of a Phase I clinical study demonstrating safe and effective treatment of metastatic melanoma in the first-in-man trial of a DNA-based therapy designed to express a therapeutic protein through in vivo delivery using electroporation.

ASTRO Publications Garner Three MarCom Awards
http://www.medicalnewstoday.com/articles/131804.php
The American Society for Therapeutic Radiology and Oncology has received three 2008 MarCom Awards for its work on its 2008 Annual Report, ASTROnews and The Radiation Oncology Treatment Team brochure.

NHS Top-Up System Has Hidden Costs That Have Not Been Accounted For, UK
http://www.medicalnewstoday.com/articles/131796.php
The "cost" of top-up payments to the NHS are not confined to the cost of the drug and require the NHS to make some long overdue changes or risk financial failure, argue two editorials published in Clinical Oncology, by Elsevier.

Bowel Cancer Screening Programme Launched
http://www.medicalnewstoday.com/articles/131785.php
University Hospitals Bristol NHS Foundation Trust (UH Bristol) is delighted to announce that the life saving NHS Bowel Screening Programme was launched in the Bristol and Weston area from Monday (1 December 2008).

Award-Winning Oncologist Leads New Advancement In Personalized Medicine
http://www.medicalnewstoday.com/articles/131783.php
After hearing the words, "you've got cancer," most patients are given a drug or combination of agents according to guidelines or standards of care. These treatments, in the oncologist's best judgment, are considered most likely to work based on the results of clinical studies in patients with similar tumor types.

Race, Ethnicity Likely Affects Emotional Well-Being Of Cancer Patients, Study Finds
http://www.medicalnewstoday.com/articles/131777.php
Black cancer patients report having poorer physical and social well-being than their white counterparts but better emotional well-being, according to a study published in the November issue of the <cite>Journal of Pain and Symptom Management</cite>, <a href="http://www.

Cancer Mortality Rate Declines Are Promising, But More Needs To Be Done, Editorial States
http://www.medicalnewstoday.com/articles/131765.php
The latest annual <a href="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=3&DR_ID=55780" target="_new">report</a> on cancer trends shows "that a long-term decline in death rates has continued for both sexes," and there "seems little doubt that the decline in cancer death rates since the early 1990s is real," a <a href="http://www.

Tumor Causing Cells Are Common In Some Cancers
http://www.medicalnewstoday.com/articles/131721.php
Scientists in the US examining how human melanoma, a deadly form of skin cancer, spreads in mice specially bred to be vulnerable to cancer, found that there was a higher proportion of tumor causing cells in cancerous tissue than had previously been assumed, overturning the "stem-cell" theory of cancer which proposes that a only a handful of specialized rogue cells is responsible for causing new tumors.

Scientists Probe Limits Of "Cancer Stem-Cell Model"
http://www.medicalnewstoday.com/articles/131717.php
One of the most promising new ideas about the causes of cancer, known as the cancer stem-cell model, must be reassessed because it is based largely on evidence from a laboratory test that is surprisingly flawed when applied to some cancers, University of Michigan researchers have concluded.

U.S. FDA Grants Orphan Drug Designation For Burzynski Research Institute's Antineoplaston Treatment For Gliomas
http://www.medicalnewstoday.com/articles/131693.php
The Burzynski Research Institute, Inc. (BRI) today announced that its antineoplaston A10 and antineoplaston AS2-1 therapy (ANP) has been granted orphan drug designation by the U.S. Food and Drug Administration ("FDA") for the treatment of gliomas.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Genetic Breakdown In Fanconi Anemia May Have Link To HPV-Associated Cancer
http://www.medicalnewstoday.com/articles/131831.php
A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene.

Hypersensitivity Reactions To The Quadrivalent HPV Vaccine Are Rare, British Medical Journal
http://www.medicalnewstoday.com/articles/131763.php
Hypersensitivity reactions to the quadrivalent HPV vaccine (4vHPV, Gardasil) are uncommon and most schoolgirls can tolerate subsequent doses, finds the first evaluation of the quadrivalent HPV vaccine published on <a href="http://www.

Women In Low-Income Areas Of England More Likely To Develop Cervical Cancer, Study Finds
http://www.medicalnewstoday.com/articles/131748.php
 Women living in England's poorest areas are twice as likely as their counterparts in affluent regions to be diagnosed with cervical cancer, according to a study by the United Kingdom's <A href="http://www.

Study Finds Allergic Reactions Uncommon With HPV Vaccine Gardasil
http://www.medicalnewstoday.com/articles/131747.php
 Allergic reactions to <A href="http://www.merck.com/" target=_new>Merck</A>'s human papillomavirus vaccine Gardasil are uncommon, and most girls and young women can tolerate further doses in the three-dose regimen, according to a <A href="http://www.

----------------------------------------------
** COLORECTAL CANCER News **

Relevance Of Computer-Aided Detection (CAD) And Image Analysis Software In Early Colon Cancer Screening And Diagnosis
http://www.medicalnewstoday.com/articles/131727.php
Medicsight PLC, an industry leader in and principal developer of Computer-Aided Detection (CAD) and medical image analysis software today announced clinical results from a new study that demonstrated CAD significantly increased the sensitivity of readers in the detection of colorectal cancers in multi-row detector CT (MDCT) colonography (CTC).

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

EpiCept Reports New Data On Benefits Of Maintenance Therapy With Ceplene(R) And Interleukin-2 For AML Patients At ASH Annual Meeting
http://www.medicalnewstoday.com/articles/131848.php
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that new data on the benefits of maintenance therapy with Ceplene® (histamine dihydrochloride) and interleukin-2 (IL-2) for Acute Myeloid Leukemia (AML) patients in complete remission will be presented at the 50th American Society of Hematology (ASH) Annual Meeting being held December 6-9 at the Moscone Center in San Francisco.

Effects Of Childhood Cancer Treatment Increase Adult Survivors' Risk Of Osteoporosis
http://www.medicalnewstoday.com/articles/131833.php
Men who survived childhood leukemia treatment into adulthood were more likely to have low bone mineral density than other adults their age, putting them at risk of osteoporosis and bone fractures, according to a new study.

The Leukemia & Lymphoma Society And Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial
http://www.medicalnewstoday.com/articles/131701.php
The Leukemia & Lymphoma Society (LLS) and Memgen, LLC jointly announce the beginning of a new clinical trial of ISF35, a cancer vaccine, at the University of California, San Diego (UCSD). LLS is collaborating on this trial in the hopes that it will speed the development and approval of a novel approach aimed at treating patients with fludarabine refractory and/or 17p deleted chronic lymphocytic leukemia (CLL).

Genta Receives Complete Response Letter From FDA To Amended Application Of Genasense(R) In Patients With Chronic Lymphocytic Leukemia
http://www.medicalnewstoday.com/articles/131688.php
Genta Incorporated (OTCBB: GNTA.OB) today announced that the Company has received a complete response letter from the Office of Oncology Drug Products (OODP) at the Food and Drug Administration (FDA) regarding the Company's amended New Drug Application (NDA) for the use of Genasense® plus chemotherapy in patients with chronic lymphocytic leukemia (CLL).

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Montpellier Prostate Cancer Patient Becomes First Cancer Patient In France Treated With Varian's RapidArc™ Radiotherapy
http://www.medicalnewstoday.com/articles/131842.php
A 60-year-old prostate cancer patient from Montpellier has become the first person in France to be treated using RapidArc™ technology from Varian Medical Systems (NYSE:VAR) for fast and precise forms of intensity modulated radiotherapy (IMRT).

Testosterone Levels Reduced By Prostate Cancer Drug In As Little As 3 Days
http://www.medicalnewstoday.com/articles/131793.php
More than 95 per cent of men who took degarelix for prostate cancer saw their testosterone levels fall dramatically as early as three days after they started treatment, according to a paper in the December issue of BJU International.

Isis Announces That OGX-011 Has Shown Overall Survival Advantage In Prostate Cancer Compared To Standard Therapy In A Randomized Phase 2 Study
http://www.medicalnewstoday.com/articles/131704.php
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that OncoGenex Pharmaceuticals, Inc. provided positive survival results from a randomized Phase 2 clinical trial of OGX-011 in combination with docetaxel and prednisone ("the OGX-011 arm") compared to docetaxel and prednisone alone ("the control arm") for first-line treatment of metastatic castrate resistant prostate cancer.

-------------------------------------------------------------

Subscription Confirmation

2008-12-04T05:49:00.001-08:00

Dear Subscriber,

You are no longer subscribed to any newsletters from The HealthCentral Network.

If you are receiving this in error and wish to continue receiving newsletters, please click here to change your subscriptions now.

Sincerely,

The MyBreastCancerNetwork.com Team

If you have questions or comments about this newsletter or about our newsletter service in general, please contact us at comments@thcn.com.

Read our privacy policy

The HealthCentral Network
1655 N. Fort Myer Drive, #400
Arlington, VA 22209
(c) 2008 The HealthCentral Network, Inc. All rights reserved.

Medical News Today News Alert

2008-12-03T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

HER2 Levels May Aid In Treatment Selection For Metastatic Breast Cancer
http://www.medicalnewstoday.com/articles/131645.php
Findings published in the December 1, 2008, issue of <a href="http://clincancerres.aacrjournals.org/" target="_blank" rel="nofollow">Clinical Cancer Research </a>, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit.

Studies Evaluate Breast Cancer Outcomes In Older Patients, Women With Breast Augmentations
http://www.medicalnewstoday.com/articles/131558.php
 The following summarizes news coverage of two recent studies on breast cancer treatment. ~ Older Patients: One in five women ages 65 and older delayed or did not complete their full radiation regimen after breast-conserving surgery, leading to an increased risk of death or recurrence, according to a <A href="http://www3.

New Mammography Technology Effective In Detecting Breast Cancer
http://www.medicalnewstoday.com/articles/131533.php
A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer.

Linda Creed Announces Volunteer Recognition Awards
http://www.medicalnewstoday.com/articles/131514.php
Linda Creed, an affiliate of Public Health Management Corporation (PHMC), will hold their annual Volunteer Recognition Awards this Saturday, December 6 at 11 a.m. The awards are given in recognition of individuals, corporations, and health organizations that have made a significant difference in the ability to provide access to basic breast health in the region.

----------------------------------------------
** CANCER / ONCOLOGY News **

PharmaEngine Receives Approval Of US IND Application For A Phase II Study Of PEP02 (Liposome Irinotecan Injection) In Pancreatic Cancer
http://www.medicalnewstoday.com/articles/131686.php
PharmaEngine, Inc. announced today that it has received approval of an Investigational New Drug (IND) application from the U.S. FDA for PEP02, a liposome formulation of irinotecan in a phase II study in patients with metastatic pancreatic cancer.

Blood Scanner That Detects Even Faint Indicators Of Cancer Developed By Stanford Researchers
http://www.medicalnewstoday.com/articles/131670.php
A team led by Stanford researchers has developed a prototype blood scanner that can find cancer markers in the bloodstream in early stages of the disease, potentially allowing for earlier treatment and dramatically improved chances of survival.

Behavior And Screening Have Biggest Impact On Drop In Cancer Deaths
http://www.medicalnewstoday.com/articles/131639.php
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.

Recurring Brain Tumors Are Treated Effectively By Gamma Knife - South Nassau Communities Hospital
http://www.medicalnewstoday.com/articles/131598.php
According to a study conducted by radiation oncologists at the Cleveland Clinic, stereotactic radiosurgery (SRS) performed on recurring brain tumors proved effective at extending the survival of the patient and controlling the tumor.

Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine For Injection) And Vidaza(R) (azacitidine)
http://www.medicalnewstoday.com/articles/131530.php
Eisai Corporation of North America announced that it plans to initiate the first clinical trial evaluating the activity of Dacogen(R) (decitabine for injection) compared to Vidaza(R) (azacitidine) in adult patients with intermediate-1, intermediate-2 or high-risk myelodysplastic syndromes (MDS), a potentially life-threatening group of bone marrow diseases that limit the production of functional blood cells.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Survival Rates In Advanced Rectal Cancer Patients May Be Improved By Preoperative Radiation
http://www.medicalnewstoday.com/articles/131673.php
Patients treated with radiation prior to surgery for advanced rectal cancer have fewer instances of cancer recurrence and better overall survival rates, according to a recent Geisinger report.

1-Stop Screening For Cancer And Osteoporosis
http://www.medicalnewstoday.com/articles/131649.php
New research reveals that computed tomography (CT) colonography, also known as virtual colonoscopy, has the potential to screen for two diseases at once - colorectal cancer and osteoporosis, both of which commonly affect adults over age 50.

----------------------------------------------
** LUNG CANCER News **

Identification Of Gene Which Protects Against Lung Cancer
http://www.medicalnewstoday.com/articles/131640.php
A study led by researchers at The University of Nottingham has identified a gene that protects the body from lung cancer.The research, published in the journal Proceedings of the National Academy of Sciences, USA and funded by a Â£72,000 grant from the British Lung Foundation, has found that the tumour suppressor gene, LIMD1, is responsible for protecting the body from developing lung cancer - paving the way for possible new treatments and early screening techniques.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

OGX-011 Shows Overall Survival Advantage In Prostate Cancer Compared To Standard Therapy In A Randomized Phase 2 Study
http://www.medicalnewstoday.com/articles/131681.php
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced positive survival results from a randomized Phase 2 clinical trial of OGX-011 in combination with docetaxel and prednisone ("the OGX-011 arm") compared to docetaxel and prednisone alone ("the control arm") for first-line treatment of metastatic castrate resistant prostate cancer.

USHIFU Announces First Sonablate(R) HIFU Device In India For Minimally Invasive Prostate Cancer Treatment
http://www.medicalnewstoday.com/articles/131539.php
USHIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies, announced the establishment of India HIFU and the launch of Sonablate(R) HIFU services in Hyderabad, India at Dr.

Phase II Study Shows That ZD4054 Could Improve Survival For Hormone Resistant Prostate Cancer (HRPC) Patients With Bone Metastases
http://www.medicalnewstoday.com/articles/131481.php
A novel compound in development by AstraZeneca as an oral tablet for hormone resistant prostate cancer (HRPC), ZD4054, could improve overall survival (OS) in men with metastatic HRPC, according to Phase II data published today in European Urology.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-02T23:02:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Curbing Hormones' Effects In Obese Patients Could Aid Against Breast Cancer
http://www.medicalnewstoday.com/articles/131480.php
Once-promising drugs that were abandoned in the fight against breast cancer still could be effective in obese patients, new research suggests.In laboratory tests, hormones produced by fat cells stimulate breast cancer cells to migrate and invade surrounding tissues, scientists at Emory University School of Medicine found.

Eating Eggs When Pregnant Affects Breast Cancer In Offspring
http://www.medicalnewstoday.com/articles/131478.php
A stunning discovery based on epigenetics (the inheritance of propensities acquired in the womb) reveals that consuming choline - a nutrient found in eggs and other foods - during pregnancy may significantly affect breast cancer outcomes for a mother's offspring.

Breakthrough Breast Cancer In Response To The Publication Of The Cancer Reform Strategy 1 Year On Report Published By The Department Of Health Today
http://www.medicalnewstoday.com/articles/131454.php
Jeremy Hughes, Chief Executive of Breakthrough Breast Cancer says: "The Cancer Reform Strategy (CRS) has made steady progress since its publication last year. Breakthrough is particularly delighted to see our Service Pledge for Breast Cancer - a tool developed to enable health professionals and patients work together towards improved breast cancer services - is highlighted in today's report.

Dual-Head Gamma Camera Significantly Increases Ability To Detect Breast Tumors Not Seen On Mammography
http://www.medicalnewstoday.com/articles/131387.php
A dual-headed dedicated gamma camera used during molecular breast imaging (MBI) can accurately detect small breast tumors less than 2 cm in size, according to a study performed at the Mayo Clinic in Rochester, MN.

Delays In Radiation Therapy Lead To Increased Breast Cancer Recurrence
http://www.medicalnewstoday.com/articles/131382.php
A new analysis of the National Cancer Institute's cancer registry has found that as many as one in five older women experience delayed or incomplete radiation treatment following breast-conserving surgery, and that this suboptimal care can lead to worse outcomes.

Molecular Breast Imaging Performs Better Than Ultrasound In Patients With Mammographic Abnormalities
http://www.medicalnewstoday.com/articles/131380.php
For difficult to diagnose patients, Breast-Specific Gamma Imaging (BSGI) is found to be a more useful adjunctive imaging tool than ultrasound for patients who need additional imaging following a questionable mammogram, this according to findings presented today at the annual meeting of the Radiological Society of North America (RSNA).

----------------------------------------------
** CANCER / ONCOLOGY News **

Harnessing MiRNA Natural Gene Repressors For Anticancer Therapy
http://www.medicalnewstoday.com/articles/131472.php
Michel Sadelain and colleagues, at Memorial Sloan-Kettering Cancer Center, New York, have developed a new approach to modulate the expression of genes for therapeutic purposes, and used this to mediate effective anticancer therapy in mice.

Ark Files Cerepro(R) Application For Marketing Authorisation With EMEA
http://www.medicalnewstoday.com/articles/131415.php
Ark Therapeutics Group plc (AKT: LSE) ("Ark" or "the Company") today announces that the Marketing Authorisation Application (MAA) for Cerepro®, Ark's novel gene-based therapy for operable malignant glioma (brain cancer), has been filed with the European medicines regulatory agency (EMEA).

Vical Receives Milestone Payment From Merck & Co., Inc. Triggered By Planned Initiation Of Investigational Cancer DNA Vaccine Trial
http://www.medicalnewstoday.com/articles/131374.php
Vical Incorporated (Nasdaq: VICL) announced the receipt of a $1.0 million milestone payment from Merck & Co., Inc. based on Merck's planned initiation of a Phase I clinical trial of an investigational plasmid DNA (pDNA) cancer vaccine.

IDO2 An Active Enzyme To Target In Pancreatic Cancer
http://www.medicalnewstoday.com/articles/131360.php
An enzyme that is overexpressed in pancreatic cancer cells may hold the key to successfully treating the disease with targeted immunotherapy, researchers from Thomas Jefferson University reported at the 2008 Annual Meeting of the Southern Surgical Association.

Study Demonstrates The Benefit Of Using Chemoradiotherapy In Elderly Patients With Locally Advanced Oesophageal Cancer
http://www.medicalnewstoday.com/articles/131355.php
Chemoradiotherapy (CRT) can be considered an "effective" treatment for elderly patients with locally advanced oesophageal cancer, reports the British Journal of Cancer. The French study, involving 109 consecutive patients with oesophageal cancer, suggests that characterising patients first with the "Charlson" score may provide useful criteria for deciding which subjects are suitable for treatment.

Wistar Scientists Find Key To Keeping Killer T Cells In Prime Shape For Fighting Infection, Cancer
http://www.medicalnewstoday.com/articles/131335.php
Like tuning a violin to produce strong, elegant notes, researchers at The Wistar Institute have found multiple receptors on the outside of the body's killer immune system cells which they believe can be selectively targeted to keep the cells in superb infection- and disease-fighting condition.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

DxS And Amgen Enter Into Collaboration To Provide A K-RAS Companion Diagnostic For Vectibix(R) In The United States
http://www.medicalnewstoday.com/articles/131471.php
DxS, a personalised medicine company, has signed an agreement with Amgen Inc. to provide a K-RAS companion diagnostic for Vectibix® (panitumumab) in the United States. Pursuant to the terms of the agreement, DxS and Amgen shall work together to further facilitate the use of Vectibix® in metastatic colorectal cancer patients with wild-type K-RAS status in the United States, with the intent that DxS' TheraScreen: K-RAS Mutation Kit will become a companion diagnostic for use with Vectibix® if approved by the FDA.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

U.S FDA Grants Pralatrexate Orphan Drug Designation For The Treatment Of Patients With Follicular Lymphoma
http://www.medicalnewstoday.com/articles/131491.php
Allos Therapeutics, Inc. (Nasdaq:ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Five Steps To Saving Lives And Improving Men's Experience Of Prostate Cancer By 2020
http://www.medicalnewstoday.com/articles/131452.php
The Prostate Cancer Charity is launching a new strategy 'Transforming The Future For Prostate Cancer' - which it believes could reduce mortality rates by 30 per cent. The strategy, which will be unveiled at a special event next Monday (1 December), outlines ambitious goals and targets for vital changes the Charity believes are necessary to improve men's experience of prostate cancer by 2020.

Multidetector CT Cystography Accurately Detects Urine Leaks After Prostatectomy
http://www.medicalnewstoday.com/articles/131386.php
Multidetector CT (MDCT) cystography (diagnostic procedure used to examine the bladder) can be used to detect vesicourethral leaks (a common problem) after prostatectomy according to a study that was performed at the Seoul National University College of Medicine in the Republic of Korea.

-------------------------------------------------------------

Medical News Today News Alert

2008-12-01T23:02:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Breast Cancer Treatment Offers Better Outcome To Women With Implants
http://www.medicalnewstoday.com/articles/131320.php
Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Breast-Lesion Biopsies May Be Reduced By New Statistical Model
http://www.medicalnewstoday.com/articles/131248.php
A new method of characterizing breast lesions found during an MRI exam could result in fewer biopsies of benign tumors with the benefits of reduced pain and expense for patients and providers, according to a paper that was presented Nov.

European Ancestry Increases Breast Cancer Risk Among Latinas
http://www.medicalnewstoday.com/articles/131209.php
Latina women have a lower risk of breast cancer than European or African-American women generally, but those with higher European ancestry could be at increased risk, according to data published in the December 1 issue of <a href="http://cancerres.

----------------------------------------------
** CANCER / ONCOLOGY News **

Marshall Edwards, Inc. Files IND Application For Triphendiol - Locally Advanced Or Metastatic Pancreatic And Bile Duct Cancers
http://www.medicalnewstoday.com/articles/131351.php
Marshall Edwards, Inc. (NASDAQ: MSHL) today announced that it has filed an application with the United States Food and Drug Administration for an Investigative New Drug (IND) approval to undertake clinical studies with triphendiol as a chemosensitizing agent in combination with gemcitabine.

Earlier Detection Of Cancer And Better Treatment For Survivors, UK
http://www.medicalnewstoday.com/articles/131345.php
Work is well underway to catch more cancer cases earlier and improve the longer term treatment for cancer survivors, National Cancer Director Professor Mike Richards said today. The first annual report setting out the Government's progress against the Cancer Reform Strategy, "Maintaining Momentum, Building for the Future", highlights the achievements made in the first year and identifies priorities for the year ahead.

Prostate Cancer Promotes The Growth Of New Nerves And The Branching Axons That Carry Their Messages
http://www.medicalnewstoday.com/articles/131307.php
Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research.

Combining Targeted Therapy Drugs May Treat Previously Resistant Tumors
http://www.medicalnewstoday.com/articles/131302.php
A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches. In their Nature Medicine report, which is receiving early online release, investigators from Dana-Farber Cancer Institute (DFCI), Massachusetts General Hospital (MGH) Cancer Center, and Beth Israel Deaconess Medical Center (BIDMC) Cancer Center report that combining two different kinase inhibitors - drugs that interfere with specific cell-growth pathways - led to significant tumor shrinkage in mice with lung cancer driven by mutations in the K-Ras gene.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Plumbagin, A Medicinal Plant-Derived Naphthoquinone, Is A Novel Inhibitor Of The Growth And Invasion Of Hormone-Refractory Prostate Cancer
http://www.medicalnewstoday.com/articles/131255.php
UroToday.com - Dr. Moammir Aziz and colleagues from the University of Wisconsin reported in the November 1, 2008 issue of Cancer Research that plumbagin, a medicinal plant derived naphthoquinone, inhibits castration-resistant prostate cancer (CaP) growth and invasion.

Dynamic Change In Phosphorylated PDGFR In Peripheral Blood Leukocytes After Docetaxel Therapy Predicts Overall Survival In Prostate Cancer
http://www.medicalnewstoday.com/articles/131254.php
UroToday.com - Accurate molecular markers for targeted therapy that correlate with traditional clinical outcomes are not common. An online article from a distinguished group of researchers demonstrates how useful this approach may be.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-30T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Method By Which A Protein That Determines Cell Polarity Prevents Breast Cancer
http://www.medicalnewstoday.com/articles/131118.php
In breast tissue, cells lining the breast's ducts have a certain shape that is required to maintain both organ structure and function. All breast cancers display a loss of this characteristic organization, but very little is known about the molecules and pathways that regulate tissue structure and the role they play during cancer.

----------------------------------------------
** CANCER / ONCOLOGY News **

Bevacizumab Associated With Increased Venous Thromboembolism
http://www.medicalnewstoday.com/articles/131247.php
Bevacizumab, a cancer drug, may be associated with an increased risk of venous thromboembolism, according to an analysis of several randomized controlled trials released on November 19, 2008 in JAMA.

Robotic Partial Nephrectomy For Renal Hilar Tumors: A Multi-Institutional Analysis
http://www.medicalnewstoday.com/articles/131244.php
UroToday.com - Our multi-institutional study on robotic partial nephrectomy for renal hilar tumors is the first to focus solely on renal hilar tumors and represents one of the largest series in the world.

Drop In Colorectal Cancer Deaths
http://www.medicalnewstoday.com/articles/131103.php
The American Society for Gastrointestinal Endoscopy (ASGE) heralds the recent news of a decline in U.S. cancer deaths and incidence rates, with colorectal cancer among the top three cancers with significant declines.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Age And Grade Trends In Prostate Cancer (1974-2003): A Surveillance, Epidemiology, And End Results Registry Analysis
http://www.medicalnewstoday.com/articles/131204.php
UroToday.com - In this study we report an analysis of prostate cancer grade migration trends, by age, using Surveillance, Epidemiology, and End Results (SEER) data over a 30-year period from 1974 to 2003.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-29T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Insight Into Adaptive Ability Of Cells Offered By Rong Li Lab
http://www.medicalnewstoday.com/articles/131071.php
The Stowers Institute's Rong Li Lab has published findings that shed light on the ability of cells to adapt to disruptions to their basic division machineries - findings that may help explain how cancer cells elude the body's natural defense mechanisms or chemotherapy treatment.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

Women Smokers' Longevity Cut By 14.5 Years Because Of Smoking
http://www.medicalnewstoday.com/articles/131229.php
One in every five adult women in the United States still smokes, even though smoking takes an average of 14.5 years off their lives, says the American College of Obstetricians and Gynecologists (ACOG).

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Diffusion And Perfusion MR Imaging Of The Prostate
http://www.medicalnewstoday.com/articles/131219.php
UroToday.com - The current gold standard for diagnosis of prostate cancer is the Transrectal Ultrasound (TRUS) guided prostate biopsy, initiated by elevated PSA-levels or a Digital Rectal Examination (DRE) suspicious for prostate cancer.

Comparing Biochemical Relapse-Free Survival Between Primary Gleason Score 3 & Primary Gleason Score 4 For Biopsy Gleason Score 7 Prostate Cancer
http://www.medicalnewstoday.com/articles/131217.php
UroToday.com - We feel that this work is an important contribution to the literature as it compares outcomes across three different modalities. One aspect with which the authors struggled was how to address the poor outcomes for surgical patients.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-28T23:02:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

New Phase III Study Of Avastin In Advanced Breast Cancer Meets Its Primary Endpoint Of Increasing The Time Patients Live
http://www.medicalnewstoday.com/articles/131155.php
Third study confirming the benefit of Avastin in breast cancer shows that Avastin can be effectively combined with commonly used chemotherapiesRoche announced that the Avastin study RIBBON-1 met its primary endpoint of increasing the time women with breast cancer lived without their disease advancing (known as progression-free survival) compared to chemotherapy alone, as determined by the treating physicians.

IU Simon Cancer Center Researchers' Breast Cancer Trials Offer Recognized Potential To Improve Treatment, Survival
http://www.medicalnewstoday.com/articles/131074.php
Two breast cancer clinical trials led by Indiana University Melvin and Bren Simon Cancer Center researchers are among 13 selected by a national panel as having the greatest potential to improve treatment and survival.

----------------------------------------------
** CANCER / ONCOLOGY News **

New Drug For Skin Cancer Approaching Commercialization
http://www.medicalnewstoday.com/articles/131152.php
A drug that is activated by light can be a quick, simple, and cheap treatment for tens of thousands of patients with skin cancer in Sweden alone. Researcher Leif Eriksson's team at rebro University in Sweden has now received about SEK 4 million from government research financiers, the Swedish Research Council and Vinnova, to further develop and commercialize the method.

Phase 3 Study Of Subcutaneous Relistor For Opioid-Induced Constipation For Chronic Non-Cancer Pain
http://www.medicalnewstoday.com/articles/131139.php
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that a phase 3 clinical study investigating RELISTOR® (methylnaltrexone bromide) subcutaneous injection to treat opioid-induced constipation (OIC) in patients with chronic, non-cancer pain achieved statistical significance for the primary and key secondary efficacy endpoints.

NICE Approves Lung-Cancer Drug Provided Manufacturer Roche Offers Discounted Price For NHS, UK
http://www.medicalnewstoday.com/articles/131131.php
The National Institute for Health and Clinical Excellence (NICE) has recommended erlotinib, an epidermal growth factor receptor inhibitor, as an alternative to docetaxel as a second-line treatment option for patients with non-small-cell lung cancer (NSCLC) provided the manufacturer (Roche) supplies erlotinib at a discounted and equivalent price to docetaxel.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

St. Jude Identifies Genomic Causes Of A Certain Type Of Leukemia Relapse
http://www.medicalnewstoday.com/articles/131144.php
Scientists at St. Jude Children's Research Hospital have identified distinctive genetic changes in the cancer cells of children with acute lymphoblastic leukemia (ALL) that cause relapse. The finding offers a pathway to designing treatments for ALL relapse in children and, ultimately, in adults.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-27T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Siemens Introduces New Standard Of Care For Breast Ultrasound
http://www.medicalnewstoday.com/articles/130982.php
Siemens Healthcare (<a href="http://www.siemens.com/healthcare" target="_blank" rel="nofollow">http://www.siemens.com/healthcare</a>) highlights the ACUSON S2000(TM) Automated Breast Volume Scanner (ABVS)(1),the world's first multi-use, automated volume breast ultrasound system, at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from November 30 to December 5 at McCormick Place (Booth #922, East Building/Lakeside Center, Hall D) in Chicago.

----------------------------------------------
** CANCER / ONCOLOGY News **

Statement On Publication Of National Audit Office Report: 'End Of Life Care' - Help The Hospices, UK
http://www.medicalnewstoday.com/articles/131049.php
Help the Hospices, the leading charity supporting hospice care throughout the UK, welcomes yeasterday's (Wednesday 26 November) publication of the first ever National Audit Office report on care at the end of life, the most in-depth study of its kind to look at this issue.

Enrollment In Provectus' Phase 2 Melanoma Clinical Trial Reaches Halfway Point
http://www.medicalnewstoday.com/articles/131029.php
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that the first fifty percent (40 of 80) of melanoma subjects have been treated in its Phase 2 clinical trial of PV-10.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
http://www.medicalnewstoday.com/articles/130984.php
Simbionix USA Corp, an international company using leading edge simulation to advance clinical performance, announces the world-wide release of a breakthrough training simulation of the laparoscopic colorectal procedure.

----------------------------------------------
** LUNG CANCER News **

NICE Issues Guidance On The Use Of Erlotinib For The Treatment Of Non-Small-Cell Lung Cancer
http://www.medicalnewstoday.com/articles/130957.php
The National Institute for Health and Clinical Excellence (NICE) has today (26 November) published final guidance on the use of erlotinib for the treatment of non-small-cell lung cancer (NSCLC).

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

2008 Prostate Cancer Retreat Available Online - Prostate Cancer Foundation
http://www.medicalnewstoday.com/articles/130969.php
The Prostate Cancer Foundation (PCF) has made presentations from its 2008 Scientific Retreat available online. The PCF's annual retreat provides a forum to review advances in prostate cancer research aimed at reducing death and suffering from this prevalent men's disease.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-26T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Racial Disparities In Breast Cancer Care May Be Reduced By The Implementation Of A Tracking And Feedback Registry
http://www.medicalnewstoday.com/articles/130892.php
Alerting surgeons when their breast cancer patients did not attend a follow-up consultation with a medical oncologist was associated with a reduction in racial disparities in adjuvant therapy, according to a non-randomized study published in the November 25 online issue of the Journal of the National Cancer Institute.

Study Finds Some Invasive Breast Cancer Tumors Might Regress Without Treatment
http://www.medicalnewstoday.com/articles/130851.php
 A new <A href="http://archinte.ama-assn.org/cgi/content/full/168/21/2311" target=_new>study</A> of breast cancer in Norwegian women suggests that some breast tumors may regress on their own over time, the <A href="http://www.

Mammogram Most Effective 12 Months After Radiation Treatment
http://www.medicalnewstoday.com/articles/130819.php
Breast cancer patients who receive breast-conserving therapy and radiation do not need a follow-up mammogram until 12 months after radiation, despite current American Society of Clinical Oncology (ASCO) and National Comprehensive Cancer Network (NCCN) guidelines that recommend follow-up mammograms at between six and 12 months after radiation, according to a November 15 study in the International Journal of Radiation Oncology Biology Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

----------------------------------------------
** CANCER / ONCOLOGY News **

Healthy Bonding Between Cells Provoked By Tiny Protein
http://www.medicalnewstoday.com/articles/130933.php
In human relationships, a certain "spark" often governs whether we prefer one person to another, and critical first impressions can occur within seconds. A team lead by Johns Hopkins researchers has found that cell-to-cell "friendships" operate in much the same way and that dysfunctional bonding is linked to the spread of cancer.

News From The Journal Of The National Cancer Institute, Nov. 25
http://www.medicalnewstoday.com/articles/130897.php
No Association Between Fat, Protein, and Meat Consumption and Kidney CancerThere is no association between consumption of fat, protein, or meat and kidney cancer, according to a pooled analysis of prospective studies.

Survival In Early Stage Endometrial Cancer Not Improved By Pelvic Lymphadenectomy
http://www.medicalnewstoday.com/articles/130886.php
Systematic use of pelvic lymphadenectomy (removal of the lymph nodes) does not improve disease-free or overall survival in women with early-stage endometrial cancer, according to a randomized trial published online November 25 in the Journal of the National Cancer Institute.

'Bodyguard' Turned Into Killer In Cancer Cells
http://www.medicalnewstoday.com/articles/130880.php
If you're a cancer cell, you want a protein called Bcl-2 on your side because it decides if you live or die. It's usually a trusted bodyguard, protecting cancer cells from programmed death and allowing them to grow and form tumors.

Lung Cancer - NICE Recommends Oral Tarceva(R) (erlotinib) As An Alternative To Intravenous Chemotherapy, UK
http://www.medicalnewstoday.com/articles/130873.php
Today the National Institute for Health and Clinical Excellence (NICE) recommends Tarceva (erlotinib) as a clinically and cost-effective alternative to IV chemotherapy (i.e. docetaxel) for the 2nd line treatment of non-small cell lung cancer.

Monash University Scientists Have Identified A Protein That Stops The Growth Of Cervical Cancer
http://www.medicalnewstoday.com/articles/130844.php
Animal studies led by Associate Professor Jun-Ping Liu, from the Department of Immunology, have shown that the protein bone morphogenetic protein-7 (BMP-7), when applied to cervical tumours in mice, can halve the size of the tumours in less than a week.

Patent For Improved Cancer Therapy Device Received: New Design Would Deliver More Precise Radiation Doses At Lower Cost
http://www.medicalnewstoday.com/articles/130833.php
Four physicists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have been awarded U.S. Patent No. 7,432,516 B2 for the design of a "medical synchrotron" capable of delivering precision doses of proton radiation to cancerous tumors with minimal damage to surrounding healthy tissue.

Ovarian Cancer Research Targets Chemo-resistance
http://www.medicalnewstoday.com/articles/130831.php
A QUT research project looking at ways to block chemo-resistant enzymes which also cause tumours to grow and spread, has been rewarded with a grant of $783,750 from the National Health and Medical Research Council.

Rates Of New Cases And Deaths From Cancer Down In The US
http://www.medicalnewstoday.com/articles/130824.php
The latest annual report by leading cancer organizations in the US found that overall rates of new cancer cases and deaths have fallen for the first time since the report was first compiled ten years ago, but within those figures there are disturbingly large state and regional differences in lung cancer rates among women, highlighting the need to tighten tobacco control in many states.

Radiation Before Surgery Improves Pancreatic Cancer Outcomes
http://www.medicalnewstoday.com/articles/130809.php
Pancreatic cancer is one of the deadliest and most difficult to treat cancers. Now, in a major step forward, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have shown that administering radiation therapy prior to surgery nearly doubles survival in pancreatic cancer patients with operable tumors.

Light Sciences Oncology Completes Patient Enrollment In Phase 3 Clinical Trial Of Litx As A Treatment For Hepatocellular Carcinoma
http://www.medicalnewstoday.com/articles/130807.php
Light Sciences Oncology, Inc. (LSO) announced the completion of enrollment in a global Phase 3 clinical trial of Light Infusion Therapy(TM) (Litx(TM)) as a treatment for unresectable hepatocellular carcinoma (HCC), also known as hepatoma or primary liver cancer.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Blogs Examine Obama Appointees, Ovarian Cancer Test, European Abortion Laws
http://www.medicalnewstoday.com/articles/130856.php
 The following is a summary of selected women's health-related blog entries. ~ "<A href="http://www.rhrealitycheck.org/blog/2008/11/24/ladies-first-newest-obama-appointments" target=_new>Progressive and Pro-Choice: Obama's Latest Team Members</A>," Amie Newman, RH Reality Check: Newman reports that two of President-elect Barack Obama's latest appointments to his incoming administration "offer much hope to advocates of women's rights.

----------------------------------------------
** COLORECTAL CANCER News **

----------------------------------------------
** LUNG CANCER News **

Annual Report To The Nation On Cancer Co-Authored By LSUHSC's Dr. Xiao Cheng Wu
http://www.medicalnewstoday.com/articles/130953.php
Xiao Cheng Wu, MD. MPH, Associate Professor and Assistant Director of the Louisiana Tumor Registry at LSU Health Sciences Center New Orleans School of Public Health, co-authored the Annual Report to the Nation on the Status on Cancer, 1975-2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Researchers Identify Novel Approach For Suppressing Prostate Cancer Development
http://www.medicalnewstoday.com/articles/130820.php
Researchers at the University of Southern California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-25T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Somo-InSIGHT Study, Breast Cancer Screening Study Beginning Early 2009 Enrolling Over 20,000 Women
http://www.medicalnewstoday.com/articles/130760.php
U-Systems, the innovative leader in dedicated breast ultrasound systems, today announced its plans to conduct a multi-center breast cancer screening study named somoâ¢InSIGHT, with more than 20,000 women, using its proprietary Automated Breast Ultrasound System (ABUS).

Breakthrough Breast Cancer Comment Re Research Suggesting Breast Screening May Detect Cancers That Would Have Otherwise Regressed
http://www.medicalnewstoday.com/articles/130669.php
Dr Alexis Willett from Breakthrough Breast Cancer says: "This research puts forward an interesting theory about breast cancer development. However, it is not currently possible to predict whether early changes picked up by breast screening will progress so treatment is usually offered to prevent breast cancer developing.

Mammograms May Identify Cancers That Would Otherwise Just Regress
http://www.medicalnewstoday.com/articles/130644.php
Researchers in Norway found there was a 22 per cent higher rate of detected breast cancer among women who had mammograms every two years compared to women screened every six years raising the possibility that some breast cancers just regress naturally without treatment.

Ipsogen Launches A New Test To Determine Tumor HER2 Status And Guide Herceptin(R) Prescription In Breast Cancer
http://www.medicalnewstoday.com/articles/130627.php
IPSOGEN SA (Marseille, France and New Haven, CT, USA), a cancer profiler that markets molecular diagnostic assays for leukemia and breast cancer announced the European launch of MapQuant Dx(TM) HER2 test.

Mammograms May Detect Some Cancers That Would Have Otherwise Regressed
http://www.medicalnewstoday.com/articles/130603.php
Breast cancer rates increased significantly in four Norwegian counties after women there began undergoing mammography every two years, according to a report in the November 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

----------------------------------------------
** CANCER / ONCOLOGY News **

Exelixis And Bristol-Myers Squibb To Co-Develop XL413, A Selective Cdc7 Inhibitor
http://www.medicalnewstoday.com/articles/130798.php
Exelixis, Inc. (Nasdaq:EXEL) today announced that Bristol-Myers Squibb Company (NYSE:BMY) has exercised its option to develop and commercialize Exelixis' investigational new drug (IND) candidate XL413, a selective inhibitor of Cdc7.

Varian Medical Systems Introducing OncoView™ - An Oncology Specific Image Management And Storage Solution
http://www.medicalnewstoday.com/articles/130790.php
Varian Medical Systems (NYSE: VAR) today is introducing a new product that makes it easier for clinicians to store, manage and view images generated during cancer treatments. Varian will showcase its new OncoView™ image management and storage solution at the Radiological Society of North America (RSNA) meeting in Chicago, November 30 - December 4, 2008.

National Comprehensive Cancer Network Receives $1.5 Million Grant To Research Targeted Therapy In Bladder Cancer
http://www.medicalnewstoday.com/articles/130780.php
NCCN (The National Comprehensive Cancer Network) has been awarded a $1.5 Million grant from Bristol-Myers Squibb Company and ImClone Systems Incorporated to fund research on the antibody cetuximab in patients with bladder cancer.

BloodCenter Of Wisconsin Launches New Test To Diagnose Resistance To Common Cancer Therapy
http://www.medicalnewstoday.com/articles/130773.php
BloodCenter of Wisconsin today announced the availability of BCR-ABL Kinase Domain Mutation Analysis, a new DNA sequencing assay designed to help oncologists develop appropriate therapeutic strategies tailored to the specific needs of patients with chronic myeloid (or myelogenous) leukemia (CML).

Clot Risk Increased By Transfusions In Hospitalized Cancer Patients
http://www.medicalnewstoday.com/articles/130755.php
Blood transfusions used to treat anemia in patients with cancer are associated with an increased risk of life-threatening blood clots, at a similar rate as other treatments for cancer-induced anemia, according to scientists at the University of Rochester Medical Center.

Novel Device May Enhance Chemotherapy Treatment In Brain Tumors
http://www.medicalnewstoday.com/articles/130743.php
NovoCure Ltd. presented results evaluating the Novo-TTF device in vitro and in a pilot clinical trial that showed the device enhanced the efficacy of standard chemotherapy (temozolomide) treatment in newly-diagnosed glioblastoma multiforme (GBM) patients.

Commercialisation Of Yondelis(R) For The Treatment Of Soft Tissue Sarcoma Approved In Russia
http://www.medicalnewstoday.com/articles/130720.php
The Russian regulatory body has approved YONDELIS® (trabectedin) for the treatment of soft tissue sarcoma in adults. This represents another approval for YONDELIS® for treatment soft tissue sarcoma (STS) following upon its approval in Europe in September 2007, which opens up new opportunities in markets with enormous growth potential.

December Is Cancer-Related Fatigue Awareness Month
http://www.medicalnewstoday.com/articles/130638.php
Between 70 and 100 percent of cancer patients receiving treatment have fatigue, according to the American Cancer Society. Up to one-half of all survivors have reported fatigue lasting months or even years after treatment.

New Cancer Treatment Shrinks Pancreatic Tumor
http://www.medicalnewstoday.com/articles/130628.php
A new cancer treatment is realizing outstanding results against pancreatic cancer. Following five weeks of treatment, a patient's large, stage 4 tumor was reduced in size by 70%. After seven more weeks of treatment, it no longer could be definitely identified on scans.

Medarex Announces Initiation Of Phase 1b Clinical Development Program With MDX-1106 For The Treatment Of Cancer
http://www.medicalnewstoday.com/articles/130625.php
Medarex, Inc. (Nasdaq: MEDX) announced it has initiated a Phase 1b clinical trial for MDX-1106 (ONO-4538: development code of Ono Pharmaceutical Co., Ltd.), a fully human anti-PD-1 antibody for the treatment of cancer.

ASGE And The Pancreatic Cancer Action Network Partner To Raise Awareness About Pancreatic Cancer
http://www.medicalnewstoday.com/articles/130621.php
The American Society for Gastrointestinal Endoscopy (ASGE) and the Pancreatic Cancer Action Network are teaming up this November to raise awareness about pancreatic cancer, educating patients about the disease and the resources that are available for them.

UM Study Finds Late Diagnosis And Under-Treatment To Blame For Disparities In Cervical Cancer Survival
http://www.medicalnewstoday.com/articles/130618.php
Disparities in cervical cancer survival can be traced to differences in access to care for certain racial, ethnic and socioeconomic groups, according to a University of Miami Miller School of Medicine study of more than 5,300 Florida women.

The Improvement Foundation's Groundbreaking Cancer Programme - Improving Public Awareness And Fast Referral Of Cancer, UK
http://www.medicalnewstoday.com/articles/130617.php
Under a 'National Awareness and Early Diagnosis Initiative' (NAEDI), launched by the Department of Health last week, work is already underway in the UK to improve public awareness and fast referral of cancer, with pilot schemes in 20 Primary Care Trusts (PCTs) run by the Improvement Foundation.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

----------------------------------------------
** COLORECTAL CANCER News **

Genomic Signature Of Colon Cancer May Individualize Treatment
http://www.medicalnewstoday.com/articles/130730.php
Researchers in the Duke Institute for Genome Sciences & Policy have developed a model for predicting risk of recurrence in early stage colon cancer patients, and have used the model to also predict sensitivity to chemotherapy and targeted therapy regimens.

----------------------------------------------
** LUNG CANCER News **

European Cancer Specialists Mandate For Change - Better Emotional Support And Resouces For Lung Cancer Patients
http://www.medicalnewstoday.com/articles/130652.php
A coalition of European cancer specialists today called for major changes in the provision of emotional support for lung cancer patients. In conjunction with the International Psycho-Oncology Society, they issued a Mandate for Change, highlighting basic rights for patients in terms of their emotional wellbeing and quality of life.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

U.S. Approval For Clolar(R) To Treat Adult Acute Myeloid Leukemia Sought By Genzyme
http://www.medicalnewstoday.com/articles/130777.php
Genzyme Corporation (Nasdaq: GENZ) announced today that it has filed a supplemental New Drug Application with the U.S. Food and Drug Administration for the use of Clolar® (clofarabine) to treat adult patients with acute myeloid leukemia (AML).

FDA Grants Pralatrexate Orphan Drug Designation For The Treatment Of Patients With Diffuse Large B-Cell Lymphoma
http://www.medicalnewstoday.com/articles/130765.php
Allos Therapeutics, Inc. (Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.

Potential New Drug Target For Chronic Leukemia Identified By UCSD Researchers
http://www.medicalnewstoday.com/articles/130721.php
Researchers at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Center have discovered what could be a novel drug target for an often difficult-to-treat form of leukemia.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

USC Researchers Identify Novel Approach For Suppressing Prostate Cancer Development
http://www.medicalnewstoday.com/articles/130656.php
Inactivation of a specific protein associated with cancer development halts prostate tumor progression in animal model Los Angeles, Calif. Nov. 24, 2008 California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-24T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer
http://www.medicalnewstoday.com/articles/130595.php
Genentech, Inc. (NYSE:DNA) today announced that a Phase III study (RIBBON 1) of Avastin® (bevacizumab), in combination with taxane, anthracycline-based or capecitabine chemotherapies for first-line treatment of metastatic HER2-negative breast cancer, met its primary endpoint of increasing the time patients lived without their disease advancing, compared to the chemotherapies alone.

First Lady Laura Bush's Partnership For Breast Cancer Awareness And Research Extends To Panama
http://www.medicalnewstoday.com/articles/130451.php
The University of Texas M. D. Anderson Cancer Center marked the beginning of a collaborative effort to eradicate breast cancer in Panama through the Partnership for Breast Cancer Awareness and Research of the Americas today at an event with Laura Bush, the First Lady of the United States, and Vivian FernÃ¡ndez de Torrijos, the First Lady of Panama.

----------------------------------------------
** CANCER / ONCOLOGY News **

Transfusion Of Fresh Blood Could Play A Role In Surgical Outcomes Of Cancer Patients
http://www.medicalnewstoday.com/articles/130573.php
Among other findings, a study presented in the December issue of Anesthesiology suggests that the use of fresh red blood cells in transfusions for cancer patients could improve cancer recurrence and long-term survival rates.

Burzynski Research Institute, Inc. Presents Promising Phase II Data On Malignant Glioma
http://www.medicalnewstoday.com/articles/130546.php
Today at the 13th Annual Scientific Meeting of the Society for Neuro-Oncology, BRI announced encouraging results from the ongoing Phase II clinical trials of two of its investigational drugs, Atengenal (A10) and Astugenal (AS2-1), defined as antineoplastons therapy (ANP).

Bad Breath Linked To Bacteria That Cause Stomach Ulcer And Cancer
http://www.medicalnewstoday.com/articles/130539.php
New research from Japan found bacteria that cause stomach ulcers and cancer living in the mouths of some people with bad breath, even though they did not show signs of stomach illnesses.The study was the work of Dr Nao Suzuki from Fukuoka Dental College in Fukuoka, Japan and colleagues and is published in the December issue of the Journal of Medical Microbiology.

Med School Discovery Could Lead To Better Cancer Diagnosis, Drugs
http://www.medicalnewstoday.com/articles/130457.php
A Florida State University College of Medicine research team led by Yanchang Wang has discovered an important new layer of regulation in the cell division cycle, which could lead to a greater understanding of the way cancer begins.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Most Wirral Parents Say Yes To Cervical Cancer Vaccination For Daughters, England
http://www.medicalnewstoday.com/articles/130566.php
The majority of the Wirral parents asked if they would consent to their daughters being immunised against cervical cancer in the first wave of vaccinations have already agreed. The majority of the Wirral parents asked if they would consent to their daughters being immunised against cervical cancer in the first wave of vaccinations have already agreed.

----------------------------------------------
** COLORECTAL CANCER News **

Colorectal Cancer Screening Detects Unrecognised Disease
http://www.medicalnewstoday.com/articles/130481.php
Screening for colorectal cancer detects four out of ten cancers and should be carefully designed to be more effective, according to a study published today on bmj.com. About one in 20 people in the UK develop bowel cancer during their lifetime.

----------------------------------------------
** LUNG CANCER News **

Lung Cancer Needs Awareness Too
http://www.medicalnewstoday.com/articles/130575.php
Lung cancer kills more than four times as many Americans as breast cancer. But while pink ribbons trumpet Breast Cancer Awareness Month throughout October, little attention is paid to lung cancer in November, which is that disease's awareness month.

Mesothelioma Victims Center Offers The Best Free Help & Advice Service For A Victim Of Mesothelioma
http://www.medicalnewstoday.com/articles/130557.php
The Mesothelioma Victims Center is a world class free service designed to assist all victims of Mesothelioma, or to assist the families of victims, who have this disease. The group has just expanded its service to assist Mesothelioma victims or their families to find the right law firm to help them.

Progression Of Precancerous Lung Lesions Analyzed
http://www.medicalnewstoday.com/articles/130551.php
The risk of precancerous lesions developing into <a href="http://www.roswellpark.org/Patient_Care/Types_of_Cancer/Lung_Cancer" target="_blank" rel="nofollow">lung cancer </a> is highest among current and heavy smokers, according to a study presented by Vijay Jayaprakash, MBBS, Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute (RPCI), at the American Association for Cancer Research (AACR) Seventh International Frontiers in Cancer Prevention Research, November 16 -19, Washington, DC.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Prediagnostic BMI, Plasma C-Peptide Concentration, And Prostate Cancer-Specific Mortality In Men With Prostate Cancer: A Long-Term Survival Analysis
http://www.medicalnewstoday.com/articles/130468.php
UroToday.com - A significant level of interest has developed in the association of prostate cancer (CaP) specific mortality (PCSM) with nutrition, lifestyle variables, and treatment effects. The data surrounding a man's body mass index (BMI) and PCSM is mixed, but likely suggest an association between high BMI and an increased risk of dying from CaP.

Nerves At The Ventral Prostatic Capsule Contribute To Erectile Function: Initial Electrophysiological Assessment In Humans
http://www.medicalnewstoday.com/articles/130466.php
UroToday.com - When performing nerve sparing radical prostatectomy, how high up on the lateral prostatic fascia do urologists need to go to release the neurovascular bundle (NVB)? Are there even functional nerve fibers higher than the main bundle located at the 5 o'clock position? This question is answered by Dr.

Inverse Association Between Histologic Inflammation In Needle Biopsy Specimens And Prostate Cancer In Men With Serum PSA Of 10-50 Ng/ML
http://www.medicalnewstoday.com/articles/130465.php
UroToday.com - In the online edition of Urology, Dr. Tomoaki Terakawa and associates reported on parameters that may help determine whether a man with a PSA between 10 and 50ng/ml with a negative prostate biopsy is likely to have prostate cancer (CaP) later on.

EMR At 1.5 Tesla To Assess Local Recurrence After Radical Prostatectomy Using T2-Weighted & Contrast-Enhanced Imaging
http://www.medicalnewstoday.com/articles/130464.php
UroToday.com - Imaging accuracy for local recurrence of prostate cancer (CaP) and the use of endorectal magnetic resonance (eMR) has not been significantly assessed. In the online version of European Radiology, Dr.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-23T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

No news for this category today.

----------------------------------------------
** CANCER / ONCOLOGY News **

Metastatic Renal Cell Carcinoma: Results Of A Population-Based Study With 25 Years Follow-Up
http://www.medicalnewstoday.com/articles/130423.php
UroToday.com - The Munich Cancer Registry (MCR) was established in 1978 as the clinical registry of the Munich Cancer Centre and in the beginning cooperated with the two University hospitals in Munich.

1st Nonphysician Elected National President Of American Cancer Society
http://www.medicalnewstoday.com/articles/130300.php
Elizabeth T. H. (Terry) Fontham, MPH, DrPH, Dean of the LSU Health Sciences Center New Orleans School of Public Health, became the first non-physician elected national President of the American Cancer Society when she was inducted at a special ceremony during the Society's National Assembly Meeting on November 20, 2008 in New York City.

Journal Of Clinical Investigation Table Of Contents: Nov. 20, 2008
http://www.medicalnewstoday.com/articles/130277.php
Preventing tumor cells from refueling: a new anticancer approach?New data, generated in mice, by Pierre Sonveaux and colleagues, at UniversitÃ© catholique de Louvain, Belgium, have identified a potential new target for anticancer therapeutics.

Delaying The Evolution Of Drug Resistance
http://www.medicalnewstoday.com/articles/130272.php
Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Promising Clinical Data On Gen-Probe's APTIMA(R) HPV Test Presented At Major European Medical Meeting
http://www.medicalnewstoday.com/articles/130391.php
Gen-Probe's (Nasdaq: GPRO) CE-marked APTIMA(R) HPV assay may be an important new molecular tool to more accurately detect high-risk human papillomavirus (HPV) infections that are associated with cervical cancer or precancerous lesions, according to nine oral presentations and two scientific posters presented last week by independent and Gen-Probe researchers at the international conference of the European Research Organization on Genital Infection and Neoplasia (EUROGIN) in Nice, France.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

For Lung Cancer Iressa Proves Just As Effective As Chemotherapy
http://www.medicalnewstoday.com/articles/130297.php
Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, according to an international Phase III clinical trial, led by researchers at The University of Texas M.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Holmium Laser Enucleation Of The Prostate-Outcomes Independent Of Prostate Size?
http://www.medicalnewstoday.com/articles/130420.php
UroToday.com - Holmium laser enucleation of the prostate (HoLEP) is emerging as the procedure of choice for men with BPH. This paper highlights the universal appeal of HoLEP for treating prostates of all sizes with excellent functional long-term outcomes and few complications.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-22T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Does Hormone Treatment Predispose Patients To Breast Cancer?
http://www.medicalnewstoday.com/articles/130407.php
Breast cancer, the leading cause of death among women in France, is the most commonly occurring cancer in women. Sporadic breast cancer, which is non-hereditary, turns out to be the most widespread, representing 85 to 90% of all cases, but remains the least well-known.

----------------------------------------------
** CANCER / ONCOLOGY News **

Mechanisms Of Cardiovascular Disease And Cancer Give Clues To New Therapies
http://www.medicalnewstoday.com/articles/130408.php
Cardiovascular conditions leading to heart attacks and strokes are treated quite separately from common cancers of the prostate, breast or lung, but now turn out to involve some of the same critical mechanisms at the molecular level.

Texas Invests Record $3.5 Million In Startup Cofounded By UT's Mauro Ferrari For Cancer Technology
http://www.medicalnewstoday.com/articles/130258.php
NanoMedical Systems Inc., (NMS), an Austin-based startup cofounded by Mauro Ferrari, Ph.D., of The University of Texas Health Science Center at Houston (UTHSC-Houston), to improve the effectiveness of anti-cancer agents and other medications, has received a record $3.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-21T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Type Of Breast Reconstruction Impacts Radiation Therapy Outcomes
http://www.medicalnewstoday.com/articles/130275.php
For breast cancer patients who underwent a mastectomy who undergo radiation therapy after immediate breast reconstruction, autologous tissue reconstruction provides fewer long-term complications and better cosmetic results than tissue expander and implant reconstruction, according to a study in the November issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

----------------------------------------------
** CANCER / ONCOLOGY News **

Man Says His Dog Detected His Skin Cancer
http://www.medicalnewstoday.com/articles/130393.php
A man from Banbury near Oxford, England, said his dog sniffed out his skin cancer, reminiscent of reports of trials that have shown dogs can detect cancer, in some cases even when screening tests can't.

Scientists Honored For Contributions To Cancer Fight
http://www.medicalnewstoday.com/articles/130371.php
The American Cancer Society - the nation's leading voluntary health organization and largest non-governmental funder of cancer research and discovery - will present its highest honor, the Medal of Honor, to four Americans who have made outstanding contributions to the fight against cancer.

Tumors Fuelled By Lactic Acid
http://www.medicalnewstoday.com/articles/130327.php
A team of researchers at Duke University Medical Center and the UniversitÃ© catholique de Louvain (UCL) has found that lactic acid is an important energy source for tumor cells. In further experiments, they discovered a new way to destroy the most hard-to-kill, dangerous tumor cells by preventing them from delivering lactic acid.

Tumor Formation May Be Spurred By The Misreading Of Damaged DNA
http://www.medicalnewstoday.com/articles/130325.php
The DNA in our cells is constantly under assault from oxygen, the sun's radiation and environmental stresses. Most of the time, our cells can repair the damage before it gets copied into a permanent mutation that could lead to cancer.

Oral Gefitinib As Effective As Injected Docetaxel For Survival Of Patients With Non-Small-Cell Lung Cancer (Interest Study)
http://www.medicalnewstoday.com/articles/130288.php
Gefitnib is as effective a second-line treatment as docetaxel for patients with non-small cell* lung cancer. The INTEREST study, published in an Article in this week's edition of The Lancet, thus establishes gefitinib as a valid treatment option for people with this condition.

Pediatric Cancer : Alteration Of A Gene Causes Neuroblastoma
http://www.medicalnewstoday.com/articles/130248.php
Olivier Delattre's team (Inserm Unit 830 "Genetics and Biology of Cancer") of the Institut Curie reveal in an article in the 16 October issue of Nature that alteration of the ALK gene is closely associated with the most frequent solid extracerebral tumor in children neuroblastoma.

Ortho Biotech Announces NDA Submission For Trabectedin For The Treatment Of Relapsed Ovarian Cancer
http://www.medicalnewstoday.com/articles/130233.php
Ortho Biotech Products, L.P. announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL(R) (doxorubicin HCI liposome injection)for the treatment of women with relapsed ovarian cancer (ROC).

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

'Urgent Need' For HPV Vaccine In Developing World, Opinion Piece Says
http://www.medicalnewstoday.com/articles/130338.php
 While officials in the United Kingdom and the U.S. are "dithering and doubting" over issues related to <A href="http://www.gsk.com/" target=_new>GlaxoSmithKline</A> and <A href="http://www.

----------------------------------------------
** COLORECTAL CANCER News **

Painless, Non-Invasive And Inexpensive Test For Colon Cancer
http://www.medicalnewstoday.com/articles/130303.php
People are often reluctant to undergo a routine but painful colonoscopy - but the consequences can be fatal. According to the American Cancer Society, colon cancer is the third most common cancer found in American men and women and kills about 50,000 Americans every year.

----------------------------------------------
** LUNG CANCER News **

Amgen, Takeda And Millennium Provide Update On Phase 3 Trial Of Motesanib In Patients With Non Small Cell Lung Cancer
http://www.medicalnewstoday.com/articles/130250.php
Amgen (Nasdaq: AMGN) and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited (TSE: 4052), announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC).

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-20T23:02:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Randomized Phase 2 Study Of IMC-A12 For HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
http://www.medicalnewstoday.com/articles/130227.php
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed randomized Phase 2 clinical trial of IMC-A12 in patients with previously treated HER2-expressing locally advanced or metastatic breast cancer has commenced patient enrollment.

Breast Cancer Drug Raises Blood Clot Risk, Should Have 'Black Box' Warning, JAMA Study Says
http://www.medicalnewstoday.com/articles/130130.php
 <A href="http://www.gene.com/gene/index.jsp?q=genentech&rls=com.microsoft:*&ie=UTF-8&oe=UTF-8&startIndex=&startPage=1" target=_new>Genentech</A>'s cancer drug Avastin -- which FDA approved in February for treatment of advanced breast cancer -- increases a patient's risk of developing blood clots in veins, a condition known as venous thromboembolism, or VTE, according to a <A href="http://jama.

Family History Raises Breast Cancer Risk Despite Absence Of BRCA Mutations, Study Finds
http://www.medicalnewstoday.com/articles/130129.php
 Women with a strong family history of breast cancer have a four times greater risk for the disease than women in the general population, even if they do not carry a mutation of the BRCA gene, according to a study presented Monday at the <A href="http://www.

Causes Of Bone Loss In Breast Cancer Survivors Identified By Study
http://www.medicalnewstoday.com/articles/130119.php
Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss.But a new study has found that cancer drugs aren't the only culprits.

----------------------------------------------
** CANCER / ONCOLOGY News **

Bovie Medical Corporation Announces FDA 510(K) Clearance To Market SEER Tissue Resection Device
http://www.medicalnewstoday.com/articles/130226.php
Bovie Medical Corporation (the "Company") (NYSE Alternext US: BVX), a manufacturer and marketer of electrosurgical products, today announced the Company received 510(k) clearance from the Food and Drug Administration (FDA) to market its SEER tissue resection device intended for initial use in liver oncology surgery.

Relapsed Ovarian Cancer - Submitted New Drug Application To FDA For Trabectedin
http://www.medicalnewstoday.com/articles/130213.php
PharmaMar announced today that Ortho Biotech Products, L.P. has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL® (pegylated liposomal doxorubicin) for the treatment of women with relapsed ovarian cancer (ROC).

Gentium Provides An Update On The Phase 3 Treatment Trial Of Defibrotide For Severe Veno-Occlusive Disease
http://www.medicalnewstoday.com/articles/130209.php
Gentium S.p.A. (NASDAQ: GENT) announced today interim results from an independent Data Safety Monitoring Board (DSMB) review of the Company's Phase 3 treatment trial of Defibrotide for Severe Veno-Occlusive Disease (VOD).

Ovarian Cancer Cells Destroyed By New Platinum-Phosphate Compounds
http://www.medicalnewstoday.com/articles/130208.php
A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published this week in the journal Proceedings of the National Academy of Sciences.

Higher Risk Of Certain Cancers Being Recorded In HIV-Positive People
http://www.medicalnewstoday.com/articles/130150.php
Physicians in the U.S. are reporting a higher risk for certain types of cancers -- such as liver, head, neck and lung -- in people living with HIV/AIDS, raising concerns that a cancer epidemic is imminent in the population, the <a href="http://www.

Common Virus Helps Quality Of Life For Sarcoma Patients Says Cancer Expert
http://www.medicalnewstoday.com/articles/130090.php
New data shows that some sarcoma patients are benefiting from treatment with REOLYSIN, developed from a harmless virus called the reovirus that most people are exposed to at some point in their lives.

Survival Of Head And Neck Cancer Patients Is Greatly Affected By Coexisting Ailments
http://www.medicalnewstoday.com/articles/130086.php
Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of the most common diseases such patients have in addition to their primary cancer, says Jay Piccirillo, M.

New Imaging Technique Tracks Cancer-Killing Cells Over Prolonged Period In First-Ever Stanford Case Study
http://www.medicalnewstoday.com/articles/130072.php
Coaxing a patient's own cells to hunt down and tackle infected or diseased cells is a promising therapeutic approach for many disorders. But until now, efforts to follow these specially modified cells after their reintroduction to the body have relied on short-term monitoring techniques that don't give a complete picture of the cells' status.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Mexican Department Of Public Health To Launch Screening For Papillomavirus, Cause Of Cervical Cancer
http://www.medicalnewstoday.com/articles/130083.php
In a campaign to significantly reduce the most common cancer affecting Mexican women, the Mexican Public Health Agency (Secretaria de Salud) announced that it is launching the first phase of a program that will offer free testing for human papillomavirus (HPV), the primary cause of cervical cancer, to all low-income women age 35-65.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Lymphoma Association Launches New Short Film
http://www.medicalnewstoday.com/articles/130121.php
The Lymphoma Association is delighted to launch their latest short film which shows the services they offer to anyone affected by lymphoma - the UK's sixth most common cancer. The charity were selected to have the film made for them for a nominal fee by the Media Trust, an organisation which helps charities raise awareness by providing them with volunteers from the TV, film and video industry who then produce videos for them.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

GenVec Announces Interim Survival Data In Pivotal Trial Of TNFerade™ In Locally Advanced Pancreatic Cancer
http://www.medicalnewstoday.com/articles/130229.php
GenVec, Inc. (Nasdaq:GNVC) announced today top-line results of an interim analysis from its ongoing Phase III Pancreatic Cancer Clinical Trial with TNFerade™ (PACT) in patients with locally advanced pancreatic cancer.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-19T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Two New Compounds Show Promise For Destroying Breast Cancer Tumors - University Of Central Florida
http://www.medicalnewstoday.com/articles/130051.php
Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors. Associate Professor James Turkson's compounds disrupt the formation and spread of breast cancer tumors in tests on mice.

Breast Cancer Prevention Differences In Postmenopausal Women Following Calorie Restriction And Exercise
http://www.medicalnewstoday.com/articles/129989.php
Scientists at the University of Texas at Austin have identified pathways by which a reduced-calorie diet and exercise can modify a postmenopausal woman's risk of breast cancer.The results, presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, suggest that both caloric restriction and exercise affect pathways leading to mTOR, a molecule involved in integrating energy balance with cell growth.

Black, Less-Educated Women Less Likely To Undergo Breast Reconstruction Surgery After Mastectomy, Study Finds
http://www.medicalnewstoday.com/articles/129969.php
Black women are 47% less likely than other women to undergo breast reconstruction after having a mastectomy, according to a study published in the November issue of <cite>Archives of Surgery</cite>, <a href="http://health.

Survival In Breast Cancer Patients Boosted By Intervention Program
http://www.medicalnewstoday.com/articles/129927.php
A new study provides the best evidence to date that a psychological intervention program designed for breast cancer patients not only improves their health - it actually increases their chance of survival.

ER/PR Negative Tumors Associated With Insurance Status
http://www.medicalnewstoday.com/articles/129905.php
African-American women are at a higher risk for ER/PR negative breast cancer. A new study, to be presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, found that race, socioeconomic characteristics and other tumor characteristics are all important predictors of having ER/PR negative breast cancer.

Teaching Breast Health Early To Reduce Breast Cancer Mortality In D.C.
http://www.medicalnewstoday.com/articles/129901.php
Early breast health education may be the key to lowering breast cancer mortality rates in Washington, D.C., which has the highest rates in the country, according to research presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

Community Factors Predict Reconstruction After Mastectomy
http://www.medicalnewstoday.com/articles/129842.php
According to new research published in the November issue of Archivesof Surgery, women who live in wealthier communities withlower population densities and a larger proportion of college-educatedindividuals are more likely to have immediate breast reconstructionafter mastectomy.

----------------------------------------------
** CANCER / ONCOLOGY News **

PharmaMar Receives "Supporting A Cure In Our Time" Sarcoma Foundation Of America Award For Commitment With Research In Soft Tissue Sarcoma
http://www.medicalnewstoday.com/articles/130059.php
PharmaMar has received the Award "Supporting A Cure In Our Time" from the Sarcoma Foundation of America (SFA) for its "support in the search for an effective cure for soft tissue sarcomas," goal of the foundation, during the congress of the Connective Tissue Oncology Society (CTOS) held in London from 13-15 November.

ZIOPHARM Oncology Presents Positive Data From Studies Of Palifosfamide
http://www.medicalnewstoday.com/articles/130057.php
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it presented positive data from a Phase I study of palifosfamide (ZymafosTM) in combination with doxorubicin at the 14th Annual Connective Tissue Oncology Society (CTOS) meeting held in London, UK, November 13 to 15.

Metastatic Melanoma - Provectus Adds 6th Center To Phase 2 Clinical Trial Of PV-10
http://www.medicalnewstoday.com/articles/130055.php
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has begun recruitment for its Phase 2 clinical trial of the Company's lead oncology agent PV-10 at a sixth major center located at the California Pacific Medical Center, in San Francisco, CA.

Cancer Drug Avastin Raised Risk Of Blood Clots, Study
http://www.medicalnewstoday.com/articles/130048.php
A new analysis of randomized controlled trials of the widely used new generation cancer drug bevacizumab (marketed by Roche and Genentech as Avastin) found it was linked to an increased risk of deep vein blood clots or venous thromboembolism in the legs or lungs compared with treatments that did not use it.

JDRF Funded Research Shows Promise For Prevention, Reversal Of Type 1 Diabetes
http://www.medicalnewstoday.com/articles/130019.php
Researchers at the University of California, San Francisco have reported that two common cancer drugs have been used to block and reverse type 1 diabetes in mice. The JDRF-funded study, published in The Proceedings of the National Academy of Sciences, was led by Jeffrey Bluestone, Ph.

Elderly Cancer Survivors' Ability To Function Improved By Home-Based Interventions
http://www.medicalnewstoday.com/articles/130017.php
Climbing stairs, carrying groceries, taking a shower - these are activities that we take for granted; however, after a cancer diagnosis, many survivors are unable to function as they used to.

Cancer-Killing Cells Tracked Over Prolonged Period Using New Imaging Technique
http://www.medicalnewstoday.com/articles/130009.php
Coaxing a patient's own cells to hunt down and tackle infected or diseased cells is a promising therapeutic approach for many disorders. But until now, efforts to follow these specially modified cells after their reintroduction to the body have relied on short-term monitoring techniques that don't give a complete picture of the cells' status.

13 New Tumor-Suppressor Genes In Liver Cancer Identified By Cold Spring Harbor Science Teams
http://www.medicalnewstoday.com/articles/129987.php
Over the years, hunting for cancer-related genes and understanding how they work has been an important, although time-consuming, exercise. At Cold Spring Harbor Laboratory (CSHL), five different research groups have now combined their expertise to speed up the rate of discovering cancer-related genes and validating their function in living animals.

Australia/New Zealand Join Forces On New Treatment Guidelines For Melanoma
http://www.medicalnewstoday.com/articles/129985.php
In a cross-Tasman first, Australia and New Zealand have collaborated with a joint approach to the development of treatment guidelines for cancer, to be launched today (19/11) at the Clinical Oncological Society of Australia Annual Scientific Meeting in Sydney.

Patients Use Touchscreen Technology To Record Pain And Distress
http://www.medicalnewstoday.com/articles/129984.php
Cancer patients in Newcastle, NSW, have been taking part in a unique Australian trial to record levels of pain and distress using touchscreen technology. When out-patients see their doctor at Calvary Mater Newcastle, they use touchscreen computers to complete pain and distress "thermometers", as well as a brief psychological assessment.

Cancer Survival Rates Impact Type Of Web Communities Used By Patients
http://www.medicalnewstoday.com/articles/129981.php
Online support communities for high survival rate cancers contain a greater amount of emotional support content than online support communities for cancers with low survival rates, according to a new study from the University of Michigan Health System and the VA Ann Arbor Healthcare System.

Vitamin Boosts Immunity Against Skin Cancer
http://www.medicalnewstoday.com/articles/129980.php
Nicotinamide (VitB3), a vitamin found in common foods like meats, nuts, grains and cereals, may provide the next advance in skin cancer prevention, according to new research from the University of Sydney.

Elderly Cancer Survivors' Physical Function Improved By Home-Based Diet And Exercise Intervention
http://www.medicalnewstoday.com/articles/129973.php
A home-based program to improve exercise and diet led to significant, clinically meaningful improvement in body weight and physical function among older long-term cancer survivors in preliminary findings from the RENEW (Reach-out to ENhancE Wellness) trial, according to Wendy Demark-Wahnefried, Ph.

A Post-code Lottery Still Exists For Cancer Patients With "exceptional Circumstances"
http://www.medicalnewstoday.com/articles/129912.php
A study of patients, at the Christie Hospital, Manchester, has shown that the decision to fund patient care depends more on where the patient lives, than the patient's health circumstances, raising public concern regarding a "postcode lottery" since each decision is made solely by the patients' local Primary Care Trust (PCT).

Individuals With HIV Have Higher Risk Of Non-AIDS Cancers
http://www.medicalnewstoday.com/articles/129895.php
The risk of non-AIDS cancer is higher for individuals infected with HIV than for the general population, according to a meta-analysis presented here at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

AACR Cancer Prevention Meeting: Georgetown University Medical Center Research Summaries
http://www.medicalnewstoday.com/articles/129993.php
Researchers from Lombardi Comprehensive Cancer Center/Georgetown University Medical Center are presenting numerous scientific findings at the Seventh Annual AACR International Conference on Frontiers in Cancer Prevention Research in Washington, Nov.

Lower Socioeconomic Status Decreases Chances Of Early Detection And Survival Of Colorectal Cancer
http://www.medicalnewstoday.com/articles/129903.php
An abstract presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research shows that lower socioeconomic status reduced the chance of early stage diagnosis and survival of colorectal cancer in Colorado.

----------------------------------------------
** LUNG CANCER News **

Lung Cancer Risk In Smokers May Be Lowered By Broccoli
http://www.medicalnewstoday.com/articles/130012.php
The cancer preventive properties of broccoli and other cruciferous vegetables appear to work specifically in smokers, according to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

High Dose Chemotherapy Significantly Prolongs Survival For Patients With Acute Myeloid Leukemia
http://www.medicalnewstoday.com/articles/129929.php
Preliminary results from a large, randomized clinical trial for patients ages 16 to 60 with previously untreated acute myeloid leukemia (AML), a cancer of the blood and bone marrow, show that patients who received a high dose of a commercially available chemotherapy drug, daunorubicin, during initial therapy lived longer than patients who received a standard dose of the same drug.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-18T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Dangerous 'Two-Faced' Protein Crucial To Breast Cancer Spread And Growth Identified By Mayo Researchers
http://www.medicalnewstoday.com/articles/129838.php
Two critical properties of cancer cells are their ability to divide without restraint and to spread away from the primary tumor to establish new tumor sites. Now, researchers from the Mayo Clinic campus in Florida have found a protein they say acts as a deadly master switch, both freeing cancer cells from a tumor while ramping up new growth.

Breast Cancer Common Among Women With Family History But Without BRCA1 Or BRCA2
http://www.medicalnewstoday.com/articles/129801.php
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.

Latinas More Likely To Regret Breast Cancer Treatment Decisions, USA
http://www.medicalnewstoday.com/articles/129782.php
Latina women who prefer speaking Spanish are more likely than other ethnic groups to express regret or dissatisfaction with their breast cancer treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.

Psychological Interventions Associated With Breast Cancer Survival
http://www.medicalnewstoday.com/articles/129778.php
A new study finds that breast cancer patients who participate in intervention sessions focusing on improving mood, coping effectively, and altering health behaviors live longer than patients who do not receive such psychological support.

Studies To Examine Factors Behind Racial Disparities In Breast, Colon Cancers
http://www.medicalnewstoday.com/articles/129775.php
The following summarizes articles about two cancer studies that examine racial disparities.<ul><li class="AdvisoryBullet">Breast cancer: Researchers from the University of North Carolina's <a href="http://cancer.

Sanofi-Aventis Pharma S.A. Withdraws Its Application For An Extension Ofindication For Taxotere And Docetaxel Winthrop (docetaxel)
http://www.medicalnewstoday.com/articles/129727.php
The European Medicines Agency (EMEA) has been formally notified by Sanofi-Aventis Pharma S.A. of its decision to withdraw its application for an extension of indication for the centrally authorised medicines Taxotere (docetaxel) 20 mg/0.

Researchers Find Clue To Stopping Breast Cancer Metastasis
http://www.medicalnewstoday.com/articles/129711.php
If scientists knew exactly what a breast cancer cell needs to spread, then they could stop the most deadly part of the disease: metastasis. New research from the University of North Carolina at Chapel Hill School of Medicine takes a step in that direction.

Study: Psychological Help Improves Breast Cancer Survival
http://www.medicalnewstoday.com/articles/129683.php
You've heard the saying 'mind over matter.' Now a new study gives that phrase some scientific backing. Researchers have learned that giving breast cancer patients psychological support along with their medical treatment can dramatically improve their odds of beating the disease.

----------------------------------------------
** CANCER / ONCOLOGY News **

New Biomarkers For Brain Tumor Discovered
http://www.medicalnewstoday.com/articles/129914.php
Researchers in the US and The Netherlands have discovered that cancer cells from a deadly type of human brain tumor called glioblastoma release tiny sacs containing proteins that traverse the brain-blood barrier and contain genetic material that could be used as biomarkers in new diagnostic tools and perhaps as new targets for treatments too.

Thallion Initiates Enrollment In Phase II Metastatic Melanoma Trial
http://www.medicalnewstoday.com/articles/129890.php
Thallion Pharmaceuticals Inc. (TSX:TLN) today announced that the first patient has been enrolled in its Phase II trial evaluating TLN-232 as a treatment for metastatic melanoma in patients who have failed one prior therapy.

In Vivo Model For Human Brain Cancer (Human Glioblastoma GBM) For Drug Discovery Applications Introduced By Celprogen
http://www.medicalnewstoday.com/articles/129880.php
Celprogen Inc., a Global leader in the Stem Cell Research and Therapeutics industry for development of stem cell technologies in regenerative medicine, today announced that they have successfully validated an in vivo model system for testing efficacy of cancer drugs and also novel drug candidates for Human Glioblastoma.

Scientists Find A Trigger To Aggressive Bowel Cancer
http://www.medicalnewstoday.com/articles/129867.php
Cancer Research UK scientists have shown how bowel cancer can become aggressive, according to research published in Nature Genetics*. The researchers, based in the Cardiff School of Biosciences, Cardiff University and at Cancer Research UK's Beatson Institute in Glasgow found that a tumour suppressor protein called Pten is critical in stopping tumours from growing in mice.

Type 1 Diabetes Prevented, Reversed By Two Cancer Drugs, UCSF Study Shows
http://www.medicalnewstoday.com/articles/129861.php
Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco.

CAPHOSOL Results In Minimal Oral Mucositis And Pain In Head/neck Cancer Patients
http://www.medicalnewstoday.com/articles/129856.php
New data show that CAPHOSOL® (www.ca<a href="http://www.caphosol.com" target="_blank" rel="nofollow">http://www.caphosol.com</a>phosol.com), an advanced electrolyte solution, results in low rates of oral mucositis and pain in patients with head and neck (HN) cancer who are undergoing chemotherapy and radiation therapy.

Breaking BubR1 Mimics Genetic Shuffle Seen In Cancer Cells
http://www.medicalnewstoday.com/articles/129837.php
A study of how one protein enzyme, BubR1, helps make sure chromosomes are equally distributed during mitosis might explain how the process of cell division goes so awry in cancer, according to researchers from Fox Chase Cancer Center.

Kidney Cancer Risk Could Be Increased By Genes Associated With Fat Metabolism
http://www.medicalnewstoday.com/articles/129804.php
A team of international scientists has identified three genes associated with the body's processing of fats that may increase susceptibility to kidney cancer. The findings were presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

Genetic 'signature' In Healthy Liver Cells Predicts Risk Of Liver Cancer Recurrence
http://www.medicalnewstoday.com/articles/129790.php
Researchers have found a gene 'signature' - a specific set of genes - in the healthy, noncancerous cells in the liver of people who have had liver cancer that is associated with better chances of survival and a second gene signature associated with late cancer recurrence, in an international study that has shown for the first time that tissue samples preserved by traditional methods can be used for genetic analysis.

3 Esophageal, Stomach Cancer Subtypes Linked To Smoking; 1 Associated With Alcohol Use
http://www.medicalnewstoday.com/articles/129789.php
Researchers who have been following the health of more than 120,000 residents of the Netherlands for more than two decades have found that smoking is associated with two forms of esophageal cancer as well as a form of stomach cancer, and that drinking alcohol is strongly linked to one form of esophageal cancer.

Silence On Drug Options "distresses" Cancer Patients
http://www.medicalnewstoday.com/articles/129748.php
Cancer patients want their oncologists to be more up-front about available drug treatments and include them in decision making, even if they cannot afford the treatment, according to new Australian research presented to the Clinical Oncolgoical Society of Australia Annual Scientific Meeting today (18/11) in Sydney.

Exercise And Sleep Reduce Women's Cancer Risk
http://www.medicalnewstoday.com/articles/129735.php
A new US study of nearly 6,000 women found that while regular exercise appeared to reduced their risk of cancer, this benefit was likely to be lost if they did not get enough sleep.The researchers presented their findings at the American Association for Cancer Research's (AACR) Seventh Annual International Conference on Frontiers in Cancer Prevention Research that is taking place in National Harbor, Maryland, this week.

EGFR-Targeting Antibody Licensed To Abbott
http://www.medicalnewstoday.com/articles/129729.php
The international Ludwig Institute for Cancer Research (LICR) has announced that one of its spin-off companies, Life Science Pharmaceuticals, has licensed its lead cancer therapy candidate, antibody 806, to pharmaceutical company Abbott.

Exercise And Rest Reduce Cancer Risk
http://www.medicalnewstoday.com/articles/129709.php
Exercise is good for more than just your waistline. A recent study presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research suggests that regular physical activity can lower a woman's overall risk of cancer but only if she gets a good night's sleep.

Three Esophageal, Stomach Cancer Subtypes Linked To Smoking; One Associated With Alcohol Use
http://www.medicalnewstoday.com/articles/129708.php
Researchers who have been following the health of more than 120,000 residents of the Netherlands for more than two decades have found that smoking is associated with two forms of esophageal cancer as well as a form of stomach cancer, and that drinking alcohol is strongly linked to one form of esophageal cancer.

Behavior/Lifestyle Factors Influence Cancer Risk Among The Elderly
http://www.medicalnewstoday.com/articles/129707.php
Behavioral risk factors have a significant effect on cancer risk in the U.S. elderly population, according to research presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

Brain Tumor Cells Release Tiny Sacs Which Carry Information That May Guide Treatment
http://www.medicalnewstoday.com/articles/129701.php
Microvesicles - tiny membrane-covered sacs - released from glioblastoma cells contain molecules that may provide data that can guide treatment of the deadly brain tumor. In their report in the December 2008 Nature Cell Biology, which is receiving early online release, Massachusetts General Hospital (MGH) researchers describe finding tumor-associated RNA and proteins in membrane microvesicles called exosomes in blood samples from glioblastoma patients.

Barrett's Esophagus May Be Affected By DFMO
http://www.medicalnewstoday.com/articles/129694.php
"While there was a suggestion that DFMO may influence the extent of Barrett's dysplasia, this finding is very preliminary and further study of this agent in a larger number of patients is needed," said Frank A.

Long-Term Vitamin E Or Vitamin C Supplementation Does Not Offer Protectiion From Cancer
http://www.medicalnewstoday.com/articles/129693.php
The Physicians' Health Study II is a large-scale, long-term, randomized clinical trial that included 14,641 physicians who were at least 50 years old at enrollment. These physicians were given 400 IU of vitamin E every other day or its placebo, or 500 mg of vitamin C daily or its placebo.

Blood Exosomes Shown To Contain Tumor Specific Genetic Information For Brain Cancer
http://www.medicalnewstoday.com/articles/129686.php
Tiny vesicles called exosomes released into the bloodstream from aggressive brain tumors contain genetic signatures that may help guide future diagnosis and treatment of this deadly disease. In their report in the December issue of Nature Cell Biology (DOI: 10.

Survey Of Beachgoers' Tanning Habits Should Help Interventions To Prevent Skin Cancer
http://www.medicalnewstoday.com/articles/129660.php
A study published in the November issue of Archives ofDermatology seeks to determine which beachgoers would benefitfrom targeted interventions to reduce skin cancer risk by identifyingsun-protection practices and risk profiles.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

Role Of Vitamin D In Cancer Therapy Clarified By Study
http://www.medicalnewstoday.com/articles/129737.php
A colon cancer cell isn't a lost cause. Vitamin D can tame the rogue cell by adjusting everything from its gene expression to its cytoskeleton. In the Nov. 17 issue of the Journal of Cell Biology, OrdÃ³Ã±ez-MorÃ¡n et al.

Calcium May Only Protect Against Colorectal Cancer In Presence Of Magnesium
http://www.medicalnewstoday.com/articles/129695.php
High magnesium intake has been associated with low risk of colorectal cancer. Americans have similar average magnesium intake as East Asian populations. If that were all that were involved, observers might expect both groups to have similar risk for colorectal cancer.

----------------------------------------------
** LUNG CANCER News **

Why Only Some Former Smokers Develop Lung Cancer
http://www.medicalnewstoday.com/articles/129803.php
Canadian researchers are trying to answer why some smokers develop lung cancer while others remain disease free, despite similar lifestyle changes.Results were presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

Extending Chemotherapy Improves Control Of Lung Cancer
http://www.medicalnewstoday.com/articles/129752.php
A new Australian study has found that extending the use of chemotherapy in patients with advanced non-small cell lung cancer better controls the disease, as well as providing a modest improvement in survival.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

Cold/Flu Breakthrough Remedy Undergoes NCI-Sponsored Trial In Leukemia Patients: Canada
http://www.medicalnewstoday.com/articles/129834.php
Cancer patients - with their weakened immune systems - are particularly vulnerable when the cold and flu season hits. To help, the U.S. National Cancer Institute (NCI) is sponsoring a landmark trial to see whether a unique Canadian cold remedy - COLD-FX - can help.

Researchers Tackle CLL, Diabetes And Trauma-Hemorrhage - Molecular Medicine, A Bi-Monthly Journal
http://www.medicalnewstoday.com/articles/129718.php
Chronic Lymphocytic Leukemia (CLL) is a disease of the B lymphocytes of the immune system. Under normal conditions, B lymphocytes (or B cells) play an important role in battling infection. CLL is a disease manifested by uncontrolled growth of these B lymphocytes.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Genetic Risk Factors May Tailor Prostate Cancer Screening Approaches
http://www.medicalnewstoday.com/articles/129805.php
Men with a family history of prostate cancer and African-American men are particularly susceptible to the disease, with a twofold to sevenfold increased risk. Assessing risk in these populations has been difficult.

Growing Number Of Young Prostate Cancer Patients Need 'sexual Rehabilitation'
http://www.medicalnewstoday.com/articles/129757.php
Prostate cancer is being detected and treated at an earlier age, resulting in more cases of erectile dysfunction in younger men. While for many this is a temporary setback, for some it can take much longer and others will never recover their former capability.

Significantly Lower PSA Levels Discovered In Men Who Take Aspirin
http://www.medicalnewstoday.com/articles/129689.php
The use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower PSA levels, especially among men with prostate cancer, say researchers at Vanderbilt University.

-------------------------------------------------------------

Medical News Today News Alert

2008-11-17T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

British Study Shows Possible Explanation For Tamoxifen Resistance In Some Breast Cancer Patients
http://www.medicalnewstoday.com/articles/129555.php
 British researchers have discovered a possible explanation for why some female breast cancer patients being treated with tamoxifen -- the most commonly used breast cancer drug -- are resistant to the treatment, increasing their risk that tumors will return, according to a <A href="http://www.

----------------------------------------------
** CANCER / ONCOLOGY News **

SciClone Agreement With FDA On Special Protocol Assessment For Phase 3 Thymalfasin Trial In Stage IV Melanoma
http://www.medicalnewstoday.com/articles/129670.php
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the Company and the U.S. Food and Drug Administration (FDA) have reached agreement on the design of a phase 3 registration trial for thymalfasin as a potential treatment for stage IV melanoma.

Plymouth Hospitals To Lead Cancer Surgery Training Programme, England
http://www.medicalnewstoday.com/articles/129636.php
Plymouth Hospitals NHS Trust has been chosen to co-ordinate the national programme for the training of existing consultants in advanced keyhole surgery for the treatment of bowel cancer. The Department of Health has appointed Consultant General Surgeon, Mr Mark Coleman as the National Clinical Lead for the Laparoscopic Colorectal Cancer Surgery Training Programme.

Main Reason Teens Get Sunburnt "I Forgot To Protect Myself"
http://www.medicalnewstoday.com/articles/129608.php
Teens continue to put themselves at unnecessary risk of skin cancer by spending excessive time in the sun and forgetting to protect themselves, according to new Cancer Council research. Findings from the Cancer Council's National Sun Protection Survey released today show teens spend an average of two hours (1hr 51mins) in the sun during peak UV, with almost a third who get sunburnt saying they "forgot" to protect themselves.

Cytopia Doses First Brain Cancer Patient In Phase Ib/II Study
http://www.medicalnewstoday.com/articles/129604.php
Cytopia Limited (ASX:CYT) has commenced dosing patients in its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, to treat glioblastoma multiforme (GBM), an aggressive brain cancer.

The Genetics Of Aging And Cancer Resistance
http://www.medicalnewstoday.com/articles/129589.php
In the November 15th issue of G&D, Dr. Kenneth Dorshkind and colleagues at the David Geffen School of Medicine (UCLA) have identified two genes - p16(Ink4a) and Arf - that sensitize lymphoid progenitor cells to the effects of aging, and confer resistance to leukemogenesis.

Efforts, Grants Seek To Raise Cancer Awareness Among Alaska Natives, Educate Elderly Hispanics On Diabetes Management, Target Infant Mortality
http://www.medicalnewstoday.com/articles/129578.php
The following is a summary of efforts and grants that seek to reduce racial and ethnic health disparities. <ul><li class="AdvisoryBullet"><a href="http://www.anthc.org/" target="_new">Alaska Native Tribal Health Consortium</a>: The <a href="http://www.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

Four-type HPV Vaccine Gardasil(R) Is Also Effective In Men
http://www.medicalnewstoday.com/articles/129676.php
The four-type (6,11,16,18) human papillomavirus (HPV) vaccine Gardasil® is also effective in men according to the primary analysis from a pivotal phase III clinical study. In previously uninfected men aged 16 to 26 years*, Gardasil® prevented 90% (95%CI: 69, 98) of external genital lesions caused by HPV types 6, 11, 16 or 18.

New Research Shows Knowledge Of HPV And Vaccination Could Improve Cervical Screening Attendance
http://www.medicalnewstoday.com/articles/129616.php
Information about vaccination against the virus that causes cervical cancer could encourage rather than discourage women to attend for cervical screening, a new survey has found.1A number of commentators have said that vaccinating women against the human papillomavirus (HPV), which causes cervical cancer, could make them complacent about attending for cervical screening (smear test), although to date there has been no evidence to support this.

New Data On Cancer Diagnostic Presented By Arbor Vita
http://www.medicalnewstoday.com/articles/129590.php
Arbor Vita Corporation (AVC), a privately held biopharmaceutical company, presented new data on its rapid, point-of-care prototype HPV test with a high positive predictive value for cervical cancer and pre-cancer.

----------------------------------------------
** COLORECTAL CANCER News **

OncoVAX, Other Vaccines Provide Hope For Colorectal Cancer Treatment, Prevention
http://www.medicalnewstoday.com/articles/129643.php
Propelled by advances in molecular biology, the treatment of colorectal cancer is on the verge of dramatic change and a promising future as innovative vaccines will replace chemotherapy.

----------------------------------------------
** LUNG CANCER News **

First Pivotal Trials Begin For Boehringer Ingelheim's Novel Triple Angiokinase Inhibitor Vargatef™ (BIBF 1120)
http://www.medicalnewstoday.com/articles/129626.php
Boehringer Ingelheim has marked a new milestone within its rapidly expanding oncology portfolio with the announcement today that the company has progressed another of its oncology compounds into pivotal phase III clinical development.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

Nymox Reports Positive New Results In 59 Week Study Of Drug For Enlarged Prostate
http://www.medicalnewstoday.com/articles/129620.php
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce positive new results from the Company's most recent study of NX-1207, its drug in development for benign prostatic hyperplasia (BPH).

Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System For Use In Prostate Surgeries
http://www.medicalnewstoday.com/articles/129597.php
Cardium Therapeutics (Amex: CXM) and its operating unit InnerCool Therapies, Inc., today announced that it has developed a pelvic cooling catheter system called UroCool(TM), which is designed to induce localized cooling during surgery for prostate cancer (radical prostatectomy).

-------------------------------------------------------------

Subscription Confirmation

2008-11-17T20:11:00.001-08:00

Dear Subscriber,

You are no longer subscribed to any newsletters from The HealthCentral Network.

If you are receiving this in error and wish to continue receiving newsletters, please click here to change your subscriptions now.

Sincerely,

The MyBreastCancerNetwork.com Team

If you have questions or comments about this newsletter or about our newsletter service in general, please contact us at comments@thcn.com.

Read our privacy policy

Medical News Today News Alert

2008-11-16T23:01:00.000-08:00

Dear Subscriber,

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

----------------------------------------------
** BREAST CANCER News **

Cancer Treatment May Result In Bone Loss
http://www.medicalnewstoday.com/articles/129429.php
New cross-Canada study in Journal of Clinical Oncology outlines risksA new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. In the online edition of the Journal of Clinical Oncology, the scientists explain how loss of bone mass might affect 46,000 people diagnosed with breast and prostate cancer each year* and place them at increased risk for osteoporosis and fractures.

----------------------------------------------
** CANCER / ONCOLOGY News **

Inflammatory Myofibroblastic Tumors Of The Genitourinary Tract--Single Entity Or Continuum?
http://www.medicalnewstoday.com/articles/129533.php
UroToday.com - Can we meaningfully separate inflammatory pseudotumor (a term used since 1937 1 from inflammatory myofibroblastic tumor (IMT, a term introduced in 1990 for lung lesions 2 and from sarcoma? The oldest large series of 38 such cases in the urinary bladder divided most of them into 17 pseudotumors and 13 sarcomas 3.

Cleveland Clinic Recognizes Circulating Tumor Cell Technology As Top Medical Innovation For 2009
http://www.medicalnewstoday.com/articles/129501.php
Veridex, LLC announced today that the technology used in the CellSearch® System to measure circulating tumor cells (CTCs) was ranked as the top medical innovation for 2009 by the <a href="http://my.

The Forgotten Cancer - European Patient Group Formed
http://www.medicalnewstoday.com/articles/129487.php
European advocacy and support groups working with patients whohave some of the rarest cancers have agreed to form a collaborativeassociation.Sarcoma Patients EuroNet (SPAEN) will start work in January2009 with the aim of extending information services, patient support andadvocacy so that patients across the whole of Europe can benefit.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

GARDASIL(R) Demonstrated Efficacy In Preventing HPV-Related Disease In Males In Phase III Study
http://www.medicalnewstoday.com/articles/129489.php
GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to 26.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

No news for this category today.

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

New Findings Offer Fresh Hope To Men With Prostate Cancer That Has Returned After Attempted Cure
http://www.medicalnewstoday.com/articles/129549.php
The link between the PSA (prostate-specific antigen) blood test and the detection of prostate cancer is well-established. In new findings released publicly for the first time today, Australian and New Zealand researchers have demonstrated how two serial measures of PSA can be used to accurately predict a patient's prognosis when prostate cancer returns after attempted cure.

Treatment Of Patients After Failed High Intensity Focused Ultrasound And Radiotherapy For Localized Prostate Cancer
http://www.medicalnewstoday.com/articles/129532.php
UroToday.com - One of the international leaders in laparoscopic radical prostatectomy, Jens-Uwe Stozenburg from Leipzig, Germany and associates has reported on the use of salvage laparoscopic extra-peritoneal radical prostatectomy (EERPE) following failed high intensity focused ultrasound therapy (HIFU), external beam radiotherapy (ERBT) or brachytherapy.

-------------------------------------------------------------